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Abstract  
Since  the  completion  of  the  human  genome  project,  the  field  of  genomics  has  relied  on  the  
human  reference  genome  for  nearly  all  analyses.  Population  genetics,  disease  association  
studies,  and  beyond  all  begin  by  comparing  an  individual’s  sequenced  genome  to  the  human  
reference.  However,  the  human  reference  genome  is  not  only  still  incomplete,  but  also  not  an  
accurate  representation  of  humanity;  it  is  derived  primarily  from  a  single  individual,  and  cannot  
possibly  represent  the  scope  of  human  diversity.  By  using  this  genome  as  a  template,  we  bias  
our  studies.  In  this  thesis  we  examine  large  regions  of  structural  variation  between  individuals  
that  are  often  missed  by  comparing  solely  to  the  human  reference  genome.  We  use  multiple  
strategies  to  uncover  variation,  including  performing  localized  assembly  on  whole  genome  
sequencing  reads  not  matching  the  reference  genome  from  910  individuals  of  African  ancestry,  
and  utilizing  new,  long-read  sequencing  technologies  in  disease  patients.  We  demonstrate  that  
vast  amounts  of  sequence  present  in  human  populations,  nearly  300  megabases  in  the  case  of  
the  African  ancestry  dataset,  are  missing  from  the  reference  genome,  as  well  as  that  many  
non-reference  sequences  are  present  in  breast  cancer  and  Mendelian  disease  patients,  which  
could  have  yet-to-be-discovered  disease  relevance.  We  find  evidence  of  novel  non-reference  
sequences  which  are  genic  and  transcribed  in  many  individuals,  which  may  have  functional  
relevance.  Finally  we  present  strategies  for  integrating  the  wealth  of  short-read  sequencing  data  
currently  available  with  the  limited  but  growing  number  of  newer,  long-read  sequenced 
samples  to  gain  new  insights  previously  inaccessible  using  short-read  data  alone.  
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Chapter  1:  Introduction  to  human  whole  genome  sequencing  
  
Sections  of  Chapter  1  have  been  previously  published  as:   
Sherman,  R.  M.  &  Salzberg,  S.  L.  (2020).  Pan-genomics  in  the  human  genome  era.  Nature  
Reviews  Genetics ,  21,  243–254.  
  
1.1  The  human  reference  genome 
Much  of  the  field  of  genomics  revolves  around  the  existence  of  reference  genomes,  which  are  
roadmaps  for  a  ‘typical’  individual  of  each  species.  The  creation  of  each  reference  was,  and  still  
remains,  a  major  focus  of  the  genomics  community,  with  13  years  and  US$2.7  billion 1   spent  on  
the  creation  of  the  human  reference  genome  alone.  An  initial  draft  of  the  human  reference  
genome  was  first  published  in  2001 2,3 .  The  genome  consisted  of  sequence  from  approximately  
20  individuals,  who  answered  an  advertisement  for  volunteers  in  the  Buffalo  News ,  a  
newspaper  in  Buffalo,  New  York,  USA.  To  sequence  these  individuals,  DNA  was  extracted  from  a  
blood  sample,  and  was  sheared  into  ~150–200 kb  pieces,  which  were  inserted  into  bacterial  
artificial  chromosomes  (BACs)  to  be  sequenced.  This  approach  meant  that  each  ~150  kb  
segment  could  be  sequenced  and  assembled  separately,  reducing  errors  caused  by  ubiquitous  
repeats  that  occur  throughout  the  genome.  Furthermore,  a  physical  map  of  the  genome  was  
created  to  determine  the  relative  locations  of  the  BAC  clones  along  the  chromosomes.  Thus  the  
human  reference  genome  was  assembled  as  a  mosaic  of  these  sequenced  individuals,  where  
one  BAC-length  segment  might  come  from  one  individual,  and  the  next  segment  from  a  
different  individual,  and  so  on.  The  individuals  who  provided  the  DNA  were  anonymous.  
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The  original  version  of  the  human  reference  genome  contained  2.69 Gbp  and  nearly  150,000  
gaps  --  regions  where  the  sequence  was  not  able  to  be  resolved.  The  genome  has  undergone  
many  major  updates  since  2001  to  produce  the  current  version,  GRCh38.p13,  which  contains  
2.95 Gbp  of  sequence  and  only  349  gaps 4 .  These  updates  have  included  filling  in  gaps  where  no  
sequence  was  present,  replacing  rare  alleles  in  the  genome  with  the  more  common  variants,  
and  adding  alternative  sequences  representing  divergent  variants  of  some  portion  of  the  
reference  genome,  although  these  alternative  sequences  are  often  not  considered  by  analysis  
pipelines,  and  in  some  cases  can  confound  downstream  analyses.  However,  the  underlying  
genetic  background  of  the  current  human  reference  remains  the  same  as  in  the  initial  version  —  
a  mosaic  of  sequences  from  a  small  number  of  anonymous  individuals.  
  
In  2010,  a  paper  describing  the  Neanderthal  genome  additionally  performed  an  analysis  on  the  
human  reference  (version  GRCh37) 5 .  That  analysis  used  the  original  BAC  information  to  trace  
which  anonymous  donor  was  the  source  for  each  segment  of  the  genome,  and  then  used  
population-specific  single  nucleotide  polymorphisms  (SNPs)  to  determine  the  ancestry  of  each  
donor.  This  process  revealed  that  ~2/3  of  the  reference  genome  sequence  was  comprised  of  
DNA  from  one  male  donor  with  the  anonymous  identifier  RPCI-11,  and  that  RPCI-11  was  almost  
certainly  50%  African  and  50%  European.  The  analysis  examined  both  the  full  makeup  of  BAC  
clones  and  inferred  ancestral  makeup  of  GRCh37  (Figure  1.1),  as  described  in  their  
supplemental  material 5   (Green  et  al  supplement,  p  146).  Because  scientists  continue  to  use  the  
human  reference  genome  as  a  baseline  for  nearly  all  human  genetics  studies,  it  is  important  to  
acknowledge  that  it  does  not  represent  the  whole  population.  Rather,  it  is  a  mixture  of  
2  
ethnicities,  predominantly  sequence  from  a  European/African  admixed  individual.  Furthermore,  
as  a  mosaic  of  many  individuals,  it  may  not  represent  variant  combinations  that  exist  in  any  
individual.   
  
  
Today,  most  human  whole-genome  sequencing  analyses  begin  by  aligning  sequencing  reads  to  
the  human  reference  genome.  The  existence  of  a  reference  eliminates  the  need  for  de  novo  
assembly,  where  reads  must  be  overlapped  and  pieced  together  to  create  the  genome  
sequence  from  scratch.  Not  only  does  de  novo  assembly  require  high  coverage  data  and  high  
computational  expense,  but  due  to  short  read  lengths  and  long  repeats  in  the  human  genome,  
de  novo  assemblies  are  typically  broken  into  many  pieces  (contiguous  sequences  called  
‘contigs’)  where  the  contigs  cannot  be  merged  together  unambiguously  either  due  to  repetitive  
content,  or  gaps  in  sequencing  in  regions  which  are  difficult  to  sequence  or  assemble  such  as  
the  centromeres.  Alignment  based  strategies  eliminate  these  problems,  instead  relying  on  the  
extensive  work  that  has  gone  into  producing  a  highly  contiguous  reference  genome,  and  using  
3  
Figure  1.1  |  Ethnic  
makeup  of  GRCh37.   
Left:  The  estimated  
breakdown  of  the  
percentage  of  BAC  
clones  derived  from  
each  original  donor.  
Right:  The  inferred  
ancestry  makeup  of  
GRCh37.  All  numbers  
were  taken  from  
Green  et  al  2010,  
supplement.  
the  reference  as  a  template.  Reads  are  lined  up  to  the  reference  to  determine  their  positions,  
and  exact  matches  are  not  required,  so  SNPs  and  small  indels  can  be  discovered  via  alignment  
strategies  (Figure  1.2).  
  
  
Alignment-based  analysis  approaches  come  with  their  own  challenges,  however.  The  alignments  
of  the  short-reads  from  a  new  individual  are  biased  by  the  reference  genome;  alignments  with  
the  fewest  mismatches  will  be  preferred,  but  the  “best”  alignment  will  not  necessarily  always  
be  the  biologically  “correct”  alignment  (aka  where  the  read  actually  came  from  in  the  
sequenced  individual).  Additionally,  reads  might  align  equally  well  to  multiple  locations  when  
4  
  
Figure  1.2  |  Alignment  vs  de  novo  assembly  strategies.  Alignment  based  strategies,  also  called  re-sequencing,  
align  reads  to  a  reference  genome  to  find  variants.  De  novo  assembly,  on  the  other  hand,  creates  a  genome  by  
overlapping  reads.  Variants  can  then  be  found  by  comparing  de  novo  assemblies.  Figure  from  Raphael  BJ  
(2012)  Chapter  6:  Structural  Variation  and  Medical  Genomics.  PLoS  Comput  Biol  8(12):  e1002821.  
repeats  are  present,  creating  ambiguity  in  not  just  alignments,  but  in  subsequent  SNP  and  small  
indel  calls  (Figure  1.3).  
  
  
Regions  of  large  difference  between  the  sequenced  individual  and  the  reference,  termed  
structural  variation,  might  be  missed  entirely,  as  short-reads  with  no  match  in  the  reference  
genome  will  be  discarded  in  downstream  analyses.  Some  of  these  problems  are  short-read  
specific,  and  newer  third  generation  sequencing  technologies  may  help  overcome  some  of  
these  caveats,  however,  even  with  improved  alignments  strategies,  the  reference  genome  
5  
 
Figure  1.3  |  Short  read  alignment  ambiguity  complicates  even  small  variant  calling.  Examples  of  possible  short  read  
alignments  in  a  region  with  a  repeat  (red).  In  (A),  there  is  a  straightforward  SNP  to  call  in  the  green  region  of  the  reference.  
However,  there  is  also  a  SNP  appearing  in  reads  aligned  to  both  repeat  regions.  This  could  reasonably  be  called  as  a  
heterozygous  SNP  in  both  regions.  We  might  infer  that  this  SNP  likely  belongs  in  the  rightmost  repeat,  based  on  presence  of  a  
read  spanning  the  repeat  edge  from  blue  to  red,  but  not  yellow  to  red.  However,  we  still  cannot  rule  out  the  possibility  this  is  
heterozygous  in  both  repeats.  A  SNP  centered  in  this  repeat  region  would  have  no  chance  of  having  this  ambiguity  resolved  via  
repeat  edge  spanning  reads.  In  (B),  the  reads  from  the  repeat  happen  to  be  aligned  to  only  the  first  copy.  While  the  coverage  
increase  in  the  first  copy  may  be  detectable,  this  also  may  be  a  deletion  of  the  second  repeat  copy;  it  is  ambiguous.  
remains  a  biased  picture  of  a  human  genome;  no  single  genome  can  realistically  represent  the  
genomic  diversity  present  across  human  populations.  
  
1.2  Second  and  third  generation  sequencing  technologies  
Second  generation,  also  known  as  next  generation  sequencing  (NGS)  or  short-read  (SR)  
sequencing  technologies  for  whole  genome  sequencing,  predominantly  Illumina  sequencing,  
consists  of  shearing  the  human  genome  into  short  sequences  of  approximately  150-250  bases  in  
length.  The  length  of  sequencing  is  limited  by  the  methodology;  longer  DNA  fragments  can  be  
produced  but  a  longer  fragment  cannot  be  sequenced  accurately.  Illumina  uses  a  strategy  called  
‘sequencing  by  synthesis’  (Figure  1.4).  This  strategy  involves  adding  fluorescent  nucleotides  
onto  single-stranded  DNA,  one  at  a  time,  and  imaging;  the  color  determines  the  added  
nucleotide  and  thus  implies  it’s  complement  (Figure  1.4c).  Each  addition  is  considered  one  
cycle.  However,  to  get  a  strong  enough  fluorescence  signal  to  image,  multiple  copies  of  the  
sequence  must  undergo  this  process  simultaneously,  so  multiple  nucleotides  will  fluoresce  the  
same  color  at  the  same  time.  Thus  an  amplification  step  precedes  nucleotide  addition  (Figure  
1.4b).  However,  as  the  sequencing  continues,  errors  such  as  a  nucleotide  not  attaching  in  a  
cycle,  or  two  attaching  in  a  cycle,  etc  on  one  of  the  molecules  will  eventually  accumulate  and  
put  the  fluorescence  of  the  copies  out  of  sync.  Once  too  many  errors  accumulate  the  
fluorescence  color  (and  thus  nucleotide  of  the  original  strand)  cannot  be  accurately  determined,  
limiting  the  read  length.  To  combat  this,  ‘reads’  are  typically  sequenced  from  each  end  of  longer  
fragments,  creating  ‘paired  end’  reads  that  are  (approximately)  some  known  distance  apart  
based  on  the  fragment  size  --  for  example,  if  150  bp  are  sequenced  from  either  end  of  ~500bp   
6  
  
fragments,  the  ‘reads’  would  be  known  to  be  ~200bp  apart.  This  paired  end  strategy  aids  in  
both  read  mapping  and  assembly,  by  providing  additional  information  about  how  reads  relate  to  
7  
  
Figure  1.4  |  Illumina  sequencing  overview .  (A)  Library  preparation  shearing  and  adding  adapters  to  the  DNA,  (B)  
amplification,  to  create  clusters  of  the  same  molecule  on  a  ‘flow  cell’,   (C)  sequencing  via  addition  of  fluorescent  
nucleotides  and  imaging,  and  (D)  read  alignment  for  Illumina  short-read  sequencing.  Figure  taken  from  Illumina’s  An  
Introduction  to  Next-Generation  Sequencing  Technology   6 .  
one  another  spatially.  Larger  fragments  can  also  be  used,  where  the  ‘mate  pair’  reads  might  be  
~3000  or  ~5000  bases  apart  from  one  another,  to  provide  some  longer-range  information  6,7 .  
  
The  majority  of  available  whole  genome  sequencing  data  is  short  read  sequencing.  Illumina  
sequencing  is  very  high  throughput,  with  the  ability  to  sequencing  many  molecules  and  many  
samples  simultaneously  in  parallel,  and  sequencing  costs  have  rapidly  decreased.  The  amount  of  
sequencing  data  available  in  the  Sequence  Read  Archive  (SRA)  is  currently  over  46  petabases,  
and  still  growing  rapidly  (https://www.ncbi.nlm.nih.gov/sra/docs/sragrowth/).  However,  NGS  
data  is  notoriously  difficult  to  assemble.  Short  reads  do  not  span  long  repeats  which  are  highly  
present  in  human  genomes  (and  even  more  so  in  many  plants),  so  the  order  in  which  unique  
sequences  between  repeated  sequence  cannot  be  determined  (Figure  1.5).  Even  with  high  
coverage  data,  de  novo  assembly  results  in  highly  fragmented  genomes,  thus  the  reference  
genome  is  heavily  utilized  for  re-sequencing  experiments,  and  nearly  all  NGS  analyses  begin  
with  alignment  to  the  human  reference  genome,  a  strategy  which  poses  other  challenges  (refer  
back  to  Chapter  1.1).  
  
Recent  advances  in  sequencing  technologies  have  led  to  two  distinct  approaches  to  generating  
longer  read  lengths.  The  two  methods  are  commonly  referred  to  by  the  companies  which  
developed  the  technologies;  Pacific  Biosciences  (PacBio)  and  Oxford  Nanopore  Technologies  
(ONT).  Both  methods  are  able  to  produce  much  longer  sequences,  but  PacBio’s  read  lengths  are  
limited  by  the  methodology,  whereas  ONT  read  lengths  are  limited  only  by  the  DNA  




PacBio  sequencing,  like  Illumina,  is  still  imaging  based,  relying  on  addition  of  fluorescent  
nucleotides.  However,  unlike  Illumina  and  similar  to  ONT,  PacBio  sequencing  is  single-molecule  
sequencing,  so  no  amplification  step  is  required,  eliminating  the  need  for  the  synchronized  
cycles  of  Illumina  sequencing.  Furthermore,  a  polymerase  adds  nucleotides  in  real  time  as  they  
are  imaged;  sequencing  is  closer  to  an  observation  of  DNA  replication  than  with  Illumina  
sequencing.  However,  the  polymerase  used,  which  is  tethered  to  the  bottom  of  a  ‘well’  where  
the  sequencing  takes  place,  declines  in  efficiency  over  the  sequencing,  limiting  read  lengths  to  
30-40kb  in  length  (Figure  1.6a).  PacBio  sequencing  also  has  a  high  fidelity  method  (HiFi),  termed  
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Figure  1.5  |  Unresolved  short-read  assembly  near  repeats .  When  read  length  is  shorter  than  the  repeat  sequence,  ordering  
of  the  intervening  unique  sequences  cannot  be  resolved.  Figure  taken  from  Sipos  et  al .  2012  8 .  
Circular  Consensus  Sequencing  (CCS).  This  type  of  sequencing  works  the  same  way  as  PacBio,  
but  a  single  molecule  is  circularized,  so  it  can  undergo  multiple  sequencing  passes.  Adapters  on  
the  end  used  to  circularize  indicate  the  start/end  of  each  pass.  Read  length  is  further  limited  by  
this  method,  since  the  ~40  kb  length  limitation  would  translate  to  4  passes  over  a  10kb  
molecule.  However,  the  ability  to  take  the  consensus  of  multiple  passes  of  sequencing  
eliminates  errors,  bringing  the  error  rate  down  from  an  estimated  8-15%  for  their  single-pass  
continuous  long  read  (CLR)  sequencing  to  an  estimated  less  than  0.5%  for  their  CCS  reads 9,10 .  
  
ONT,  on  the  other  hand,  uses  a  non-imaging,  and  non-synthesis  based  method.  DNA  is  pulled  
through  a  ‘nanopore’  and  electrical  current  is  monitored  as  the  DNA  moves  through  the  pore.  
Different  combinations  of  bases,  read  5  or  6  at  a  time  (depending  on  the  technology  version)  
have  differing  currents,  so  by  examining  the  current  in  a  sliding  windowed  fashion,  by  running  
base-calling  software  on  a  profile  of  the  currents,  the  most  likely  sequence  to  have  produced  
those  currents  can  be  determined  (Figure  1.6b).  Basecalling  methods  have  evolved  and  
improved  as  have  the  sequencing  instruments  themselves  from  initial  use  of  HMMs  to  higher  
accuracy  methods  using  deep  learning  methods  to  call  bases  from  the  electric  signals 11 .   
  
Error  profiles  for  the  various  sequencing  technologies  differ.  While  Illumina  sequencing  shows  a  
decline  in  base  quality  at  the  ends  of  reads,  iis  prone  to  more  errors  (or  sequencing  failures)  in  
high  GC  regions,  and  is  more  likely  to  have  single-nucleotide  errors  when  an  error  is  present,  
PacBio  and  Nanopore  data  are  more  prone  to  indel  errors,  where  multiple  bases  in  a  row  are  
erroneously  inserted,  or  bases  are  erroneously  skipped  over.  ONT  sequencing  is  also  prone  to  
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incorrectly  reporting  the  length  of  homopolymers,  as  the  current  remains  constant  and  
determining  how  many  bases  passed  through  the  pore  during  that  time  can  be  challenging,  as  
the  DNA  does  not  move  through  the  pore  at  a  constant  rate 11,12 .   
  
  
Long  reads  provide  the  benefit  not  only  of  being  able  to  span  larger  repeats  in  the  genome,  
creating  better  resolved  assemblies,  including  recently,  the  first  complete  telomere-to-telomere  
assembly  of  a  human  chromosome,  but  also  enable  the  discovery  of  more  variation  via  read  
mapping  based  approaches.  With  short  reads,  if  an  individual  has  an  inserted  sequence  
approaching  the  size  of,  or  larger  than,  the  read  length,  the  read  will  not  align  to  the  reference  
genome.  However,  with  a  longer  read  length,  the  read  will  align  to  the  reference  genome  on  
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Figure  1.6  |  PacBio  and  Oxford  Nanopore  sequencing  approaches.  (a)  PacBio  sequencing  attaches  a  single  molecule  to  the  
bottom  of  a  “zero  mode  waveguide”  well,  where  a  polymerase  attaches  fluorescent  nucleotides.  This  is  imaged  from  above  as  
nucleotides  are  added;  many  wells,  each  with  one  read,  are  imaged  simultaneously.   (b)  Nanopore  sequencing  uses  a  motor  
protein  to  pull  a  DNA  strand  through  a  pore;  the  current  as  it  passes  through  the  pore  is  measured,  and  signal  can  then  be  
matched  to  k- mers,  a  process  referred  to  as  basecalling.  Figure  from  Goodwin  et  al ,  2016  12 .  
either  side  of  the  inserted  sequence,  allowing  pinpointing  of  the  insertion  within  the  reference  
genome.  While  long  reads  provided  these  benefits,  Illumina  sequencing  remains  the  dominant  
data  type  used  in  whole  genome  analyses.  Long  read  sequencing  costs  are  declining,  but  a  deep  
coverage  sequencing  run  is  still  more  expensive  with  long  reads,  especially  with  PacBio  
technologies.  Furthermore,  these  techniques  are  lower  throughput,  and  cannot  be  multiplexed  
(samples  are  pooled,  then  separated).  In  this  thesis,  strategies  for  finding  variation  using  both  
short  and  long  reads  are  examined.  Though  long  read  sequencing  is  expected  to  become  more  
dominant  as  costs  decrease  and  error  rates  decline  even  further,  we  also  discuss  strategies  for  
utilizing  long  reads  to  gain  additional  new  insights  from  the   wealth  of  short  read  data  that  has  
already  been  sequenced.  These  cross-technology  approaches  will  help  advance  discoveries  
while  new  data  is  slowly  being  generated,  and  maximize  the  utility  of  already  funded,  available,  
data  sets.  
  
1.3  Structural  variant  detection  strategies  
Structural  variation  is  typically  defined  as  variants  50  base  pairs  or  larger  which  differ  between  
individuals  of  a  species.  They  are  often  further  broken  down  into  the  following  types:  insertions,  
duplications,  deletions,  inversions,  and  translocations  (Figure  1.7).  As  discussed  in  Chapter  1.1  
and  1.2,  short  reads  often  struggle  to  detect  large  structural  variation,  particularly  insertion  
sequences  approaching  or  longer  than  the  read  length.  However,  a  number  of  strategies  can  be 
used  for  detecting  structural  variants  via  alignment  of  short  reads  to  a  reference  genome.  
Signatures  of  variation  can  be  detected  using  coverage,  paired  end  read  alignments,  or  split  
read  alignments.  A  drop  in  coverage  is  an  indication  of  a  deletion,  whereas  duplications  would  
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be  indicated  by  a  pile-up  of  reads,  since  the  reads  from  each  copy  of  the  duplication  will  align  to  
the  same  location  in  the  reference  (Figure  1.7a).  If  paired  end  reads  align  farther  apart  or  closer  
together  than  expected,  this  indicates  a  deletion  or  an  insertion,  respectively.  Inversions  can  be 
inferred  where  paired  end  reads  align  in  unexpected  orientation.  Translocations  will  be  
indicated  by  reads  aligning  to  far  apart  locations  in  the  reference,  and  duplications  might  be  
indicated  by  unexpected  orientation  and/or  by  reads  aligning  too  close  together,  since  a  
duplication  is  a  form  of  insertion  (Figure  1.7b).   
  
  
Split  read  alignments,  where  a  read  aligns  in  two  distinct  pieces  rather  than  contiguously,  or  
alignments  with  soft  clipping  (the  end  of  a  read  does  not  align  at  all  and  is  ‘clipped’  off  in  the  
alignment)  can  also  present  signatures  of  variation,  though  these  alignments  are  not  especially  
common  for  short  reads,  as  a  split  alignment  of  a  short  read  is  generally  not  considered  good  
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Figure  1.7  |  Signatures  of  short  read  alignments  inferring  structural  variation.  (a)  A  drop  in  read  depth/coverage  can  be  used  
to  detect  a  deletion,  while  a  doubling  of  coverage  would  indicate  a  two-copy  duplication.  (b)  Paired  end  alignments  can  be  used  
to  infer  other  SV  types,  based  on  the  alignment  distance  and  orientation  of  the  paired-end  reads  relative  to  the  expectation  
based  on  the  fragment  size  used  when  sequencing.  Figure  from  Escaramís  et  al ,  2015  13 .  
  
enough  to  report  by  alignment  methods.  Spots  where  the  ends  of  read  alignments  are  all  soft  
clipped  might  indicate  an  insertion;  the  clipped  bases  being  part  of  the  novel  non-reference  
sequence.  Split  alignments  between  different  parts  of  the  genome  would  be  an  indication  of  a  
translocation,  and  split  alignments  across  a  small  region  would  indicate  a  deletion.  However,  
these  signature  based  approaches  all  infer  the  presence  of  a  variant;  they  cannot  align  a  single  
read  through  it,  and  thus  the  inferred  variants  may  be  due  to  misalignments  rather  than  truly  
present.  Short  read  variant  callers  such  as  Lumpy 14 ,  Delly 15 ,  and  Manta 16   focus  on  analyzing  
these  signatures  to  call  larger  variants  whereas  many  callers  such  as  Strelka2 17   or  Freebayes 18   
only  detect  small  variants  (under  50bp).  However,  these  methods  are  well  known  to  have  a  high  
false  positive  rate 19–21   and  typically  cannot  report  any  novel  sequence  at  a  variant  site  even  if  a  
variant  is  detected,  as  reads  consisting  of  novel  sequence  won’t  align  to  the  reference  genome.  
As  these  approaches  are  known  to  be  error  prone,  commonly  pipelines  take  the  consensus  of  
multiple  short  read  structural  variant  callers  and  report  the  highest  confidence  variants  as  those  
called  by  multiple  tools  and  signature  types 22–24 ,  but  even  these  consensus  strategies  yield  
erroneous  calls  when  read  alignments  systematically  produce  signatures  that  don’t  reflect  the  
true  variant,  and  may  miss  variants  called  correctly  by  only  a  single  caller.  
  
Long  read  sequencing  has  dramatically  improved  structural  variant  detection.  Studies  
performing  structural  variant  detection  from  the  alignment  of  long  reads  to  the  reference  
genome  have  reported  on  the  order  of  20,000-30,000  structural  variants  per  healthy  individual  
relative  to  the  reference,  far  more  than  previously  expected 21,25–27 .  Although  variant  detection  is  
affected  by  the  alignment  algorithms  used,  algorithms  which  are  necessarily  different  for  short  
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and  long  reads,  long  read  aligners  are  able  to  align  through  a  variant,  provided  there  is  sufficient  
sequence  matching  on  either  side  of  the  variant  in  the  read.  This  allows  not  only  the  discovery  
of  new  variants  with  weak  signatures  from  short  reads  and  base  pair  level  resolution  of  novel  
inserted  sequence,  but  has  also  illuminated  systematic  errors  in  short  read  variant  calling,  such  
as  insertions  around  repetitive  regions  being  called  erroneously  as  translocations  due  to  
mis-alignments  of  reads  in  repetitive  sequence  (Figure  1.8).  These  systematic  errors  are  
particularly  problematic  in  short  read  variant  calling.  Since  the  read  alignments  show  clear  
signatures  which  are  likely  to  be  called  by  multiple  variant  callers,  consensus  methods  will  not  




Figure  1.8  |  Alignments  
of  short  reads  and  long  
reads  around  
disagreeing  variant  
calls.  Short  read  
alignments  lead  to  a  
translocation  call,  as  
reads  are  soft  clipped,  
and  pairs  align  to  
another  chromosome.  
However,  both  PacBio  
and  ONT  long  reads  
indicate  an  insertion  
(indicated  by  the  purple  
bands  in  the  alignment).  
It  is  likely  the  inserted  
sequence  is  similar  
sequence  on  another  
chromosome,  causing  
mis-alignments  of  the  
short  reads  and  thus  a  
false  translocation  
signature.  Figure  from  
Sedlazeck  et  al  2018 26 .  
However,  as  long  read  sequencing  data  is  still  limited,  examining  structural  variation  on  a  
population  level,  as  short-read  studies  have  done,  is  only  beginning  to  become  a  possibility.  
While  Iceland  has  produced  a  variant  call  set  on  1,817  individuals,  the  long  read  data  is  not  
publicly  available 28 .  Additionally,  as  Iceland  is  a  fairly  homogenous  population,  this  study  is  
unlikely  to  reveal  the  scope  of  human  structural  variation.  Other  studies  surveying  a  range  of  
populations  with  long  reads  are  considerably  smaller;  to  date,  there  are  perhaps  dozens  of  
publicly  available  long  read  sequenced  human  samples 27,29 .  If  we  are  to  capture  the  scope  of  
human  variation,  waiting  for  long  read  data  to  be  generated  that  approaches  the  scale  of  
available  short  read  data  will  take  at  best  years,  and  at  worst  may  take  a  decade  or  more,  
particularly  as  long  read  technologies  are  lower  throughput.  As  we  continue  to  produce  long  
read  data,  utilizing  information  from  a  handful  of  individuals  may  help  enable  population  
screening  on  short-read  datasets.  For  example,  in  Figure  1.8,  if  an  algorithm  is  aware,  a  priori ,  
that  some  individuals  are  known  to  have  an  insertion  at  that  location,  then  given  only  short  
reads,  it  would  be  reasonable  to  produce  an  insertion  call,  rather  than  a  translocation  call,  since  
the  signature  seen  in  short  reads  could  also  be  consistent  with  an  insertion,  and  we  have  a  prior  
that  an  insertion  is  likely.  These  hybrid  approaches  may  provide  new  insights,  without  the  need  
for  massive  long  read  data  sets;  novel  methods  to  perform  these  analyses,  and  applications  in  
cancer  data  sets,  are  covered  in  Chapter  4.  
  
1.4  Pan-genomic  scale  sequencing  and  approaches  for  human  populations  
The  ability  to  compare  a  newly  sequenced  individual  to  a  reference  and  find  differences  has  
enabled  myriad  discoveries  and  innovations,  and  in  human  genomics  this  ability  forms  the  basis  
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of  thousands  of  studies  seeking  the  genetic  origins  of  disease.  However,  as  discussed  in  Chapter  
1.3,  capturing  variation  based  on  alignment  to  a  single  reference  genome  has  many  limitations,  
especially  when  using  short  read  sequencing  data.  One  tactic  to  better  capture  the  variation  
missed  by  using  a  single  reference,  is  to  create  and  utilize  a  ‘pan-genome’,  a  collection  of  all  the  
DNA  sequences  that  occur  in  a  species.  Ideally,  this  pan-genome  structure,  containing  all  known  
variation,  could  then  be  aligned  to,  improving  read  alignment  due  to  missing  variation  in  the  
reference  genome.  
  
Cataloguing  the  DNA  from  all  individuals  in  a  species  is  a  daunting  task.  The  first  pan-genomes  
were  developed  for  small,  easy-to-sequence  bacteria,  but  even  in  that  context,  pan-genomes  
provided  novel  scientific  insights.  The  consideration  of  genetic  diversity  within  bacterial  species  
has  contributed  to  our  understanding  of  underlying  differences  in  pathogenicity,  virulence  and  
drug  resistance,  and  can  even  help  predict  how  pathogenic  a  new  strain  will  be 30–39 .  
Pan-genome  studies  of  plants  and  animals  remained  elusive  at  first,  due  to  the  large  genome  
sizes  and  vast  amounts  of  intergenic  sequence  in  these  species.  However,  in  recent  years,  
thanks  to  dramatic  improvements  in  the  efficiency  of  sequencing  technology,  the  scientific  
community  has  been  able  to  sequence  dozens,  hundreds,  or  even  thousands  of  individuals  of  a  
single  plant  or  animal  species 40 .  Additionally,  new  long-read  sequencing  technologies  now  allow  
us  to  better  assemble  repetitive  regions  of  large  genomes,  including  centromeric  regions,  that  
are  difficult  to  characterize  with  short  reads 41,42 ,  as  described  in  Chapter  1.1  and  1.2.   
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Human  sequencing  too  has  accelerated.  Over  the  past  few  years,  a  flurry  of  publications  have  
described  large  collections  of  newly  sequenced  human  genomes,  including  population-specific  
cohorts  from  Iceland 28,43,44 ,  Denmark 45 ,  Sweden 46 ,  Papua  New  Guinea 47 ,  Mongolia 48 ,  and  
Africa 49–51 ,  and  large-scale  surveys  of  the  entire  world 19,52–54 .  As  these  genome  collections  have  
accumulated,  computational  scientists  have  been  working  to  develop  new  methods  to  detect,  
represent,  and  analyze  large-scale  structural  variants,  which  had  previously  been  sidelined  while  
most  genetic  studies  focused  on  single-nucleotide  polymorphisms  (SNPs).  New  representations  
must  be  able  not  only  to  capture  the  variation  from  large  collections  of  genomes,  but  also  to  
enable  efficient  means  of  searching  these  genomes.  Regardless  of  what  methods  are  chosen,  it  
is  now  clear  that  the  community  must  move  beyond  reliance  on  a  single  reference  genome.  
While  the  use  of  a  single  reference  has  advanced  genetics  immensely,  it  has  not,  as  some  had  
hoped,  allowed  us  to  find  the  cause  of  all  genetic  disease,  a  shortcoming  that  prompted  some  
commentators  to  call  the  Human  Genome  Project  a  failure 55,56 .  Although  we  now  know  that  
many  diseases  are  caused  by  complex  mixtures  of  multiple  genetic  variants,  if  we  are  to  attempt  
to  uncover  the  genetic  causes  of  many  still-unexplained  diseases,  one  of  the  many  factors  we  
must  consider  is  the  vast  genetic  diversity  present  in  the  pan-genome.  
  
The  concept  of  a  pan-genome  was  first  described  by  Tettelin  et  al 32   in  2005,  in  the  context  of  
bacteria.  They  described  a  pan-genome  as  a  “ core  genome  containing  genes  present  in  all  
strains,  and  a  dispensable  genome  composed  of  genes  absent  from  one  or  more  strains  and  
genes  that  are  unique  to  each  strain ”;  under  this  definition,  the  pan-genome  captures  the  
whole  of  the  genic  content  of  a  species.  The  dispensable  genome  is  often  further  sub-divided  
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into  genes  unique  to  one  strain  (termed  ‘unique  genes’)  and  genes  shared  between  some  but  
not  all  strains  (termed  ‘accessory  genes’)  (Figure  1.9  a).   Restricting  the  pan-genome  to  gene  
content  makes  less  sense  in  eukaryotes,  particularly  those  with  large  genomes  (>500 Mb)  where  
more  than  50%  of  the  genome  may  be  intergenic,  and  where  the  gene  sequences  themselves  
are  dominated  by  long  introns 57 .  In  addition,  eukaryotes  do  not  exchange  DNA  as  freely  as  
bacteria,  making  their  gene  content  much  more  stable.  For  a  species  such  as  humans,  where  
exons  occupy  only  ~2%  of  the  genome 58 ,  a  pan-genome  comprised  of  only  exonic  sequences  
would  yield  little  information  about  within-species  differences.  Thus  a  eukaryotic  pan-genome  is  
commonly  defined  to  include  all  of  the  DNA  sequence  in  a  collection  of  genomes,  not  just  the  
genes.  Although  eukaryotic  pan-genome  studies  sometimes  borrow  the  terms  core  and  
dispensable  genomes,  in  eukaryotes  these  descriptors  refer  additionally  to  intergenic 
sequences,  rather  than  sets  of  genes,  with  unique  sequences  referred  to  as  ‘singletons’  (Figure  
1.9  b).  
  
In  the  past  several  years,  large-scale  human  sequencing  projects  have  become  increasingly  
common.  No  project  to  date  has  produced  a  comprehensive,  analyzable,  human  pan-genome  
that  surveys  a  wide  variety  of  human  populations,  captures  both  genic  and  intergenic  variation,  
and  incorporates  this  variation  into  a  single  utilizable  pan-genome.  Efforts  are  underway,  
however,  to  create  population-specific  pan-genomes,  as  well  as  to  discover  as  many  human  
SNPs  and  structural  variants  as  possible,  and  a  recent  National  Human  Genome  Research  
Institute-funded  initiative  has  been  launched  to  build  a  human  pan-genome  reference  from  350  
diverse  individuals 59 .  With  continued  development  of  computational  methods  capable  of  
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handling  larger  and  larger  datasets,  these  variant  catalogues  may  ultimately  provide  the  data  
needed  to  perform  pan-genomic  analyses  in  humans.  
  
  
  Scientists  have  been  cataloguing  human  variants  since  well  before  the  completion  of  the  
Human  Genome  Project.  However,  with  the  completion  of  a  full  reference  genome  came  the  
ability  to  catalogue  variation  genome-wide,  leading  to  the  creation  of  large  databases  including  
dbSNP 60   and  ClinVar 61 ,  as  well  as  continued  updates  to  pre-existing  databases  such  as  Online  
Mendelian  Inheritance  in  Man  (OMIM) 62 .  ClinVar  and  OMIM  track  variants  of  clinical  interest  or  
with  known  phenotypic  associations,  although  nearly  all  of  the  variants  tracked  to  date  are  SNPs  
and  small  insertions  or  deletions  (indels)  relative  to  the  reference  genome.  While  these  variants  
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Figure  1.9  |  Core  and  dispensable  genomes .  a)  Bacterial  and  other  prokaryotic  genomes  consist  predominantly  of  genes  with  
little  intergenic  sequence.  The  core  genome  of  a  species  consists  of  genes  shared  by  all  strains.  The  dispensable  genome  is  
made  up  of  genes  shared  by  some  but  not  all  strains  (accessory  genes)  and  genes  present  in  only  one  strain  (unique  genes).  
Together  the  core  and  dispensable  genomes  make  up  the  pan-genome.  b)  Eukaryotic  genomes  are  not  highly  variable  in  their  
genic  content.  Pan-genomes  consider  intergenic  sequence  as  well  as  genes,  resulting  in  an  ordered  pan-genome  of  all  sequence  
present  in  at  least  one  individual.  
can  be  incorporated  into  genome  analyses  using  SNP-aware  aligners  such  as  HISAT2 63 ,  
mrsFAST-Ultra 64   or  SNPwise 65 ,  we  now  know  that  any  given  individual  is  likely  to  contain  on  the  
order  of  20,000  structural  variants  (>50 bp)  relative  to  the  reference  genome 9,21,25,26 .  More  
recent  databases  such  as  dbVar,  DGVa 66 ,  and  DGV 67   aim  to  catalogue  these  larger  variants,  
although  they  cannot  yet  be  easily  incorporated  into  most  standard  alignment  and  subsequent  
analysis  pipelines.  Several  projects  have  attempted  to  survey  the  landscape  of  human  structural  
variation  across  the  globe,  including  the  1000  Genomes  Project  (1KGP) 19 ,  Trans-Omics  Precision  
Medicine  (TOPMed) 68 ,  and  the  Simons  Genome  Diversity  Project 52 .   
  
The  1KGP  was  the  first  attempt  at  a  large-scale  global  project  for  human  genome  sequencing.  
The  1KGP  was  performed  in  three  phases,  initially  collecting  SNP  array  data  and  later  generating  
low-coverage  (mean  7.4×)  whole-genome  sequence  (WGS)  data  for  2,504  samples  from  26  
populations.  (In  2019,  an  updated  re-sequencing  of  these  2,504  genomes  was  released  to  
improve  data  quality  and  consistency.  However,  to  date  no  studies  have  been  published  
analyzing  this  new  data  release.)  An  analysis  of  structural  variants  in  the  WGS  data  reported  
over  40,000  deletions,  6,000  duplications,  nearly  3,000  copy  number  variants,  and  nearly  
17,000  mobile  element  insertions  by  comparison  with  the  human  reference  genome 69 .  60%  of  
the  variants  detected  were  novel  relative  to  the  pre-existing  Database  of  Genomic  Variants,  a  
database  consisting  of  variants  reported  from  55  studies  at  the  time  of  its  publication  in  2013 67 .  
In  addition  to  reporting  novel  variation,  one  major  finding  of  the  1KGP  was  a  detection  of  
homozygous  deletions  of  large  portions  of  240  human  genes 19 .  The  discovery  that  these  genes  
are  missing  or  severely  altered  in  many  individuals  studied  indicates  that  these  genes  are  part  of  
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the  dispensable  genic  pan-genome,  a  concept  infrequently  considered  in  human  genomics.  This  
dispensable  gene  set  was  enriched  for  two  classes  of  proteins,  glycoproteins  and  
immunoglobulins,  and  nearly  all  of  the  deletions  were  found  in  multiple  populations.  Other  
deleted  regions  in  their  set  of  over  40,000  deletions  are  likely  to  represent  dispensable  
non-genic  regions.  Although  these  findings  from  the  1KGP  are  an  important  step  in  
understanding  the  dispensable  and  core  human  pan-genome,  deletion  discovery  is  only  one  
step.  The  reference  genome  is  missing  dispensable  sequences  as  well,  which  would  appear  as  
insertions  in  the  1KGP  samples,  but  low-coverage  WGS  data  is  ill-suited  to  discovering  novel  
insertions  and  this  was  not  attempted.  
  
Other  global  projects  have  examined  novel  sequence  content.  The  Simons  Genome  Diversity  
Project  generated  deep  coverage  (30–40×)  in  short-read  sequencing  of  300  individuals  from  142  
diverse  populations 52 .  The  project  assembled  sequences  that  failed  to  align  to  the  reference  
genome  and  discovered  5.8 Mb  of  novel,  non-repeat  sequences  in  the  collection.  They  also  
catalogued  34.4  million  SNPs,  2.1  million  small  indels,  and  1.6  million  short  tandem  repeats.  
Many  of  these  variants  —  up  to  11%  of  heterozygous  SNP  variants  in  one  population  —  were  
missing  from  the  1KGP  variant  calls,  despite  the  1KGP  dataset  containing  more  individuals,  
highlighting  the  need  to  continue  collecting  additional  samples  from  diverse  populations.  A  
more  recent  project,  TOPMed,  has  examined  short-read  WGS  data  from  53,831  individuals,  and  
using  a  similar  method  of  assembling  unaligned  reads  discovered  2.2 Mb  of  novel  sequence 68 .  
Although  the  TOPMed  data  contained  many  more  genomes  than  the  Simons  Genome  Diversity  
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Project,  the  investigators  discarded  any  sequence  without  a  good  match  to  one  of  five  hominid  
genomes,  perhaps  explaining  why  they  reported  a  smaller  amount  of  novel  sequence.  
  
All  of  these  global  projects  have  limitations.  Each  of  them  utilized  short-read  sequencing  data  
(usually  100-bp  reads)  that  they  aligned  to  the  human  reference  genome,  so  although  some  
variation  can  be  uncovered,  the  data  necessary  to  build  a  pan-genome  —  that  is,  the  union  of  all  
sequences  in  all  humans  —  remains  elusive,  in  part  because  reference-based  genome  assembly  
methods  will  entirely  miss  large  insertions  in  other  genomes.  Furthermore,  none  of  these  large  
projects  has  had  a  primary  goal  of  creating  a  human  pan-genome,  and  in  each  case  the  analysis  
of  novel  sequences  was  secondary  to  their  main  findings.  Each  study  has  contributed  snippets  
of  what  is  needed,  such  as  dispensable  sequences  deleted  or  inserted  in  many  individuals,  as  
well  as  other  detectable  variation,  small  and  large,  but  this  variation  has  not  been  aggregated  in  
any  way  into  a  pan-genome.  Although  we  now  have  a  comprehensive  gene  set  of  core  and  
dispensable  genes  for  many  bacteria  and  some  plants,  even  this  limited,  genic  pan-genome  
view  does  not  yet  exist  for  human  populations,  in  part  because  we  still  lack  a  standardized  
comprehensive  human  gene  set 70,71 .  The  pan-genome  with  intergenic  variation  included  thus  
remains  even  more  elusive.   
  
In  addition  to  the  global  projects  that  have  touched  on  discovering  novel  sequence  insertions,  
several  recent  efforts  have  focused  solely  on  discovering  these  novel  non-reference  sequences  
within  and  across  populations,  utilizing  both  short-  and  long-read  technologies.  Many  of  these  
efforts  state  the  explicit  goal  of  building  a  pan-genome,  although  to  date  no  project  has  
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characterized  the  insertion  and  deletion  landscape  completely  enough  to  generate  a  full  
pan-genome,  even  for  a  single  homogeneous  population.  Many  of  the  efforts  to  do  so  are  
ongoing,  but  they  remain  complicated  by  the  difficulty  of  determining  which  repeat  sequences  
are  truly  novel,  and  without  telomere-to-telomere  assemblies  of  all  human  chromosomes,  it  is  
difficult  to  tell  where  repeat  copies  fall  within  each  individual  genome.  Thus,  definitions  of  novel  
sequence  vary  widely  between  projects,  and  as  a  result  so  does  the  amount  of  novel  sequence  
discovered.  Estimates  of  novel  sequence  in  human  populations  vary  from  0.33 Mb  in  15,219  
Icelandic  individuals,  to  our  estimate  of  296.5 Mb  in  910  African-ancestry  individuals  (see  
Chapter  2).  Recent  estimates  are  presented  in  Table  1.1.  
  
It  remains  unclear  how  much  of  this  non-reference  sequence  is  shared  across  individuals,  and  
thus  it  is  unknown  how  many  individuals  must  be  sequenced  before  the  human  pan-genome 
can  be  considered  complete.  We  expect,  though,  that  far  fewer  individuals  are  needed  if  only  
non-repetitive  sequence  is  being  considered,  since  nearly  25  times  as  much  sequence  has  been  
found  on  average  in  studies  considering  repeats  as  opposed  to  studies  which  do  not  (Table  1.1).  
While  non-repetitive  sequences  may  be  simpler  to  analyze,  repeat  elements  can  have  
substantial  biological  effects  on  gene  expression 72   and  disease-related  phenotypes 73,74   and  these  




T able  1.1  |  Reported  novel  sequences  from  efforts  to  examine  structural  variation  in  large  cohorts  of  human  individuals.  
Population  and  
consortium  (if  
applicable)  
Number  of  
individuals  Data  type  
Total  novel  
sequence  
reported 
Average  per  
individual  
Additional  
requirements   
Publication  
Year  Refs  
Swedish,  SweGen  
1,000   
[Subset  of  2]  
Short  read 
[Long  
read]  
46 Mb   
[17.3 Mb]  
  
0.6 Mb  
[12.1 Mb]  
  
Over  300 bp  
[Over  100 bp]  
2019  
[2018]  
46   
[ 75 ]  
Han  Chinese  275  Short  read  29.5 Mb  
~5 Mb  fully  
unaligned  +  




~6 Mb  partially  
unaligned  to  
reference  
Mixed,  TOPMed  53,831  Short  read  2.2 Mb  0.2–0.5 Mb  
Must  align  to  a  
hominid  genome  
2019  68   




reads  (10X  
Genomics)  
60 Mb  14.2 Mb  >2 kb  2019  77   
Mixed  15  Long  read  21.3 Mb  6.4 Mb  
Not  in  
peri-centromeric  
regions,  over  
50 bp  
2019  27   
African-ancestry,  
Consortium  on  
Allergy  in 
African-ancestry  
Populations  
910  Short  read  296.5 Mb  2.5 Mb  >1 kb  2019  78   
Mixed  17  
Linked  
reads  (10X  
Genomics)  
2.1 Mb  0.71 Mb  
Breakpoint  
resolved,  over  
50 bp  of  
non-repetitive  
content  per  
sequence  
2018  79   




2017  43   
Danish,  Danish  
Genome  Project  
150  Short  read  
>15,000  
insertions* , 
‡   
Not  reported  >50 bp  2017  45   
Dutch,  Genome  
of  the  
Netherlands  
769  Short  read  4.3 Mb  Not  reported  >150 bp  2016  72   
Mixed  10,545  Short  read  3.26 Mb  0.7 Mb  
Non-repetitive,  
>200 bp  
2016  53   
Mixed,  data  from  
1KGP  
45  Short  read  61.6  Mb  
17,700–20,500  
insertions *,§   
No  size  or  other  
restrictions  
reported 
2016  80   
Mixed,  The  
Simon’s  Genome  
Diversity  Project  
300  Short  read  
5.8 Mb   




Not  reported  
Non-repetitive,  
>500 bp  
2016  52   




1,070  Short  read  
9,354  
insertions *   
45  insertions *   >1 kb  2015  81   
Summary  of  reported  novel  sequences  from  global  and  population  efforts  to  sequence  and  analyze  structural  variation  in  
large  cohorts  of  human  individuals.  *Did  not  report  number  of  bases.  ‡  Estimated  based  on  Figure  2b  from  Maretty  et  al  
2017  45 .  §  Estimates  separated  into  average  number  of  contiguous  sequences  per  population  with  at  least  a  partial  match.  
The  61.6 Mb  reported  was  in  30,879  insertions.  
However,  cataloging  variation  is  just  the  first  step  in  creating  a  human  pan-genome.  Although 
databases  of  SNPs  and  structural  variants  (e.g.,  dbSNP  and  dbVar)  provide  a  valuable  resource  
for  genetic  analysis,  a  comprehensive  pan-genome,  in  whatever  form  it  is  stored,  is  likely  to  
present  considerable  new  challenges  for  scientists  who  wish  to  use  it.  The  amount  of  sequence  
data  alone  is  likely  to  be  extremely  large,  especially  if  the  pan-genome  includes  all  variants  of  
repeat  sequences.  In  addition,  the  number  and  variety  of  rearrangements  is  both  large  and  
difficult  to  capture  in  a  form  that  is  easy  to  use  with  current  bioinformatics  tools.  To  date,  no  
computational  approach  is  practically  scalable  enough  to  represent  and  analyze  a  full  human  
pan-genome  created  from  thousands  or  millions  of  individuals.  
  
Currently  the  most  commonly  used  approach  to  include  divergent  human  sequences  in  a  
genetic  analysis  is  to  simply  include  these  extra  sequences  when  performing  read  alignment  to  
the  reference  genome.  The  reference  genome  already  contains  several  hundred  of  these  
alternative  or  ‘alt’  sequences,  although  they  do  not  represent  any  systematic  attempt  to  
capture  human  variation.  This  strategy  poses  a  number  of  problems.  First,  although  the  
Genome  Reference  Consortium  provides  locations  for  the  alt  sequences  and  alignments  to  the  
main  chromosomes  of  the  reference  genome 82,83 ,  most  sequence  alignment  programs  were  not  
designed  to  handle  variant  information  provided  in  this  manner.  As  a  result,  most  aligners  
simply  treat  the  alt  sequences  as  additional  sequence  tacked  onto  the  genome,  and  as  a  result  
the  variants  are  treated  as  repeats.  Some  aligners  such  as  bwa 84   have  created  ‘alt-aware’  modes  
to  account  for  this,  but  even  with  these  fixes,  this  approach  is  not  sustainable.  As  we  continue  
to  add  divergent  sequences,  storing  and  searching  the  reference  genome  becomes  increasingly  
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space-  and  time-intensive.  Furthermore,  including  these  additional  sequences  separately  does  
not  accurately  represent  the  underlying  biology.  Although  in  some  cases  we  know  where  these  
sequences  belong  in  the  genome,  what  sequences  they  are  alternatives  to,  or  what  populations  
they  are  prevalent  in,  that  information  is  lost  by  simply  including  them  as  additional  sequences  
and  continuing  to  use  current  algorithms  for  alignment.  
  
There  are  a  number  of  approaches  for  capturing  pan-genomic  data  which  allows  efficient  
storage  and  alignment.  These  approaches,  primarily  based  on  graph  based  representations  of  
the  genome  and  its  variants,  pose  other  challenges,  however.  These  are  well  described  
elsewhere;  please  refer  to  recent  reviews  by  Sherman  &  Salzberg 85 ,  The  Computational  
Pan-Genomics  Consortium 86   and  Paten  et  al 87 .  for  additional  details.  Graphical  representations  
tend  to  provide  compact  representations  for  a  pan-genome,  but  the  goal  is  not  only  to  store,  
but  also  to  analyze  pan-genomic  data.  Given  that  short-read  sequencing  (with  read  lengths  in  
the  range  100–250 bp)  is  the  current  standard,  this  means  that  researchers  must  be  able  to  
align  short-read  data  to  the  pan-genome  representation.  Short  reads  are  difficult  to  align  
accurately  in  repetitive  regions,  even  when  aligning  to  a  linear  reference.  Reads  may  be  
misaligned  if,  for  example,  a  SNP  or  a  sequencing  error  causes  them  to  be  identical  to  a  different  
copy  of  a  repeat  elsewhere  in  the  genome.  By  adding  in  large  numbers  of  variants,  we  increase  
the  number  of  places  a  repetitive  read  might  align,  and  increase  the  chances  that  a  read  might  
be  aligned  to  an  incorrect  location  (Figure  1.10).  The  study  describing  the  FORGe  variant  
prioritization  tool  demonstrated  that  when  8–12%  of  known  SNPs  are  included,  graph  aligners  
such  as  HISAT2  have  the  fewest  number  of  incorrectly  mapped  reads.  However,  when  the  
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number  of  variants  included  is  increased  beyond  that,  accuracy  declines 88 .  Although  only  SNPs  
and  small  indels  were  examined  in  that  analysis,  the  logic  extends  to  structural  variants  as  well,  
particularly  when  variants  belong  to  a  high-copy-number  repeat  class,  such  as  the  HSAT  II  and  III  
centromeric  repeats.  Another  study  demonstrated  that  whereas  graph-based  mapping  with  vg 89   
and  SevenBridges 90   yields  higher  accuracy  than  linear  alignment  on  reads  that  contain  known  
variants,  linear  genome  alignment  is  superior  when  the  reads  do  not  contain  variants 91 .   
  
  
Despite  these  challenges,  a  clear  advantage  of  human  pan-genome  analyses  is  that  scientists  
can  discover  variants  that  are  missing  from  the  reference  genome  and  then  link  those  variants  
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Figure  1.10  |  Inclusion  of  variants  complicates  read  alignment.  A  graph-based  representation  includes  alternate  variants  (blue,  
green)  at  position  P1,  whereas  the  reference  contains  only  the  pink  reference  allele.  These  variants  are  within  a  repeat  (dark  
blue).  The  addition  of  each  alternate  variant  increases  alignment  ambiguity.  The  six  reads  with  the  blue  variant  allele  align  
perfectly  only  to  P3  in  the  original  reference,  and  now  align  to  P1  and  P3  equally  well.  Likewise,  the  six  reads  with  the  green  
variant  allele  now  align  to  P1  or  P2  perfectly,  not  just  P2.  Ambiguous  reads  are  highlighted  with  yellow  outlines.  
to  phenotypes,  which  might  include  both  beneficial  and  harmful  traits.  For  example,  any  
sequence  longer  than  a  few  hundred  nucleotides  that  is  missing  from  GRCh38  is  essentially  
invisible  to  most  downstream  analysis  tools,  regardless  of  how  many  individuals  are  sequenced,  
because  any  reads  containing  that  sequence  will  simply  fail  to  align.  If  such  a  sequence  contains  
a  disease-causing  or  disease-preventing  variant,  that  variant  will  be  undiscoverable  unless  this  
sequence  is  included  in  the  analysis  (Figure  1.11).  An  illustration  of  this  arose  in  the  Icelandic  
human  sequencing  project,  where  their  examination  of  15,219  Icelandic  individuals  found  a  
766 bp  insertion  at  high  allele  frequency  (65%),  the  presence  of  which  was  found  to  significantly  




Figure  1.11  |  Augmenting  the  reference  genome  can  lead  to  novel  variant  discoveries.  When  the  reference  genome  sequence  
is  augmented  with  a  known  insertion,  reads  will  align  to  this  region  for  individuals  containing  this  insertion.  The  1,250-bp  
insertion  included  on  chromosome  17  (chr  17)  is  within  the  gene  KDM6B  and  has  been  reported  in  numerous  studies 27,43,68,85   
including  at  a  frequency  of  1  in  the  Trans-Omics  Precision  Medicine  (TOPMed)  dataset  of  over  53,000  individuals 68 ,  and  thus  
appears  to  be  present  in  all  or  most  individuals.  With  the  insertion  included  in  a  pan-genome  reference,  reads  from  sequenced  
individuals  will  align  to  the  region,  allowing  for  the  detection  of  single-nucleotide  polymorphisms  (SNPs).  Here  a  SNP  can  be  
detected  that  is  present  in  individual  A  but  not  individual  B.  However,  when  no  pan-genomic  variation  is  included  in  the  
reference,  neither  the  insertion  sequence  nor  the  SNP  in  individual  A  can  be  detected.  The  depicted  coordinates  and  the  length  
of  the  KDM6B  insertion  were  taken  from  Sherman  et  al  2019 85 ,  although  they  are  nearly  identical  in  all  reports.  
repeat  expansion  causing  neuronal  intranuclear  inclusion  disease,  a  fatal  neurodegenerative  
disease  that  causes  symptoms  ranging  from  deterioration  of  motor  function  to  dementia 92 .  That  
study  utilized  long  reads  to  discover  the  repeat  expansion,  and  then  demonstrated  that  the  
repeat  expansion  could  be  genotyped  in  other  individuals  using  short  reads  alone.  Although  our  
ability  to  efficiently  sequence  and  analyze  large  collections  of  human  genomes  is  still  limited,  
these  recent  examples  are  a  demonstration  of  the  potential  to  detect  new  and  important  
variants  as  we  become  increasingly  able  to  analyze  human  pan-genomes.  We  present  several  
examples  of  our  work  detecting  these  variants,  and  attempting  to  determine  their  relevance  in  
both  population  genomics  and   in  clinical  settings  in  the  remainder  of  this  thesis.   
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Chapter  2:  Novel  sequence  discovery  in  910  genomes  of  African-descent  
  
A  version  of  Chapter  2  has  been  previously  published  as:   
Sherman,  R.  M.,  Forman,  J.,  Antonescu,  V.,  Puiu,  D.,  Daya,  M.,  Rafaels,  N.,  ...  &  Salzberg,  S.  L.  
(2019).  Assembly  of  a  pan-genome  from  deep  sequencing  of  910  humans  of  African  descent.  
Nature  Genetics ,  51 (1),  30-35.  
  
2.1  Background:  Including  genomic  diversity  in  human  sequencing  
Since  its  initial  publication 2,3 ,  the  human  genome  sequence  has  undergone  continual  
improvements  aimed  at  filling  gaps  and  correcting  errors.  The  latest  release,  GRCh38,  spans  3.1  
gigabases  (Gb)  with  just  875  remaining  gaps 4 .  The  ongoing  effort  to  improve  the  human  
reference  genome,  led  by  the  Genome  Reference  Consortium,  has  in  recent  years  added  
alternate  loci  for  genomic  regions  where  variation  cannot  be  captured  by  single  nucleotide  
polymorphisms  (SNPs)  or  small  insertions  and  deletions  (indels).  These  alternate  loci,  which  
comprise  261  scaffolds  in  GRCh38,  capture  a  small  amount  of  population  variation  and  improve  
read  mapping  for  some  data  sets.  
  
Despite  these  efforts,  the  current  human  reference  genome  derives  primarily  from  a  single  
individual 5 ,  limiting  its  usefulness  for  genetic  studies,  especially  among  admixed  populations  
such  as  those  representing  the  African  diaspora.  In  recent  years,  a  growing  number  of  
researchers  have  emphasized  the  importance  of  capturing  and  representing  sequence  data  
from  more  diverse  populations  and  incorporating  these  data  into  the  reference  genome  and  
genomics  studies  in  general 93–95 .  The  alternate  loci  in  GRCh38  offer  one  possible  way  to  add  such  
diversity,  although  it  is  unclear  whether  such  a  solution  is  sustainable  as  more  populations  are  
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sequenced.  Among  other  problems,  the  addition  of  alternate  loci  as  separate  contigs  can  
mislead  sequence  alignment  programs,  which  were  designed  under  the  assumptions  that  each  
read  has  a  single  true  point  of  origin,  and  that  the  genome  is  represented  as  a  linear  haploid  
sequence 83 .  
  
The  lack  of  diversity  in  the  reference  genome  poses  many  challenges  when  analyzing  individuals  
whose  genetic  background  does  not  match  the  reference.  This  problem  may  be  addressed  by  
using  large  databases  of  known  SNPs  (e.g.,  dbSNP 60 ),  but  this  solution  only  addresses  
single-base  differences  and  small  indels,  and  is  not  adequate  for  larger  variants.  Findings  from  
the  1000  Genomes  Project  indicate  differences  between  populations  are  quite  large;  examining  
26  populations  across  five  continents,  86%  of  discovered  variants  were  found  to  be  present  in  
only  one  continental  group.  In  that  study,  the  five  African  populations  examined  had  the  highest  
number  of  variant  sites  compared  to  the  remaining  21  populations 54 .  
  
One  way  to  address  the  limitations  of  a  single  reference  genome  is  to  sequence  and  assemble  
reference  genomes  for  other  human  sub-populations.  The  1000  Genomes  Project,  Genome  in  a  
Bottle,  and  other  projects  have  assembled  draft  genomes  from  various  populations,  including  
Chinese,  Korean,  and  Ashkenazi  individuals 96–101 .  Others  have  used  highly  homogenous  
populations  (e.g.,  Danish,  Dutch,  or  Icelandic  individuals)  together  with  assembly-based  
approaches  to  discover  SNPs  and  structural  variants  (SVs),  including  up  to  several  megabases  of  
non-reference  sequence  common  to  these  populations 43,45,72,102 ,  as  described  in  Chapter  1.4  and  
Table  1.1.  While  these  variant  analyses  are  a  step  in  the  right  direction,  to  date  none  have  
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produced  a  reference-quality  genome  that  can  replace  GRCh38 4 ,  although  this  is  an  explicit  goal  
of  the  Danish  Genome  Project  
( http://www.genomedenmark.dk/english/about/referencegenome/ ).  
  
While  efforts  to  produce  new  reference  genomes  are  worthwhile,  attempts  to  create  a  
“pan-genome”  of  a  human  population;  i.e.,  a  collection  of  sequences  representing  all  the  DNA  
in  that  population,  are  rare.  Although  pan-genomes  are  often  created  for  bacterial  
species 32,103,104 ,  pan-genomes  for  animal 105,106   or  plant  species 107–112   are  still  in  their  infancy  
compared  to  these  bacterial  pan-genomes.  These  eukaryotic  pan-genomes  often  consist  of  
variant  calls  on  a  reference  genome  rather  than  a  comprehensive  pan-genome  including  novel  
sequences,  though  some  recent  efforts  attempt  to  capture  novel  sequence  from  de  novo  
assembly  as  well,  including  the  goat  pan-genome,  which  captured  38Mb  of  novel  sequence  
relative  to  the  goat  reference  genome 106 .  For  more  details  on  pan-genomics  and  variant  calling  
in  general,  refer  to  Chapter  1.  The  lack  of  pan-genomes  is  due  in  part  to  the  technical  challenges  
of  assembling  many  deeply-sequenced  genomes  de  novo  and  combining  them  into  one  
genome.  While  the  Danish  Genome  Project  focused  on  50  trios  of  non-admixed  individuals  
(removing  admixed  samples  from  their  study 45 ),  our  study  focuses  on  a  highly  heterogeneous  
group  of  admixed  individuals.  Because  the  human  reference  genome  is  largely  complete  (i.e.,  
the  sequence  has  very  few  gaps),  our  strategy  for  creating  a  pan-genome  focused  on  finding  
large  insertions.  This  approach,  although  computationally  demanding,  made  the  African  
pan-genome  assembly  process  described  here  feasible.   
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A  2010  study  that  sequenced  one  Asian  and  one  African  individual  used  the  novel  sequences  
identified  to  estimate  that  a  full  human  pan-genome  would  contain  an  additional  19-40  
megabases  (Mb)  not  in  the  current  reference  genome 96 .  Recent  efforts  to  sequence  a  Dutch  
population  and  a  set  of  10,000  individuals  have  supported  this  estimate,  reporting  4.3  and  3.3  
Mb  of  non-reference  sequences  respectively 53,72 ,  however  neither  study  was  designed  with  the  
primary  goal  of  discovering  long,  non-reference  sequences.  A  2017  study,  where  two  haploid  
human  genomes  (hydatidiform  moles)  were  sequenced  using  long  reads,  estimated  that  a  single  
diploid  genome  may  differ  by  as  much  as  16  Mb  from  the  reference  genome 20 .  As  we  describe  
here,  our  analysis  of  910  deeply  sequenced  individuals,  all  from  the  Consortium  on  Asthma  
among  African-ancestry  Populations  in  the  Americas  (CAAPA) 51 ,  produced  a  much  larger  amount  
of  novel  sequence  (i.e.  sequence  absent  from  GRCh38)  in  the  African  pan-genome  spanning  
296.5  Mb.  This  finding,  which  we  published  in  2019  in  Nature  Genetics,  has  since  seen  
validation  in  the  form  of  other  studies  discovering  large  amounts  of  novel  sequence  using  long  
read  technologies,  most  notably  Audano  et  al  27   which  found  more  than  double  the  amount  of  
average  novel  sequence  per  individual,  though  the  study  size  was  much  smaller.  Our  findings  
here  and  other  recent  and  ongoing   studies  demonstrate  just  how  much  we  are  missing  when  
we  ignore  human  diversity  and  base  all  genomic  studies  on  a  single  imperfect  reference  
genome.  
  
2.2  Integrating  alignment  and  assembly  to  discover  novel  sequence  from  short-reads  
Due  to  the  challenges  of  de  novo  assembly  of  short-read  data,  particularly  across  a  large  data  
set  of  nearly  1000  WGS  sequenced  individuals,  we  present  here  an  approach  combining  
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alignment  to  the  reference  genome,  and  subsequent  assembly  of  only  reads  which  do  not  
aligned  to  the  reference,  GRCh38.  This  strategy  allows  for  the  assembly  of  wholly  novel  
sequences  relative  to  GRCh38,  while  limiting  the  computational  resources  and  time  needed  to  
perform  de  novo  assembly,  since  assembly  is  only  performed  on  a  small  subset  of  the  reads  
(typically  1-3%  of  total  reads  do  not  align  to  the  reference).  This  combined  alignment-assembly  
approach  will  assemble  contigs  of  novel  sequence,  but  the  primary  caveat  is  that  these  novel  
sequences  will  not  be  localized  relative  to  the  reference  genome.   
  
  Attempting  to  place  the  novel  sequences  within  the  reference  genome  with  this  approach  
presents  a  challenge,  but  mate  pair  information  from  Illumina  sequencing  data  can  be  used  to  
try  and  localize  sequences.  In  cases  where  one  mate  was  assembled  into  a  novel  sequence  
contig  but  the  mate  pair  aligned  to  the  reference  genome,  contigs  can  be  linked  to  their  
approximate  reference  genome  location.  Utilizing  this  linking  mate  information,  we  attempt  to  
place  the  assembled  sequences  into  the  reference  genome,  taking  care  to  only  report  an  exact  
location  when  it  can  be  unambiguously  determined.  Additionally,  the  presence  of  a  contig  in  
many  individuals  can  be  leveraged  here  --  if  a  contig  is  present  in  many  individuals  in  a  cohort,  it  
is  more  likely  that  mate  linking  information  will  be  present  and  unambiguous  in  at  least  one  
individual,  allowing  for  placement.  Thus,  common  sequences  within  the  cohort  are  more  likely  
to  be  localized  in  the  reference.  As  we  attempt  to  build  a  pan-genome,  ensuring  the  inclusion  of  
common  sequences  is  more  critical  than  including  rare,  singleton  variants,  so  the  examination  
of  large  cohorts  helps  overcome  the  caveat  of  placement  difficulty  using  this  
alignment-assembly  hybrid  strategy.  In  future  studies,  long  reads,  which  are  able  to  span  novel 
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sequence  insertions,  will  not  only  enable  discovery  of  new  novel  insertion  sequences  but  may  
also  aid  with  placement  of  sequences  such  as  those  we  report  in  this  study.  
  
We  present  in  the  remainder  of  Chapter  2.2  a  detailed  methodology  for  this  
alignment-assembly-  placement  strategy  which  we  performed  on  WGS  data  from  910  genomes  
of  African  ancestry.   
  
Data  Overview  
We  used  whole-genome  shotgun  sequence  data  from  910  individuals  whose  genomes  were  
sequenced  as  part  of  the  CAAPA  project,  available  from  dbGaP  as  accession  phs001123.v1.p1.  
The  total  data  set  contains  1.19  trillion  (1.19  x  10 12 )  100  bp  paired  end  reads,  from  ~300bp  
fragments,  representing  an  average  of  30-40X  coverage  for  each  individual’s  genome.  
Sequencing  was  performed  on  an  Illumina  HiSeq  2000.  The  subjects  in  the  study  were  all  of  
African  ancestry  and  were  selected  from  19  populations  across  the  Americas,  the  Caribbean,  
and  continental  Africa  (Table  2.1) 51 .  Due  to  the  short-read  nature  of  the  data,  we  describe  below  
a  hybrid  alignment/assembly  approach  to  assemble  large  non-reference  insertions,  while  
avoiding  whole-genome  assembly,  which  would  use  extensive  computational  resources  for  poor  




Assembly  of  novel  contigs  
For  each  sample,  we  aligned  all  reads  to  GRCh38.p0  using  Bowtie2 113 ,  and  extracted  unaligned  
reads  and  their  mates  using  Samtools 114   (Figure  2.1).  GRCh38  alternate  loci  were  excluded  from  
the  reference  index,  but  were  considered  later  in  the  process.  We  then  assembled  all  unaligned  
reads  with  the  MaSuRCA  assembler 115 ;  if  neither  mate  in  a  pair  aligned  to  GRCh38,  MaSuRCA  
treated  the  reads  as  paired-ends  with  a  fragment  size  of  300  bp,  and  if  only  one  mate  was  
unaligned  MaSuRCA  treated  it  as  an  unpaired  read.  
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Table  2.1  |  Cohorts  of  CAAPA  samples.  
Cohort  Number  of  Samples  
African  American  (Atlanta) 50  
African  American  (Baltimore-DC)  50  
African  American  (Chicago)  50  
African  American  (Detroit)  50  
African  American  (Jackson,  MS)  50  
African  American  (Nashville)  48  
African  American  (NYC)  48  
African  American  (San  Francisco)  50  
African  American  (Winston-Salem)  50  
Barbados  49  
Brazil  47  
Colombia  50  
Dominican  Republic   47  
Gabon  34  
Honduras  50  
Jamaica  50  
Palenque  34  
Nigeria  50  
Puerto  Rico  53  
Data  was  collected  from  19  distinct  cohorts  across  the  Americas,  the  Caribbean,  and  
Africa  resulting  in  910  analyzed  samples.  
Figure  2.1  |  Overview  of  methods.  Raw  reads  are  aligned  to  GRCh38  and  unaligned  reads  assembled  with  MaSuRCA.  
Assembled  contigs  are  then  filtered  for  contaminants  with  Centrifuge  and  contigs  shorter  than  1  kb  are  removed  (blue  box).  
Assembled  contigs  are  placed  based  on  their  mate’s  alignment  locations  when  possible,  by  checking  if  over  95%  of  mates  align  
to  the  same  location.  If  such  a  placement  is  found,  the  exact  breakpoint  is  determined  via  a  nucmer  alignment  to  the  region  for  
each  end  of  the  contig  (yellow  box).  Contig  placement  locations  are  then  compared  between  all  individuals,  nearby  placements  
are  clustered,  and  a  representative  is  chosen.  All  contigs  are  then  aligned  to  the  representatives  to  determine  which  samples  
contain  a  given  placed  insertion.  Contigs  in  or  aligning  to  placed  clusters  are  removed  from  the  unplaced  set,  and  the  remaining  
unplaced  contigs  are  aligned  to  one  another  with  nucmer  to  remove  redundancy  and  result  in  a  final  nonredundant  unplaced  
set  of  contigs  (purple  box).   
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We  filtered  the  resulting  assemblies  to  exclude  contigs  shorter  than  1000  bp  (Figure  2.1)  and  
evaluated  all  remaining  contigs  with  the  Centrifuge  metagenomics  program 116 ,  scanning  against  
the  comprehensive  NCBI  nucleotide  database  to  obtain  a  taxonomic  classification  of  each  
contig.  We  considered  any  contigs  labeled  by  Centrifuge  as  non-chordates  (e.g.,  bacterial  or  viral  
contigs)  to  be  contaminants  and  removed  them  from  further  consideration.   
  
Positioning  contigs  within  GRCh38  
We  attempted  to  place  the  assembled  contigs  in  a  precise  location  in  the  human  genome  using  
mapping  information  from  paired  reads  ("mates").  We  masked  contigs  with  RepeatMasker 117   
with  the  low  complexity  option  off  (-nolow),  and  used  Bowtie2  to  re-align  all  unaligned  reads  
from  read  pairs  in  which  only  one  mate  had  aligned  originally.  For  each  read  R  aligning  within  
500  bases  of  the  end  of  a  contig,  we  examined  the  alignment  of  R 's  mate  to  GRCh38  to  
determine  if  the  contig  had  a  unique  placement  in  the  reference  genome.  The  fragment  length  
for  all  paired-end  libraries  was  300  bp;  by  considering  reads  within  500  bp  of  the  end  of  a  contig  
we  reduced  the  likelihood  that  one  or  both  of  the  alignments  was  a  spurious  match.  This  
process  resulted  in  a  pool  of  linking  mates  corresponding  to  the  beginning  and  end  of  each  
contig.  
  
We  then  separated  contigs  into  several  groups  based  on  their  linking  information:   
1. No  linking  mates  existed  on  either  end  of  the  contig;  i.e.,  the  reads  mates  did  not  align  
to  GRCh38.  
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2. Placement  was  unambiguous  (or  unique)  for  at  least  one  end  of  the  contig.  We  define  
"chromosome  unambiguous"  to  mean  >95%  of  the  linking  mates  linked  to  the  same  
chromosome.  We  define  "region  unambiguous"  to  mean  that  of  the  >95%  of  mates  
aligned  to  the  same  chromosome,  all  mates  aligned  within  2  kb  of  each  other.  When  
both  conditions  hold,  we  say  placement  is  unambiguous.  These  contigs  were  further  
divided  into  two  subgroups:  
a. Both  ends  of  the  contig  were  placed  unambiguously,  or  
b. Only  one  end  was  placed  unambiguously.  
3. At  least  one  end  of  the  contig  was  chromosome  unambiguous,  but  neither  end  was  
region  unambiguous.  
4. Neither  end  was  chromosome  unambiguous.  
  
For  all  contigs  in  the  second  group,  we  used  NUCmer 118   to  align  them  to  the  region  determined  
by  the  linking  mates  (Figure  2.1).  If  a  contig  end  had  one  or  more  consistent  exact  matches  of  at  
least  15  bases  (and  no  inconsistent  alignments),  we  then  determined  the  contig  end’s  exact  
insertion  location  based  on  alignment  coordinates.  We  permitted  an  exact  two-ended  
placement  only  if  both  ends  aligned  to  the  same  reference  region  with  the  same  orientation.  
The  insertion  position  was  either  a  single  breakpoint,  if  both  ends  of  the  contig  were  placed  
identically,  or  a  range  if  the  insertion  location  of  the  two  ends  was  not  identical.  For  contigs  with  
only  a  single  end  exactly  placed,  we  recorded  their  exact  single-end  insertion  position  and  the  
number  of  overlapping  bases  (i.e.  bases  to  be  trimmed  off  the  end  of  the  contig).   One  a  region  
was  unambiguously  determined  for  a  contig  end,  we  performed  NUCmer  alignments  to  
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determine  the  exact  placement  location.  For  unambiguous  contig  ends,  we  aligned  the  terminal  
200  bp  of  sequence  to  the  region  determined  by  the  mate  placements.  These  regions  were  up  
to  2  kb  in  length,  which  we  padded  with  an  additional  500  bp  taken  from  both  sides  of  the  
region.  Alignments  were  performed  without  repeat-masking  because  the  region  had  already  
been  unambiguously  identified.  We  used  the  parameters  --minmatch  15  --breaklen  1  
to  disallow  gaps  or  mismatches  in  the  alignments  and  left  all  other  parameters  as  defaults.  If  we  
found  at  least  one  exact  match  of  at  least  15  base  pairs  within  5  bases  of  the  contig  end,  and  all  
exact  matches  were  consistent  with  one  another,  an  exact  breakpoint  was  determined  by  
chaining  the  alignments.  The  resultant  aligned  portion  of  the  contig  was  recorded  (to  be  
trimmed  off  later  in  the  pipeline)  and  the  endpoint  of  the  alignment  was  recorded  as  the  
insertion  location  for  that  end  of  the  contig.  
  
Insertion  discovery  with  PopIns   
To  supplement  the  list  of  placed  contigs  determined  by  the  procedure  above,  we  ran  the  PopIns  
program 102 ,  which  was  used  previously  for  a  set  of  genomes  from  Icelandic  individuals,  and  was  
designed  to  find  insertions  from  a  relatively  genetically  homogenous  population.  We  ran  PopIns  
beginning  with  the  popins  merge  step,  using  the  cleaned  MaSuRCA  contig  assemblies  
described  above.  We  ran  subsequent  PopIns  steps  as  recommended  in  the  PopIns  
documentation,  through  the  popins  place-finish  step.  In  the  popins  merge  step,  
PopIns  produces  new  contigs  by  merging  those  provided  to  it  into  new  merged  contigs.  To  
obtain  clusters  of  placed  contigs  which  could  be  more  easily  merged  with  our  pipeline,  we  
aligned  all  MaSuRCA  contigs  to  each  merged  contig  created  and  placed  by  PopIns.  We  grouped  
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contigs  that  fully  aligned  with  over  98%  identity  into  a  single  cluster  representing  one  insertion  
and  location.  For  all  contigs  in  each  cluster,  we  then  aligned  each  contig’s  ends  to  the  placement  
location  with  NUCmer,  as  described  above,  to  attempt  to  determine  its  exact  placement.   
  
Notably,  PopIns  generates  placements  of  a  single  end  of  a  contig  using  the  VCFv4.2  breakend  
format  to  specify  how  much  of  a  merged  contig  is  inserted  at  a  breakpoint.  Thus  in  many  cases  
PopIns  output  several  placements  for  the  same  contig  that  did  not  agree  in  orientation  or  
placement  location.  If  we  could  not  verify  a  placement  made  by  PopIns  via  our  independent  
alignment  of  the  contig  ends  to  the  placement  region,  we  excluded  it  from  the  final  set  of  
placed  insertions.  Of  the  contigs  in  a  cluster  that  could  be  exactly  placed  with  NUCmer,  if  one  or  
multiple  contigs  had  both  ends  placed,  the  longest  of  these  was  reported  as  the  representative  
of  the  cluster  and  the  insertion  was  added  to  the  set  of  two-end  placed  insertions.   
  
If  no  single  contig  had  both  ends  placed  by  NUCmer,  up  to  two  representatives  were  chosen,  
with  the  longest  contig  being  chosen  as  the  representative  for  each  end  of  the  contig.  This  
resulted  in  the  potential  for  two  separate  one-ended  clusters,  which  were  then  added  to  the  
one-end  placed  insertion  set  as  follows.  All  PopIns  representatives  where  the  contig  had  already  
been  placed  in  a  two-ended  placement  cluster  were  excluded  regardless  of  location  conflicts,  as  
the  two-ended  clusters  necessarily  had  more  evidence  supporting  them.  We  further  excluded  as  
redundant  any  PopIns  placements  within  100  bases  of  an  existing  one-ended  or  two-ended  
placement  location.   
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Once  PopIns  placements  were  incorporated  into  the  one  and  two  end  placement  sets  and  
clusters  had  been  finalized,  we  attempted  to  verify  contig  placements  produced  by  PopIns.  To  
verify  the  placements  we  examined  the  placement  locations  of  linking  mates  from  all  contigs  in  
the  cluster  of  a  PopIns  placement.  Clusters  in  which  fewer  than  25%  of  all  linking  mates  aligned  
within  5  Kb  of  the  GRCh38  placement  location  were  removed  from  the  placed  set.  If  no  mates  
existed,  the  cluster  was  not  removed.  This  resulted  in  the  removal  of  a  number  of  PopIns  
placements,  including  several  for  which  we  had  determined  a  one-ended  placement  with  very  
strong  mate-pair  support  but  a  PopIns’  two-ended  placement  disagreed.  
  
Clustering  of  placed  contigs  
Once  contig  locations  were  determined  for  each  individual  sample,  we  aligned  all  insertions  to 
one  another  and  clustered  them  to  determine  which  contigs  represented  the  same  insertion  
across  individuals  (Figure  2.1).  
  
Clustering  two-ended  placements  
For  contigs  with  both  ends  placed,  we  ran  BEDTools  merge 119   to  group  contigs  placed  at  
approximately  the  same  location.  We  used  the  -d  option  with  a  distance  of  10,  to  allow  
placements  within  10  bases  of  each  other  to  be  combined.  We  also  ran  the  merge  using  -d   
100 ,  which  produced  identical  results.  For  each  resulting  region  and  contig  cluster,  we  chose  
the  longest  contig  in  the  cluster  as  the  cluster’s  representative  ( R ),  and  these  representatives  
formed  the  initial  set  of  two-ended  placed  contigs,  2EP.  Two-ended  placement  clusters  from  
PopIns  were  then  added  to  2EP.  We  verified  clusters  by  aligning  all  contigs  in  each  cluster  to  its  
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representative,  R ,  with  default  nucmer  parameters  and  removing  from  the  cluster  any  contigs  
that  did  not  have  any  alignments  to  R .  To  find  the  complete  set  of  samples  containing  each  
insertion,  we  then  aligned  all  remaining  contigs  (including  unplaced  contigs)  to  the  contigs  in  
the  clusters.  Any  contig  aligning  with  greater  than  99%  identity  that  was  fully  contained  within  a  
contig  in  a  cluster  C  and  covered  at  least  80%  of  the  contig  in  C  was  included  in  C  as  part  of  the  
final  set.  Contained,  99-100%  identical  contigs  aligning  with  less  than  80%  coverage  were  also  
included  if  they  had  at  least  5  linking  mates  and  at  least  25%  of  those  mates  linked  to  within  5kb  
of  the  placement  location.  The  longest  representative  contig  in  each  cluster  was  used  as  the  
final  insertion  sequence  for  the  African  Pan-Genome  (APG)  contig  collection  (Supplementary  
Tables  1-2  in  Sherman  et  al  2019 78 ).   
  
Clustering  one-ended  placements  
We  separated  contigs  with  only  one  end  placed  into  two  groups:  (1)  contigs  where  the  “left”  
end  aligned  to  the  reference,  so  that  the  contig  extends  into  a  gap  to  the  right  of  the  placement  
location;  and  (2)  contigs  with  their  “right”  end  placed,  so  the  contig  extends  into  a  gap  to  the  
left  of  the  placement  location  (Figure  2.1).  Left  and  right  were  determined  by  the  orientation  of  
the  chromosomes  in  GRCh38.  We  then  created  clusters  separately  for  the  two  groups  using  
BEDTools  merge  ( -d  100 )  as  described  above,  identifying  the  longest  representative  R  for  each  
group.  This  formed  the  initial  set  of  one-ended  placed  contigs,  1EP.  Any  placements  within  100  
bases  of  a  two-ended  cluster  (in  the  set  2EP)  were  then  removed  from  1EP,  and  each  contig  in  
these  1EP  clusters  was  aligned  to  the  representative  of  the  2EP  cluster(s)  within  100  bases.  If  
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any  1EP  contig  in  the  cluster  aligned  with  ≥  80%  coverage  and  ≥  90%  identity  to  the  2EP  contig,  
the  1EP  contig  was  added  to  the  2EP  cluster.  
  
We  then  added  PopIns  one-ended  placement  clusters  to  the  right  and  left  placements  in  1EP.  
Then  for  all  clusters,  we  used  NUCmer  with  default  parameters  to  align  contigs  within  each  
cluster  to  the  representative  R .  If  no  alignment  was  found  between  a  contig  and  R ,  the  contig  
was  removed  from  the  cluster.  We  then  re-aligned  all  other  contigs  to  those  in  each  of  these  
filtered  clusters,  excluding  contigs  already  determined  to  be  part  of  a  two-ended  insertion.  
Contigs  >  99%  identical  over  their  whole  length  to  any  member  of  a  cluster  C  and  covering  at  
least  80%  of  the  contig  in  C  were  added  to  C .  Contained,  99-100%  identical  contigs  aligning  with  
less  than  80%  coverage  were  also  included  if  they  had  at  least  5  linking  mates  and  at  least  25%  
of  those  mates  linked  to  within  5  kb  of  the  placement  location.  
  
We  then  evaluated  the  one-ended  placements  to  determine  if  two  contigs  might  belong  to  the  
same  longer  insertion,  where  one  contig  would  "fill"  the  left  side  of  a  gap  and  the  other  would  
fill  the  right  side,  possibly  meeting  in  the  middle.  In  some  of  these  cases,  the  contigs  might  
overlap,  allowing  us  to  merge  them  and  create  a  single,  longer  insertion  sequence.  If  placement  
positions  were  within  500  bases  of  one  another,  we  ran  nucmer  --maxmatch   
--nosimplify ,  followed  by  show-coords  -o  (with  annotation)  to  align  the  
representative  contigs  of  clusters  that  were  candidates  for  merging.  If  NUCmer  annotated  the  
representatives  as  identical,  or  if  it  found  that  either  contig  contained  the  other  with  at  least  
97%  identity,  we  merged  the  clusters  and  reported  the  longer  representative  contig.  In  cases  
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where  the  ends  of  two  contigs  overlapped  in  the  correct  arrangement  and  orientation  relative  
to  their  placements,  we  merged  the  overlapping  ends  by  extending  the  sequence  of  the  longer  
contig  with  that  of  the  shorter  contig  as  indicated  by  the  alignments.  The  resulting  merged  
sequence  and  cluster  was  then  moved  to  the  2EP  set.  If  NUCmer  identified  other  alignments  
between  representatives  covering  at  least  50%  of  one  of  the  representatives  and  the  clusters  
shared  any  contigs  (i.e.  at  least  one  contig  was  contained  in  both  representatives),  the  clusters  
were  merged.  However,  because  these  representatives  were  more  divergent  the  
representatives  were  not  merged  and  the  longer  representative  was  reported  in  the  1EP  set  
(Supplementary  Table  1  in  Sherman  et  al  2019 78 ).  
  
Finally,  to  remove  any  potential  redundancy  from  placed  clusters,  we  aligned  all  representatives  
from  both  one-  and  two-end  placed  clusters  to  one  another  (using  nucmer  --maxmatch   
--nosimplify )  regardless  of  placement  distance.  If  two  representatives  aligned  with  ≥  98%  
identity,  covering  ≥  95%  of  one  of  the  contigs,  and  were  placed  within  5  kb  of  one  another,  
these  clusters  were  merged.  To  determine  the  representative  (and  therefore  reported  
placement)  of  the  merged  clusters,  two-ended  placed  representatives  were  favored  over  
one-ended  ones,  then  our  placements  were  preferred  over  PopIns,  then  longer  contigs  were  
favored  over  shorter  contigs.  By  merging  only  placements  within  5  Kb,  we  avoided  merging  
contigs  that  were  similar  solely  due  to  repetitive  sequences  but  were  unambiguously  linked  to  
different  locations.  
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Unplaced  contigs  
For  all  unplaced  contigs,  we  ran  nucmer  --maxmatch  --nosimplify  with  a  minimum  
seed  length  of  31  ( -1  31 )  and  a  minimum  cluster  size  of  100  ( -c  100 )  to  align  all  contigs  
against  one  another.  Contigs  contained  within  another  contig  and  aligning  with  >  95%  identity  
were  removed,  and  if  contigs  were  annotated  as  identical  by  show-coords  with  >  97%  
identity,  the  smaller  of  the  two  was  removed.  If  the  ends  of  two  contigs  overlapped  by  at  least  
100  bases  and  a  third  contig  was  contained  within  the  joined  contigs,  the  contained  contig  was  
also  removed.  Trimming  of  up  to  100  bases  was  permitted  for  finding  overlaps.  Finally,  we  
aligned  all  resulting  unplaced  contigs  to  the  placed  representatives  pre-trimming.  If  an  unplaced  
contig  aligned  with  ≥  80%  coverage  and  ≥  90%  identity,  it  was  removed  from  the  unplaced  set,  
though  it  was  not  added  into  the  placed  cluster,  as  it  did  not  meet  the  stricter  placement  or  
containment  criteria  used  to  create  the  clusters.   
  
In  an  additional  attempt  to  place  more  contigs  in  the  reference  genome,  we  repeated  the  
placement  procedure  described  above,  this  time  considering  only  the  subset  of  linking  mates  
that  mapped  to  GRCh38  with  a  mapping  quality  >10,  and  only  attempting  to  place  a  contig  if  the  
contig  end  had  a  minimum  of  5  such  linking  mates.  This  mapping  quality  criterion  decreased  the  
overall  ambiguity  of  the  putative  locations  for  unplaced  contigs  (Figure  2.2),  however  this  
additional  placement  effort  only  placed  150  additional  contigs.  We  produced  a  file  of  putative  
linking  locations  for  unplaced  contigs  by  examining  separately  for  each  end,  the  linking  mates  
with  a  mapping  quality  >10.  If  greater  than  50%  of  these  high-quality  linking  mates  for  a  given  
end  pointed  to  the  same  region,  where  a  region  was  defined  by  grouping  mates  within  2kb  of  
47  
each  other,  we  reported  that  region  as  the  putative  placement  location  for  that  end  of  the  
contig,  as  well  as  the  total  number  of  high-quality  mates,  and  the  percentage  of  those  mates  
linking  to  that  location.  For  this  report,  the  two  contig  ends  were  allowed  to  putatively  link  to  
different  locations;  in  such  cases  both  the  start  and  end  regions  identified  are  provided  as  these  
are  the  two  most  likely  placement  regions  for  the  contig  (Supplementary  Table  3  in  Sherman  et  
al  2019 78 ).  The  putative  locations  include  high-copy  repetitive  sequences  that  may  be  
underrepresented  in  GRCh38,  and  thus  are  overrepresented  as  linking  locations.  
  
  
We  examined  these  over-represented  genomic  locations  to  which  >100  contigs  linked  in  five  
randomly  selected  samples  (Figure  2.3) .  All  regions  in  all  five  individuals  had  excessively  deep  




Figure  2.2  |  Ambiguity  of  linking  mate  placement  
locations.  Mates  linking  a  contig  end  to  GRCh38  were  
considered  for  all  unplaced  contigs.  Contigs  which  
had  at  least  5  linking  mates  were  included  in  the  
histogram.  The  x-axis  represents  the  percentage  of  
mates  mapping  to  the  “best”  placement  region.  For  
example,  if  a  contig  had  10  linking  mates,  and  4  
mapped  to  chr1:50000-55000,  3  mapped  to  a  
chr2:88000-90000  and  the  remaining  3  mates  all  
mapped  to  different  locations,  then  the  percent  
mapped  consistently  to  the  best  location  would  be  
40%.  When  mates  of  all  mapping  qualities  are  
considered,  there  is  considerably  more  ambiguity,  
although  there  are  also  more  APG  contigs  with  at  
least  5  linking  mates  considered.  Although  the  
number  of  APG  contigs  with  at  least  5  linking  mates  
drops  from  117,454  (blue)  to  53,205  (green)  when  
filtered  for  mapping  qualities  above  10,  far  more  
contigs  can  be  linked  to  a  placement  location  with  
high  confidence  and  the  number  of  contigs  where  all  
mates  point  to  the  same  region  roughly  triples.  
these  datasets.  We  also  observed  that  all  regions  had  an  abundance  of  mismatches  in  the  
alignments.  These  mismatches  in  the  read  pile-ups  indicate  that  these  sequences  occur  in  many  
copies  throughout  the  genome,  with  somewhat  diverged  sequence,  but  are  presented  by  only  a  
few  copies  in  the  GRCh38  reference  genome.  Many  of  these  sequences  occur  in  or  near  
centromeric  regions,  in  which  this  phenomenon  has  been  previously  detected 37 .  Since  the  
contigs  linking  to  these  regions  did  not  meet  our  merging  criteria,  and  the  locations  linked  to  
are  not  high  confidence,  the  contigs  were  left  as  separate  sequences  in  our  APG  set. 
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Figure  2.3  |  Regions  with  an  over-representation  of  linking  mates.  Several  genomic  regions  have  an  over  abundance  of  APG  contigs  
tentatively  linked  to  them  via  mate  alignment  information,  though  the  linkages  were  not  unambiguous  enough  to  meet  placement  
criteria  (Supplementary  Table  3  in  Sherman  et  al  2019 78 ).  Three  randomly  selected  CAAPA  samples  all  have  read  alignments  to  these  
regions  at  far  greater  than  expected  coverage,  ranging  from  ~15  times  (chrY)  to  ~3000  times  (chrUn)  greater  coverage  than  the  
expected  (30-40X).  Vertical  panels  are  labeled  with  approximate  location  of  the  coverage  peak.  For  each  of  the  three  samples  the  
coverage  is  displayed  in  the  upper  frame  with  the  max  coverage  indicated,  and  a  subset  of  the  aligned  reads  are  shown  in  the  lower  
frame,  with  mismatches  colored  according  to  the  base.  All  regions  have  an  abundance  of  mismatches  in  the  alignments.  These  
mis-alignments  resulting  in  read  pile-ups  may  indicate  that  these  sequences  occur  in  many  copies  throughout  the  genome,  with  
somewhat  diverged  sequence,  but  only  occur  a  single  time  in  the  reference  genome.  In  fact,  several  of  these  sequences,  including  
those  pictured  on  chr5  and  chrUn_KI270438v1,  have  only  been  present  in  the  reference  genome  since  the  release  of  GRCh38,  and  
may  still  be  underrepresented  in  GRCh38  due  to  difficulties  in  assembling  these  sequences.  Coverage  and  alignment  images  were  
produced  by  IGV  ( Thorvaldsdóttir,  H.,  Robinson,  J.  T.,  &  Mesirov,  J.  P.  Integrative  Genomics  Viewer  (IGV):  high-performance  genomics  
data  visualization  and  exploration.  Briefings  in  bioinformatics ,  14 (2),  178-192,  2013).  
Another  consideration  in  assessing  the  accuracy  of  the  putative  linking  mates  is  repetitive  
genomic  regions,  even  if  the  regions  are  not  at  deeper  than  expected  coverage,  as  repetitive  
sequences  are  expected,  since  GRCh38  has  over  50%  repetitive  content.  We  ran  RepeatMasker  
(with  species  set  to  human,  using  the  rmblastn  algorithm)  on  the  APG  contigs,  separately  
considering  the  placed  and  unplaced  contigs.  As  might  be  expected  since  non-repetitive  
sequence  is  more  easily  anchored  unambiguously,  the  placed  contigs  were  not  as  repetitive  
overall  as  the  unplaced  contigs.  RepeatMasker  masks  61%  of  the  placed  sequence  as  repetitive,  
half  of  which  (31%)  was  made  up  of  simple  repeats,  with  most  of  the  remaining  repetitive  
sequence  made  up  of  LINE,  SINE,  and  LTR  elements.  The  unplaced  sequence  was  more  
repetitive,  with  an  overall  masking  of  88%,  where  again  the  largest  category,  at  64%,  was  simple  
repeats,  with  another  22%  classified  as  satellites  (Figure  2.4).  Mate  information  linking  contigs  
to  regions  containing  simple  repeats  or  other  repeat  elements  are  less  reliable  links  than  those  





Figure  2.4  |  African  pan-  
genome  repeat  content.  
Breakdown  of  repeats  in  the  
APG  contigs,  placed  and  
unplaced,  as  classified  by  
RepeatMasker  with  species  set  
to  human  and  the  rmblastn  
algorithm.  
  
Additional  screening  and  analyses  
To  screen  for  contaminants  missed  by  Centrifuge,  we  used  the  Kraken  metagenomics  classifier 120   
on  our  final  set  of  representative  contigs  to  compare  them  to  a  database  containing  all  
complete  bacterial  and  archeal  genomes,  all  viral  genomes,  selected  fungi  and  protists,  human,  
mouse,  and  known  contaminant  sequences.  Any  unclassified  contig  or  contig  hitting  something  
other  than  mouse  or  human  was  further  examined  by  running  the  blastn  program 121   to  align  the  
contig  to  NCBI's  non-redundant  nucleotide  database.  We  removed  all  contigs  (as  likely  
contaminants)  that  had  alignments  to  a  non-chordate  covering  greater  than  50%  of  the  contig  
with  a  BLAST  e-value  less  than  10 -10 .  We  additionally  removed  a  single  contig,  also  an  apparent  
contaminant,  hitting  Canis  familiaris  at  90%  identity  over  the  entire  contig,  but  lacking  any  
strong  matches  to  primates.  As  expected,  all  of  these  contaminant  contigs  were  found  in  the  set  
of  unplaced  contigs.  We  further  examined  the  classifications  of  all  removed  contigs  classified  as  
viral  or  as  Plasmodium  to  determine  if  any  individuals  appeared  to  have  viral  infections  or  
malaria.  All  contigs  with  these  classifications  from  Centrifuge  or  Kraken  were  screened  for  false  
positives  by  running  blastn  to  align  the  contig  to  NCBI's  non-redundant  nucleotide  database.  
Only  contigs  where  all  top  BLAST  hits  covered  at  least  95%  of  the  contig  at  an  e-value  less  than  
10 -20   were  considered  to  be  true  hits.  This  resulted  in  several  contaminants  of  interest,  including  
human  betaherpesvirus  and  malaria.  Since  only  assembled  contigs  were  screened,  all  
contaminants  discovered  were  assembled  into  at  least  one  contig  of  a  minimum  size  of  1  kb  
with  some  individuals  containing  hundreds  or  thousands  of  assembled  contaminant  contigs,  
likely  indicating  a  highly  active  infection.  This  resulted  in  the  incidental  discovery  of  29  
individuals  with  malaria  infections  and  1  with  human  betaherpesvirus  (Table  2.2).  
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To  ensure  the  final  set  of  contigs  were  truly  absent  from  the  human  reference  genome,  we  
re-aligned  all  APG  contigs  to  GRCh38.p10  using  bwa-mem 84   with  default  parameters.  Two  
separate  alignments  were  performed,  one  to  the  primary  sequence  and  one  to  all  patches  and  
alternate  loci.  Although  the  reads  used  to  assemble  these  contigs  had  initially  failed  to  align  to  
the  genome,  in  some  cases  the  resulting  contigs  had  sufficient  similarity  that  they  could  be  
aligned  to  primary  sequence  at  or  above  90%  identity  over  at  least  80%  of  the  contig's  length.  
This  resulted  in  the  removal  of  five  two-ended  placements,  24  one-ended  placements,  and  249  
unplaced  contigs.  Among  the  29  placed  contigs  that  were  removed  at  this  step,  all  had  
alignments  between  90%  and  93%  identity  and  were  present  in  10  or  fewer  samples;  this  may  
indicate  that  some  individuals  simply  had  slightly  more  divergent  sequence  than  the  overall  
population,  explaining  why  Bowtie2  failed  to  align  their  reads  initially.  The  best  alignment  
locations  that  had  at  least  50%  of  the  contig  aligned  to  GRCh38.p10  at  ≥  80%  identity  were  
determined  by  taking  alignments  to  both  primary,  alternate,  and  patch  sequences,  and  
calculating  a  score  by  multiplying  the  percent  identity  by  the  alignment  length  (Supplementary  
Tables  1-2  in  Sherman  et  al  2019 78 ).  All  placed  locations  were  intersected  with  the  NCBI  
provided  gene  annotations  for  GCF_000001405.36,  which  is  the  union  of  GenBank  and  RefSeq  
annotations  for  GRCh38.p10,  and  a  translated  BLAST  search  (blastx)  was  run  against  the  NCBI  







2.3  Genomic  locations  and  analysis  of  296  Mb  non-reference  sequence  
In  total,  we  discovered  296.5  Mb  of  novel  DNA  distributed  across  125,715  sequences  assembled  
from  910  individuals  of  African  descent  (Table  2.3,  Figure  2.5).  A  total  of  33,599  contigs  with  a  
combined  length  of  81,096,662  bases  represented  sequences  present  in  at  least  two  individuals  
in  the  CAAPA  cohort.  When  alignments  above  80%  coverage  and  90%  identity  to  Chinese  and  
Korean  genome  assemblies  were  also  considered  shared,  the  number  of  non-private  insertions   
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Table  2.2  |  Contigs  assembled  from  contaminants  of  interest.   
  





(#  contigs)  
Plasmodium  
malariae  
(#  contigs)  
Human  
betaherpesvirus  6B   
(#  contigs)  
LP6005271-DNA_C04  Gabon  4184  -  -  
LP6005271-DNA_D04  Gabon  3  -  -  
LP6005271-DNA_E04  Gabon  2615  -  -  
LP6005271-DNA_A03  Gabon  2  -  -  
LP6005271-DNA_A04  Gabon  1  -  -  
LP6005271-DNA_B03  Gabon  4077  -  -  
LP6005271-DNA_C02  Gabon  6  2  -  
LP6005271-DNA_C03  Gabon  2  -  -  
LP6005271-DNA_F02  Gabon  36  -  -  
LP6005092-DNA_B02  Nigeria  3  -  -  
LP6005092-DNA_E03  Nigeria  8  -  -  
LP6005092-DNA_H02  Nigeria  1  -  -  
LP6005092-DNA_C02  Nigeria  1  -  -  
LP6005092-DNA_A04  Nigeria  2  -  -  
LP6005092-DNA_C01  Nigeria  1  -  -  
LP6005092-DNA_G02  Nigeria  676  -  -  
LP6005092-DNA_G03  Nigeria  89  -  -  
LP6005092-DNA_H03  Nigeria  2  -  -  
LP6005092-DNA_A06  Nigeria  1  -  -  
LP6005092-DNA_B05  Nigeria  16  -  -  
LP6005092-DNA_F06  Nigeria  15  -  -  
LP6005092-DNA_A07  Nigeria  2  -  -  
LP6005092-DNA_B06  Nigeria  7  -  -  
LP6005092-DNA_B07  Nigeria  -  10  -  
LP6005092-DNA_D06  Nigeria  5  -  -  
LP6005092-DNA_E02  Nigeria  6  -  -  
LP6005092-DNA_F05  Nigeria  1  -  -  
LP6005092-DNA_G05  Nigeria  1  -  -  
LP6005092-DNA_H06  Nigeria  1  -  -  
LP6005107-DNA_F03  African  American  
(Winston-Salem)  
-  -  3  
Contigs  from  Plasmodium  falciparum ,  Plasmodium  malariae ,  or  human  betherpesvirus  6B  were  assembled  in  30  individuals.  
Though  most  Plasmodium  contigs  detected  were  falciparum,  one  individual  had  contigs  present  from  both  Plasmodium  species  
and  one  solely  from  malariae .  All  individuals  with  Plasmodium  contigs  were  from  either  the  Gabon  or  Nigeria  cohorts.   
  
  
increased  to  61,410,  totaling  160,475,353  bases  and  leaving  64,305  singleton  contigs,  a  ~51%  
singleton  rate.  Of  the  125,715  APG  sequences,  1,548  (total  length  4.4  Mb)  were  anchored  to  a  
specific  location  in  the  primary  GRCh38  assembly.  On  average  each  individual  contained  859  of  
these  inserted  sequences,  with  a  single  sequence  being  shared  among  6  individuals  (Table  2.4).  
Placed  contigs  were  shared  among  more  individuals,  196  on  average,  as  shared  sequences  were  
more  likely  to  meet  the  placement  criterion  in  at  least  one  individual.  
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Table  2.3  |  Novel  sequences  in  the  African  pan-genome.  
  Number  of  
sequence  
contigs  
Total  length  
(bp)  
Bases  with  no  alignment  to  
GRCh38  (<  80%  identity)  
Longest  contig  
(bp)  
Two  ends  placed  302  667,668  431,656  20,732  
One  end  placed  1,246  3,687,028  1,866,699  79,938  
Unplaced  124,167  292,130,588  202,629,979  152,806  
Total  125,715  296,485,284  204,928,334  152,806  
Non-private  only  33,599  80,098,092  50,044,650  152,806  
Number  and  length  of  novel  sequences  in  the  African  pan-genome.  Bases  with  no  alignment  to  GRCh38  were  
calculated  by  subtracting  the  lengths  of  all  subsequences  that  aligned  with  at  least  80%  identity.  The  remainder  
represents  truly  novel  sequence.  Non-private  insertions  were  insertions  shared  by  at  least  two  CAAPA  cohort  
individuals.  
Figure  2.5  |  APG  
contig  length  
distribution.  The  
125,715  APG  contigs  
range  in  length  from  
just  under  1  kb  to  
152.8  kb.  All  contigs  
under  1  kb  are  
placed  contigs  which  
passed  the  1  kb  
threshold  pre  
trimming;  the  219  
contigs  from  704  bp  
to  999  bp  are  not  
pictured. 
  
We  fully  resolved  the  location  for  302  of  these  sequences,  and  resolved  the  breakpoint  of  one  
end  of  the  insertion  for  the  remaining  1,246  (Supplementary  Table  1  in  Sherman  et  al  2019 78 ).  
Placement  locations  were  determined  by  complementing  our  methods  with  results  from  the  
PopIns  program 102 ,  which  corroborated  many  placements  and  resolved  placements  for  some  
insertions  where  our  method  was  ambiguous.  Of  the  1,246  one-ended  placements,  our  pipeline  
found  1,229,  while  PopIns  16   found  an  additional  17  and  confirmed  60.  Of  the  302  pan-genome  
contigs  for  which  both  ends  were  placed,  70  were  placed  by  both  our  method  and  PopIns,  129  
by  our  method  only,  and  103  by  PopIns  only.  Those  placed  solely  by  PopIns  were  verified  via  
alignment  of  contig  ends  (as  described  above  in  Chapter  2.2).   
  
  
PopIns  was  able  to  resolve  placement  locations  for  some  insertions  where  our  method,  which  
uses  both  contig  and  mate-pair  alignments,  gave  ambiguous  results.  This  is  likely  a  result  of  
PopIns'  utilization  of  split-read  alignments  to  determine  exact  placement  locations,  which  
provides  some  additional  power.  However,  our  approach  has  advantages  when  the  contigs  
shared  between  individuals  are  more  divergent,  as  they  tend  to  be  in  the  CAAPA  populations. 
PopIns  merges  similar  sequences  prior  to  attempting  placement  but  excludes  from  further  
analysis  contigs  which  have  a  partial,  but  insufficient  (for  merging)  match  to  many  other  contigs.  
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Table  2.4  |  African  pan-genome  contig  presence/absence  statistics.   
  Number  of  contigs  Mean  #  insertions  per  individual Mean  #  individuals  per  insertion 
Two  ends  placed  302  120  (39.7%)   363  (of  910)  
One  end  placed  1,246  212  (17.0%)  155  (of  910)  
Unplaced  124,167  527  (0.4%)   4  (of  910)  
Total  125,715  859  (0.7%)   6  (of  910)  
Non-private  only  33,599  758  (2.2%)  21  (of  910)  
Statistics  on  the  presence  or  absence  of  the  African  pan-genome  contigs.  Presence/absence  was  determined  by  aligning  all  
raw  contigs  for  each  individual  to  the  final  set  of  APG  contigs.  Alignments  of  one  or  more  contigs  yielded  a  presence  call  if  
the  alignments  covered  at  least  80%  of  an  APG  contig  at  at  least  90%  identity.  Additional  presence  calls  were  made  for  the  
placed  contigs  if  the  individual  had  a  similar  contig  placed  in  the  same  location,  even  if  the  alignment  thresholds  were  not  
met.  
This  resulted  in  PopIns  considering  only  5%  of  the  full  set  of  assembled  contigs  (81,650  of  
1,536,049),  while  our  approach  placed  many  of  these  “unmergeable”  contigs  by  placing  all  
contigs  first,  and  then  clustering  based  on  location.  While  this  pre-merging  step  prior  to  
placement  worked  well  for  the  highly  homogenous  Icelandic  population  for  which  PopIns  was  
designed,  it  was  less  effective  for  our  more  heterogenous  African-descended  populations.  
  
The  remaining  124,167  sequences  could  not  be  fully  localized.  However,  mate-linking  
information  pointed  to  a  consistent  location  for  at  least  one  end  for  an  additional  57,655  of  
these  sequences  (Supplementary  Table  3).  The  longest  placed  sequence  was  79,938  bp  and  
appeared  in  197  samples,  and  the  longest  unplaced  sequence  was  152,806  bp,  which  appeared  
in  11  samples  (Table  2.3).  Among  all  placed  sequences,  387  intersected  known  genes,  with  
placements  within  exons  in  48  distinct  genes,  and  within  introns  in  an  additional  267  genes.  
(Some  genes  contained  more  than  one  insertion.)  Of  the  315  genes  containing  insertions,  292  
were  named  (i.e.,  had  names  other  than  "hypothetical"  or  a  non-meaningful  identifier).  An  
additional  133  placed  insertions  and  46  already  intersecting  a  protein  coding  gene  intersected  
142  distinct  lncRNAs,  21  of  which  were  named  (Supplementary  Table  4  in  Sherman  et  al  2019 78 ).  
A  translated  BLAST 121   search  on  unplaced  sequences  against  NCBI’s  nr  database  yielded  an  
additional  10,667  contigs  hitting  a  chordate  protein  with  ≥  70%  identity  and  an  e-value  less  than  
10 -10 .  Placement  locations  and  gene  intersections  were  dispersed  throughout  the  genome,  and  
placed  pan-genome  elements  were  found  on  every  chromosome  (Figure  2.6),  in  addition  to  115  
insertions  in  chromosome-specific  “random”  sequence  and  103  more  in  “unlocalized”  
sequences  included  in  the  primary  assembly  of  GRCh38.  
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Of  our  APG  contigs,  31,354,079  bases  aligned  to  a  GRCh38  “patch”  or  ALT  locus  as  part  of  an  
alignment  with  an  identity  of  ≥  80%.  An  additional  60,202,871  bases  aligned  to  the  primary  
assembly  at  ≥  80%  identity;  however,  most  of  these  alignments  covered  a  small  portion  of  an  
APG  contig,  and  can  be  explained  by  the  presence  of  extra  copies  of  small  repetitive  elements.  
Supplementary  Tables  1  and  2  in  Sherman  et  al  2019 78   report  alignments  to  ALT,  patch,  or  
primary  assembly  sequences  covering  at  least  50%  of  the  contig  length  with  ≥  80%  identity.  
Requiring  that  at  least  50%  of  a  contig  be  aligned  to  any  single  location  in  GRCh38  produced  a  
much  smaller  subset:  of  the  125,715  contigs,  only  17,140  aligned  to  any  part  of  GRCh38.p10  
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Figure  2.6  |  African  pan-genome  contig  locations.  Map  of  the  human  genome  showing  the  locations  of  all  African  
pan-genome  contigs,  for  those  that  could  be  placed  accurately  along  one  of  the  chromosomes.  Yellow  lines  represent  an  
intergenic  location;  blue  lines  represent  insertion  points  with  RNA  but  not  exonic  annotations,  and  red  lines  indicate  
intersections  within  exons.  All  exon-intersecting  insertions  are  labeled  with  the  gene  name.  mRNA  and  lncRNA  gene  names  
are  reported  in  Supplementary  Table  4  in  Sherman  et  al  2019 78 .  In  some  cases  insertions  are  too  close  together  for  lines  to  be  
resolved;  when  this  occurs  within  exons,  gene  names  are  listed  in  order  by  chromosome  position.  Line  width  is  not  to  scale.  
with  a  single  alignment  at  ≥  80%  identity  covering  ≥  50%  of  the  contig  length.  These  17,140  
contigs  contain  22,420,979  aligned  bases,  with  13,770,950  bases  being  alignments  to  a  
reference  chromosome.  Although  very  few  ALT  loci  in  GRCh38.p10  are  tagged  with  
population-specific  information,  alignments  of  the  CAAPA-specific  sequences  to  these  loci  
suggest  an  African  source  for  some  of  these  ALT  sequences.   
  
  
2.4  Presence  of  novel  sequences  in  other  genomes  
We  performed  two  different  analyses  to  examine  the  presence  of  the  APG  sequences  in  other  
genomes.  We  performed  comparisons  to  recent  human  assemblies  of  Chinese  (HX1) 99   and  
Korean  (KOREF1.0) 100   individuals,  and  several  primate  genomes  by  aligning  our  APG  sequences  
to  these  assemblies  using  bwa-mem 84 .  We  additionally  examined  the  presence  or  absence  of  
the  APG  sequences  in  additional  individuals  sequenced  with  short-read  WGS,  from  an  
independently  sequenced  cohort.  To  do  this  we  used  an  identical  alignment-assembly  approach  
of  assembling  unaligned  reads  from  these  individuals,  and  compared  the  resultant  contig  
sequences  against  the  finalized  APG  contigs.   
  
Comparisons  to  additional  genome  assemblies 
We  aligned  all  APG  contigs  to  four  additional  genome  assemblies:  a  Chinese  genome  assembly  
14 ,  a  Korean  genome  assembly  15 ,  the  chimpanzee  ( Pan  troglodytes )  genome  30   (Genbank  
accession  NC_006484,  assembly  GCA_000001515.7),  and  the  rhesus  macaque  ( Macaca  
mulatta)  genome  31   (Genbank  accession  GCA_000772875.3).  All  alignments  were  performed  
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using  bwa-mem  with  default  parameters.  Because  bwa-mem  sometimes  found  multiple  distinct  
alignments  for  a  contig,  the  best  query-consistent  set  of  alignments  for  each  contig  was  
retained,  so  no  part  of  an  APG  contig  aligned  to  more  than  one  location  in  the  reference.  The  
best  query-consistent  set  was  determined  by  comparing  the  sums  of  alignment  length  weighted  
by  percent  identity.  We  then  filtered  these  alignments  to  the  Chinese,  Korean,  chimpanzee,  and  
rhesus  macaque  genomes,  retaining  alignments  with  an  overall  identity  ≥  90%  that  covered  ≥  
80%  of  the  contig.  
  
We  compared  each  APG  contig's  alignment(s)  on  the  Chinese  and  Korean  genomes  to  all  
alignments  of  the  same  contig  to  GRCh38.p10  including  patches  and  alternate  loci,  obtained  as  
previously  described.  Among  the  contigs  aligning  to  the  Chinese  or  Korean  genomes,  we  
examined  further  those  with  a  better  alignment  (higher  identity  x  coverage)  to  the  Chinese  or  
Korean  genome  than  to  GRCh38.p10.  We  separated  these  further  into  two  categories,  those  
contigs  with  a  "reasonably  good"  alignment  to  GRCh38.p10  (≥  50%  contig  coverage  and  ≥  80%  
identity  for  query-consistent  sets  of  alignments  within  1  kb  of  one  another),  and  those  lacking  
reasonably  good  alignments  to  GRCh38.p10.  We  compared  alignments  to  the  chimpanzee  and  
rhesus  macaque  genomes  with  alignments  to  GRCh38.p10  in  the  same  manner,  as  well  as  
performing  the  same  analysis  comparing  chimpanzee  and  rhesus  macaque  alignments  to  the  
Chinese  and  Korean  alignments.  For  this  analysis  we  used  all  query-consistent  alignments  to  the 
Chinese  and  Korean  genomes,  not  just  those  with  ≥  90%  identity  and  ≥  80%  coverage.  
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We  detected  42,207  contigs  totaling  120.7  Mb  aligning  to  either  the  Korean  or  Chinese  
assemblies  with  ≥  90%  identity  and  ≥  80%  contig  coverage,  and  matching  the  Chinese  or  Korean  
assembly  better  than  GRCh38.  A  vast  majority  of  these  contigs  (32,955)  had  no  alignment  at  ≥  
80%  identity  and  ≥  50%  coverage  to  GRCh38.p10,  indicating  that  these  sequences  were  not  
simply  divergent  from  GRCh38,  but  rather  were  not  present  at  all  (Table  2.5).  An  example  of  
such  a  sequence  and  its  alignments  to  GRCh38  and  HX1  are  shown  in  Figure  2.7a.  This  suggests  
these  sequences  have  been  lost  in  the  small  number  of  individuals  used  to  create  GRCh38,  




While  Shi  et  al.  reported  12.8  Mb  of  novel  DNA  in  the  HX1  genome 99 ,  we  found  a  total  of  68.1  
Mb  shared  by  HX1  and  the  unique  sequences  in  the  APG  contigs  (Table  2.5).  To  examine  this  
further,  we  aligned  the  pan-genome  sequences  to  the  12.8  Mb  of  novel  sequence  from  HX1  and  
separately  to  the  entire  HX1  genome.  We  confirmed  that  the  68.1  Mb  of  sequences  do  align  to  
HX1  (with  ≥  90%  identity  and  ≥  80%  coverage  for  each  contig),  and  these  same  sequences  align  
poorly  or  not  at  all  to  GRCh38.  For  example,  CAAPA_26854,  a  15,617-bp  APG  sequence,  aligned  
from  positions  386–15617  (97.5%  coverage)  to  HX1  Super-Scaffold_142  from  positions  
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Table  2.5  |  Comparison  of  African  pan-genome  contigs  to  the  Chinese  and  Korean  genomes.  
  Best  GRCh38  alignment  is  
80-90%  identical  with   
50-80%  coverage  
  Best  GRCh38  alignment   
is  <  80%  identical  or  
<  50%  coverage   
    
  
Total  
  Contigs  Length  (bp)    Contigs  Length    Contigs  Length  
  Matches  Chinese  only  1,625  2,898,106    7,607  25,475,277    9,232  28,373,383  
  Matches  Korean  only  2,242  3,989,277    15,635  48,642,664    17,877  52,631,941  
Matches  both  5,385  9,720,662    9,713  29,981,048    15,098  39,701,710  
Total  9,252  16,608,045    32,955  104,098,989    42,207  120,707,034  
Contigs  with  a  better  alignment  to  the  Chinese  or  Korean  assemblies  than  to  GRCh38.  Alignments  to  the  Chinese  and  Korean  
assemblies  were  required  to  have  ≥  90%  identity  and  ≥  80%  coverage  to  be  considered.  Lengths  shown  are  the  sums  of  the  
contig  lengths,  not  the  alignment  lengths.  
1338365–1353606  at  99.7%  identity.  To  verify  this  sequence  was  novel,  we  aligned  it  to  
GRCh38.p10  using  BLAST   26   and  nucmer   34   in  addition  to  bwa-mem   28 .  The  best  match  was  an  
alignment  of  just  425  bp  at  81.9%  identity,  demonstrating  that  this  sequence  is  essentially  
absent  from  GRCh38.  However,  Super-Scaffold_142:1338365-1353606  was  not  included  in  the  
12.8  Mb  of  novel  sequence  reported  as  unique  to  the  Chinese  genome   14 .  This  reporting  
discrepancy  is  methodological:  the  Chinese  genome  assembly  has  relatively  large  scaffolds  
which  were  considered  unique  only  if  a  large  proportion  of  the  scaffold  failed  to  align  to  
GRCh38.  
  
Additional  comparisons  to  the  chimpanzee  and  rhesus  macaque  genomes  were  performed  to  
help  ensure  the  APG  sequences  were  not  contaminants.  Because  ~90%  of  the  human  genome  
can  be  aligned  to  chimpanzee  at  >  98%  identity,  we  expected  much  of  the  pan-genome  should  
be  detectably  similar  to  chimpanzee.  After  filtering  to  retain  only  query-consistent  alignments,  
123,582  contigs  had  some  portion  aligning  to  chimpanzee,  with  the  alignment  lengths  totaling  
177,388,896  bases.  Although  the  alignment  lengths  to  chimpanzee  only  make  up  ~60%  of  the  
total  APG  sequence,  an  additional  17,544,523  bases  that  did  not  align  to  chimpanzee  aligned  to  
rhesus  macaque,  for  a  total  of  194.9  Mb  on  123,603  contigs  aligning  to  at  least  one  non-human  
primate.  Furthermore,  over  98%  of  APG  contigs  had  at  least  a  partial  alignment  to  chimpanzee 
or  rhesus  macaque,  providing  further  validation  that  these  sequences  are  human  in  origin  
rather  than  contaminants.  Additionally,  near-perfect  alignments  to  chimpanzee  intersecting  
known  genes  may  provide  additional  clues  about  the  functionality  of  these  sequences.  For  
example,  the  novel  sequence  in  one  of  our  placed  contigs  contained  an  exon  of  the  KDMB6  
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gene  in  chimpanzee,  though  this  exon  is  missing  from  the  GRCh38  annotation  (Figure  2.7b).  It  
appears  that  this  exon  is  present  in  some  humans  as  well  as  in  chimpanzee.  This  KDMB6  
insertion  has  since  been  validated  by  the  discovery  of  this  variant  in  independent  datasets  
including  TOPMed 68   and  Audano  et  al 27 ,  both  of  which  report  finding  this  insertion  in  all  of  their  
sequenced  individuals,  indicating  that  the  reference  sequence  is  either  a  rare  deletion  or  an  




Figure  2.7  |  APG  alignments  to  other  genomes.  (a)  An  example  of  an  alignment  which  does  not  meet  the  50%  coverage,  80%  
identity  threshold  for  a  “reasonably  good”  alignment  to  GRCh38.  The  APG  contig  is  shown  at  the  top,  with  the  best  consistent  
alignments  to  GRCh38  in  the  middle.  The  three  constituent  alignments  (blue,  red,  and  yellow  segments)  cover  801  bases,  just  
under  25%  of  the  contig,  with  a  cumulative  weighted  identity  of  87.9%.  CAAPA_113686  has  a  single  near  perfect  alignment  to  a  
Chinese  HX1  contig  (delineated  by  dotted  lines)  covering  over  80%  of  CAAPA_113686  at  over  90%  identity.  The  APG  contig  also  
aligns  very  well  to  Korean  and  chimpanzee  contigs  (not  shown).  (b)  Detailed  alignments  of  a  1250-bp  APG  contig  (1386  bp  
untrimmed)  to  GRCh38  and  chimpanzee  (Pan_tro  3.0).  The  alignment  of  both  ends  indicates  the  contig's  position  on  human  
chromosome  17  (top),  where  it  is  missing  from  GRCh38.  Red  segments  represent  the  aligned  regions,  which  were  trimmed  prior 
to  reporting  the  final  APG  sequence.  CAAPA_TwoEndPlaced_219  aligns  end-to-end  to  chr17  of  the  chimpanzee  genome  
(bottom),  where  it  intersects  two  annotated  exons  of  the  KDM6B  gene.  On  GRCh38  the  exon  beginning  after  the  inserted  
sequence  is  the  first  exon  of  the  gene.  
Of  the  123,582  contigs  with  some  alignment  to  chimpanzee,  just  668  contigs  (1,666,093  bases,  
or  0.56%  of  the  total  APG  sequence)  aligned  better  to  chimpanzee  than  to  the  three  human  
assemblies  (and  aligned  to  chimpanzee  with  ≥  90%  identity  and  ≥  80%  coverage),  and  329  of  
these  (934,222  bp)  were  entirely  missing  from  the  three  human  assemblies  (Table  2.6).  
Comparisons  to  rhesus  macaque  yielded  an  additional  18  contigs  (50,174  bp)  aligning  better  
than  to  all  three  human  assemblies,  4  of  which  (9,403  bp)  were  missing  from  the  three  human  
assemblies.  These  sequences,  while  present  in  multiple  individuals  from  the  CAAPA  collection,  
may  have  been  lost  in  other  lineages.  It  is  also  possible  the  sequences  are  present  in  those  





As  an  additional  check  to  ensure  the  APG  sequences  were  not  contaminants,  we  examined  what  
portion  of  contigs  had  some  match,  even  just  a  partial  one,  to  the  GRCh38,  Korean,  or  Chinese  
assemblies.  After  filtering  to  retain  only  query-consistent  alignments,  98%  of  the  contigs  
(123,600)  had  some  portion  aligning  to  either  the  Chinese,  Korean,  or  GRCh38  assemblies.  The  
Korean  assembly  had  the  most  alignment,  with  123,585  contigs  contained  an  alignment  totaling  
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Table  2.6  |  African  pan-genome  contigs  with  better  alignments  to  chimpanzee  than  human.  
Pan-genome  contig  
aligns  better  to  
chimpanzee  than:  
   
Human  alignment  
≥  80%  identity  and  
≥  50%  coverage  
 Human  alignment  
<  80%  identity  or  
<  50%  coverage  
     
   
Total  
Contigs  Length  (bp)   Contigs  Length    Contigs  Length  
GRCh38  1,184 2,207,895 1,466 3,807,254 2,650 6,015,149 
Chinese  genome  476 1,074,143 480 1,298,145 956 2,372,288 
Korean  genome  633 1,373,570 448 1,266,471 1,081 2,640,041 
All  3  human  assemblies  -- -- 329 934,222 668 1,666,093 
African  pan-genome  contigs  that  align  better  to  chimpanzee  than  to  the  GRCh38,  Chinese,  or  Korean  genomes.  All  contigs  had  
alignments  to  chimpanzee  with  ≥  90%  identity  and  ≥  80%  coverage.  Lengths  shown  are  the  sums  of  the  contig  lengths.  
247.2  Mb  of  aligned  length,  or  83%  of  the  total  APG  sequence,  although  only  31,033  contigs,  
totaling  80.9  Mb  of  alignment,  aligned  with  over  ≥  90%  identity  and  ≥  80%  coverage.  
  
Determining  presence/absence  of  APG  contigs  in  WGS-sequenced  samples  
We  additionally  called  presence/absence  of  the  APG  insertions  in  short-read  sequencing  data  
from  12  individuals  from  6  European  populations  and  12  individuals  from  6  continental  African  
populations  from  the  Simons  Genome  Diversity  Project  (SGDP)   27 .  As  with  the  CAAPA  individuals,  
short  reads  from  these  24  individuals  were  aligned  to  the  reference  genome,  and  unaligned  
reads  assembled  with  MaSuRCA.  Raw  contigs  from  the  MaSuRCA  assemblies  (including  contigs  
under  1  kb)  were  aligned  to  the  final  set  of  APG  contigs  with  bwa  mem  using  default  
parameters.  Alignments  to  an  APG  contig  aligning  within  300  bp  of  one  another  were  chained  to  
create  longer  alignments  where  possible.  Identity  of  the  chained  alignment  was  taken  to  be  the  
identity  of  these  alignments  weighted  by  length,  and  coverage  was  taken  to  be  the  total  aligned  
bases  over  the  total  APG  contig  length.  If  an  individual’s  raw  contig  alignments  produced  an  
alignment  with  ≥  90%  identity  and  ≥  80%  coverage  to  an  APG  contig,  that  APG  contig  was  called  
as  present.  
  
The  SGDP  samples  varied  widely  in  the  number  of  APG  sequences  they  contained;  4  of  the  
Africans  and  4  of  the  Europeans  contained  ~1000  APG  sequences  each,  while  5  Africans  and  1  
European  (English)  sample  contained  ~700  insertions  (Figure  2.8).  This  could  be  due  to  
admixture  in  the  CAAPA  samples,  in  which  9  of  19  cohorts  were  African-American,  or  to  
admixture  in  the  European  SGDP  samples,  or  some  combination  of  both.  
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To  further  examine  how  well  the  APG  contigs  represent  continental  African  populations,  we  
additionally  examined  the  APG  contigs  present  in  only  the  continental  African  SGDP  samples  
and  only  the  European  SGDP  samples,  but  not  both.  The  European  SGDP  samples  cumulatively  
contained  4,645  of  the  APG  insertions,  while  the  African  samples  contained  4,381  insertions,  
with  1,961  of  these  insertions  appearing  in  both  populations.  We  examined  the  2,684  present  in  
the  12  European  samples  but  not  the  African  samples,  as  well  as  2,420  present  in  the  African  
but  not  European  samples.  Although  these  sequences  may  not  be  fully  specific  to  these  
populations  because  we  examined  only  12  samples,  we  took  these  to  represent  sequences  
tending  toward  European  and  African  specificity.  The  European-specific  contigs  were  found  at  a  
somewhat  lower  frequency  in  the  CAAPA  samples  (47  contigs  per  individual  on  average)  than  
65  
Figure  2.8  |  APG  contigs  present  in  Simons  Genome  Diversity  Project  populations.  Twenty-four  individuals  from  the  Simons 
Genome  Diversity  Project  from  12  populations,  6  African  (red)  and  6  European  (blue),  were  examined  to  determine  
presence/absence  of  the  APG  contigs.  Each  individual’s  assembled  contigs  were  aligned  to  the  APG  contigs  to  determine  the  
number  of  APG  contigs  present  in  the  individual.  The  same  analysis  was  performed  to  determine,  via  this  genotyping  method,  
the  average  number  of  contigs  per  CAAPA  cohort  individual  (green).  
the  African  specific  contigs  (63  per  individual  on  average).  This  difference  provides  some  
evidence  that  despite  the  admixed  nature  of  the  dataset,  the  APG  sequences  reported  
represent  sequences  present  in  African  populations  more  so  than  European  populations,  
though  the  inclusion  of  European  derived  DNA  is  expected  in  the  APG  sequences  due  to  
admixture. 
  
The  same  alignment  procedure  was  performed  for  all  910  CAAPA  individuals  as  well  to  
determine  presence/absence  of  each  APG  contig  in  each  individual.  This  genotyping  was  done  
after  finalizing  the  APG  insertion  set  both  due  to  the  possibility  that  an  APG  insertion  originally  
assembled  in  multiple  pieces  under  1kb,  and  thus  was  not  initially  included,  but  was  indeed  
present  in  a  CAAPA  individual,  as  well  as  due  to  the  difficulty  of  tracking  best  alignments  during  
the  stage  where  contigs  from  all  910  individuals  were  iteratively  merged.  We  report  this  
presence/absence  genotyping  in  the  CAAPA  individuals  as  a  matrix  of  contigs  by  individuals,  
where  a  “1”  was  included  in  the  matrix  if  the  alignment  criteria  described  above  were  met  
(Supplementary  Data  in  Sherman  et  al  2019 78 ).  
  
Additionally,  for  the  placed  contigs,  because  we  had  already  determined  which  individuals  
contained  these  sequences,  the  genotype  matrix  was  supplemented  by  adding  a  presence  call  
(“1”)  if  we  had  determined  that  an  individual  had  a  contig  in  the  placement  cluster.  This  
additional  calling  allowed  for  increased  sensitivity  for  individuals  who  had  mate  placement  
information  available  for  the  insertion,  even  when  the  contigs  did  not  meet  the  
identity/coverage  criteria  used  for  genotyping.  The  “genotype”  matrix  entries  indicate  
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presence/absence  calls  represented  as  1  or  0;  heterozygous  and  homozygous  genotypes  are  not  
differentiated.  
  
Using  the  genotype  matrix,  we  estimated  whether  the  pan-genome  would  continue  to  grow  as  
more  individuals  were  sequenced  by  randomly  sampled  varying  numbers  of  individuals  within  
our  dataset  and  using  the  genotype  matrix  to  determine,  in  each  subset,  how  much  of  the  APG  
sequence  was  present.  Each  data  point  was  an  average  of  10  random  samplings,  each  with  the  
same  number  of  individuals.  The  amount  of  DNA  added  to  the  pan-genome  appears  to  be  
increasing  approximately  linearly  as  the  sample  size  grows,  and  has  not  reached  an  asymptote  
with  910  individuals,  though  the  amount  of  shared  sequence  begins  to  level  off,  indicating  that  
as  more  individuals  are  sequenced,  the  number  of  private  insertions  grows  more  dramatically  
than  shared  sequences  (Figure  2.9).  
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Figure  2.9  |  Amount  of  
APG  DNA  by  number  of  
individuals.  Individuals  
were  randomly  sampled  
and  the  combined  lengths  
of  the  set  of  APG  contigs  
contained  in  those  
individuals  was  recorded,  
as  determined  by  the  
presence/absence  
genotyping  matrix.  Each  
point  is  an  average  of  10  
random  samples  of  the  
given  number  of  
individuals.  Error  bars  are  
standard  deviation.  For  
the  blue  markers,  only  
DNA  present  in  more  than  
one  of  the  910  individuals  
is  counted  in  the  total.  
2.5  Implications  of  discovering  296  Mb  of  non-reference  sequence  in  910  individuals  
Our  findings  here  demonstrate  that  the  standard  human  reference  genome  lacks  a  substantial  
amount  of  DNA  sequence  compared  to  other  human  populations.  The  APG  sequences  contain  
296.5  Mb,  equal  to  10%  of  the  genome,  regions  that  will  necessarily  be  missed  by  any  efforts  
relying  only  on  GRCh38  to  study  human  variation,  as  nearly  all  studies  do  today.  Of  these  296.5  
Mb,  120.7  Mb  were  shared  by  the  Korean  or  Chinese  populations,  suggesting  those  regions  may  
have  been  lost  more  recently  or  may  be  rare  in  the  specific  populations  represented  in  GRCh38.  
Additional  analyses  of  the  APG  sequences  have  also  examined  satellite  repeats.  While  we  
reported  via  RepeatMasker  that  satellite  DNA  comprises  ~22%  of  the  sequences,  a  subsequent,  
more  focused  analysis  by  Karen  Miga  determined  that  ~85%  of  the  APG  sequences  have  exact  
oligo  matches  to  HSAT  II  or  III  repeats 73 .  The  variation  in  HSAT  II  and  III  repeats  between  
individuals  and  populations  is  understudied,  in  part  because  of  a  lack  of  representation  of  these  
sequences  in  GRCh38,  though  these  centromeric  satellites  have  been  implicated  in  disease  
association  studies.  The  APG  sequences  we  present  here  can  aid  in  examining  HSAT  variation,  
and  be  a  first  step  to  producing  better  references  for  these  diverse  regions.  
  
Overall  these  results  suggest  that  a  single  reference  genome  is  not  adequate  for  
population-based  studies  of  human  genetics.  And  although  we  are  amassing  a  wealth  of  
pan-genomic  data  in  both  global  and  population-specific  studies  such  as  ours,  what  to  do  with  
these  data  remains  an  open  question.  The  creation  of  a  single,  global  human  pan-genome  holds  
conceptual  appeal,  and  cataloguing  all  human  variation  is  a  noble  goal.  However,  to  date  no  
computational  method  is  capable  of  aligning  human  sequences  to  a  pan-genome  of  all  human  
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variation,  while  enforcing  that  alignments  be  biologically  plausible,  although  research  on  
efficient  indexing,  storage,  and  traversal  of  graphical  representations  is  actively  underway  that  
might  solve  this  problem 122–124 .   
  
Instead,  a  better  approach  may  be  to  create  reference  genomes  for  all  distinct  human  
populations,  which  over  time  will  eventually  yield  a  comprehensive  pan-genome  capturing  all  of  
the  DNA  present  in  humans.  Efforts  to  develop  additional  reference  genomes  are  gaining  steam  
in  recent  years,  in  part  because  our  ability  to  accurately  assemble  these  genomes  is  rapidly  
improving.  Recently  the  first  telomere-to-telomere  assembly  of  a  human  chromosome 125   
demonstrated  that  newly  produced  genomes  utilizing  third-generation  sequencing  have  the  
potential  to  be  of  higher  contiguity  than  the  current  reference.  We  recently  produced  an  
assembly  of  an  Ashkenazi  individual  with  contiguity  surpassing  GRCh38  and  complete  gene  
annotation 101 ,  using  PacBio  and  Nanopore  data  and  a  recent  paper  produced  an  assembly  of  a  
widely  used  cell  line,  WI-38  using  PacBio  data,  which  contains  153  scaffolds  over  1  kb  which  
align  to  our  APG  contigs 126 ,  demonstrating  that  better  assemblies  will  capture  some  of  the  novel  
sequences  we  have  reported  which  are  present  in  many  individuals  but  absent  from  GRCh38.  
With  a  plethora  of  human  reference  genomes,  individuals  could  be  analyzed  by  comparing  them  
to  their  closest  matching  population  or  populations,  even  if  this  information  is  not  known  a  
priori,  resulting  in  far  fewer  ‘missed’  sequences  when  aligning  an  individual  to  a  reference  
genome.   
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Regardless  of  what  representations  are  ultimately  used  to  capture  these  genomes,  it  seems  
inevitable  that  we  will  soon  move  beyond  our  reliance  on  a  single  human  reference  genome,  
which  as  we  have  demonstrated  in  our  African  pan-genome  analyses,  is  not  sufficiently  
representative  of  human  populations.  Approaches  that  capture  the  vast  amounts  of  variation  in  
the  population,  whatever  computational  form  they  may  end  up  taking,  will  be  a  critical  tool  in  
helping  us  understand  and  analyze  the  genetic  instructions  that  make  us  human.  
  
2.6  Commands  and  parameters  
---------------------------------------  
Bowtie  2  alignment,  per  sample  
---------------------------------------  
bowtie2-build  [GRCh38_no_alt]  [GRCh38_no_alt_idx]  
bowtie2  -x  [GRCh38_no_alt_idx]  [reads1]  [reads2]  >  [alignments.bam]  
  
---------------------------------------------------------------------------------  
Extraction  of  unaligned  reads  (and  mates)  via  samtools,  per  sample  
---------------------------------------------------------------------------------  
samtools  fastq  –f  12  [alignments.bam]  -1  [mateUnmapped_R1.fq]  -2  
[mateUnmapped_R2.fq]  
samtools  fastq  –f  68  –F  8  [alignments.bam]  >  [R1_mateMapped.fq]  
samtools  fastq  –f  132  –F  8  [alignments.bam]  >  [R2_mateMapped.fq]  
samtools  view  –f  8  –F  4  [alignments.bam]  >  [GRCh38Links.bam]  
  
-----------------------------------------  
MaSuRCA  assembly,  per  sample  
-----------------------------------------  
masurca_config.txt :  
**********************************************************  
DATA  
PE=  pe  300  50  [mateUnmapped_R1.fq]  [mateUnmapped_R2.fq]  
PE=  s1  300  50  [R1_mateMapped.fq]  














masurca  masurca_config.txt  &&  ./assemble.sh  
  
----------------------------  
Centrifuge,  per  sample  
----------------------------  
centrifuge  --report-file  [centrifuge.report]  -x  [centrifugedb]  -k  1  
--host-taxids  9606  -f  [masurca_contigs_over1kb.fa]  >  [centrifuge.output]  
 
centrifuge-kreport  -x  [centrifugedb]  [centrifuge.output]  --min-score  0  
--min-length  0   >  [centrifuge.krakenOut]  
  
***  centrifuge.krakenOut  was  used  to  filter  any  non-chordate  identified  reads.  ***  
  
---------------------------------------------------------  
RepeatMasker  on  assembly  contigs,  per  sample  
---------------------------------------------------------  
RepeatMasker  -nolow  -species  human  [filteredContigs.fa]  
  
-------------------------------------------------------------  
Bowtie  2  alignment  of  reads  to  contigs,  per  sample  
-------------------------------------------------------------  
bowtie2-build  [filteredContigs.fa.masked]  [contigIdx]  




Linking  mates  to  implicated  region,  and  aligning  to  region,  per  sample  
-------------------------------------------------------------------------------------  
samtools  view  -h  -F  256  [readContigAlignment.sam]  |  samtools  sort  -  -n  –O  bam  
|  bedtools  bamtobed  -i  stdin  |  awk  '{OFS=”\t”}{print  $4,$1,$6,$2,$3}'  |  sort  >  
[readContigAlignment.txt]  
 
samtools  view  -H  [GRCh38Links.bam]  |  cat  -  <(awk  'FNR==NR{main[$1]=$0;next}  $1  
in  main  {print  main[$1]}'  <(samtools  view  [GRCh38Links.bam])  
[readContigAlignment.txt])  |  samtools  sort  -n  –O  bam  |  bedtools  bamtobed  -i  
stdin  |  awk  '{OFS=”\t”}{print  $4,$1,$6,$2,$3}'  |  sed  -e  's/\/[1-2]//g'  |  sort  
>  [matchedMates.txt]  
 
join  -j  1  [readContigAlignment.txt]  [matchedMates.txt]  >  [mateLinks.txt]  
  
***  Filtering  was  performed  here  using  python  scripts  to  examine  links  to  contig  ends  only,  and  
filter  based  on  described  unambiguity  criteria  as  described  in  Chapter  2.2.  Contig  ends  and  
GRCh38  regions  meeting  criteria  were  extracted  with  samtools  faidx  ***  
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Clustering  of  placed  contigs  
----------------------------------  
bedtools  merge  -d  100  -c  4  -o  distinct  [placedCtgLocations.bed]  >  
[mergedClusters.bed]  
nucmer  -p  [deltaFile]  [repCtg.fa]  [restOfClusterCtgs.fa]  
nucmer  -p  [deltaFile]  [verifiedClusterCtgs.fa]  [unplacedCtgs.fa]  
  
----------------------------------------------------------------------------  
Left/Right  one  end  placement  merging  into  two  end  placement  
----------------------------------------------------------------------------  
nucmer  --maxmatch  --nosimplify  -p  [deltaFile]  [leftEndedPlaced.fa]  
[rightEndPlaced.fa]  
show-coords  -H  -T  -l  -c  -o  [deltaFile]  >  [coordsFile]  
  
------------------------------------------  
Removal  of  redundant  placements  
------------------------------------------  
nucmer  --maxmatch  --nosimplify  -p  [deltaFile]  [allPlaced.fa]  [allPlaced.fa]  
  
-------------------------------------  
Clustering  of  unplaced  contigs  
-------------------------------------  
nucmer  --maxmatch  --nosimplify  -l  31  -c  100  -p  [deltaFile]  [unPlaced.fa]  
[unPlaced.fa]  
show-coords  -H  -T  -l  -c  -o  [deltaFile]  >  [coordsFile]  
  
***  Additional  analysis  was  performed  on  the  alignments  to  find  and  remove  contigs  contained  
within  two  contigs  with  the  ends  overlapping  (see  Chapter  2.2)  ***  
  
----------------------  
Further  screening  
----------------------  
kraken  --db  [database]  [APG_Sequences.fa]  
 
blastn  -db  [nt]  -query  [kraken_nonMammalHits.fa]  -outfmt  "6  qseqid  sseqid  
pident  length  mismatch  gapopen  qstart  qend  sstart  send  qlen  slen  evalue  
bitscore  qcovs  qcovhsp  staxids  sscinames"  -max_hsps  1  -max_target_seqs  1  –out  
[blastOutput]  
  
bwa  index  [GRCh38.p10_primaryChrs]  
bwa  index  [GRCh38.p10]  
bwa  mem  [GRCh38.p10_primaryChrs]  [APG_Sequences_noContamiants.fa]  




Genotyping,  per  sample  
-----------------------------  
bwa  index  [APG_Sequences_final.fa]  




Comparisons  to  other  genomes  
--------------------------------------  
bwa  index  reference   
bwa  mem  [reference]  [APG_Sequences_final.fa]  
  
------------------------------  





In  addition  to  these  primary  commands,  additional  filtering  steps  and  custom  analyses  were  
performed,  as  described  previously.  Filtering  commands  were  primarily  performed  using  awk  
and  filtering  for  identity  and  coverage  was  always  performed  on  coords  files  produced  by  
show-coords ;  if  bwa  was  used  for  alignments  in  place  of  nucmer ,  the  sam  files  were  





GRCh38_no_alt  GCA_000001405.15_GRCh38_no_alt_analysis_set.fna  
GRCh38.p10  GCF_000001405.36_GRCh38.p10_genomic.fna  
KOREF  GCA_001712695.1_KOREF1.0_genomic.fna  
HX1  hx1f4s4full_3rdfixedv2.fa  
Chimpanzee  GCA_000001515.7  
Rhesus 
Macaque 
 GCA_000772875.3  
2.7  Addendum  
A  recent  BioRxiv  paper  performed  additional  analyses  on  the  African  pan-genome  sequences  
described  here  to  determine  if  they  contain  any  non-human  contaminants 127 .  This  analysis  went  
beyond  our  sequence-based  filtering,  using  a  combination  of  translated  nucleotide  searches  
against  a  protein  database  with  Kaiju 128 ,  plus  additional  DIAMOND 129 ,  BLASTn 121 ,  and  protein  
prediction/family  identification  on  the  non-repetitive  sequences  in  the  APG  contigs.  The  paper  
reports  1,475  APG  contigs  as  contaminants.  933  of  these  were  additionally  previously  reported  
as  contamination  in  a  large-scale  analysis  of  GenBank  and  RefSeq,  where  over  2  million  
contaminated  GenBank  entries  were  found,  including  1,003  contigs  from  the  APG  set 130 .  We  
have  since  updated  the  GenBank  entry  for  the  APG  sequences,  removing  all  1,475  contigs  
reported  as  contamination  in  the  Manni  and  Zbobnov  BioRxiv  paper.  The  results  in  Chapter  2  
have  not  been  updated  since  this  removal,  so  the  numbers  presented  are  slightly  different  than  
they  would  be  if  recalculated  with  the  updated  APG  set.  However,  as  only  ~1%  of  the  total  APG  
sequence  was  removed,  the  overall  findings  and  conclusions  from  Chapter  2  remain  unchanged.  
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Chapter  3:  Utilizing  RNA-seq  to  discover  novel  exons  in  non-reference  sequences  
  
  
Some  of  the  work  in  Chapter  3  was  performed  by  my  summer  undergraduate  mentee,  William  
Cho,  under  my  supervision.  
  
3.1  Background:  RNA-sequencing  and  analyses  
RNA  can  be  sequenced  in  a  similar  manner  to  DNA;  mRNA  is  taken  from  the  cell  and  used  as  a  
template  strand  to  create  cDNA  (complementary  DNA),  which  can  be  sequenced  as  described  in  
Chapter  1.2.  Recent  developments  also  allow  for  sequencing  RNA  from  a  single  cell,  and  direct  
sequencing  of  RNA,  but  these  advances  will  not  be  discussed  here.  The  majority  of  RNA  
sequencing  (RNA-seq)  is  RNA  taken  from  many  cells  at  once  (bulk  RNA-seq),  though  tissues  are  
generally  separated,  and  RNA-seq  is  often  used  to  examine  tissue  specific  expression.  Since  in  
humans,  genes  contain  introns  and  exons,  and  the  introns  are  spliced  out  to  create  mRNA,  
aligning  sequenced  mRNA  back  to  the  human  genome  will  necessarily  not  align  in  one  piece;  
RNA-seq  will  only  align  to  exonic  regions,  and  reads  spanning  the  splicing  boundary  between  
exons  will  align  non  continuously  in  a  split  manner,  half  to  the  end  of  one  exon,  half  to  the  start  
of  the  next,  with  an  intron  between.  To  account  for  this,  specialized  spliced  aligners  are  used  for  
RNA-seq  data,  including  STAR 131 ,  TopHat2 132 ,  and  HISAT2 63 ,  which  consider  that  these  alignments  
split  across  exons  should  be  ‘good’  alignments.  These  aligners  can  take  in  gene  annotation  
information  on  the  reference  genome  to  provide  an  additional  prior  for  where  read  splits  are  
expected,  though  the  aligners  can  find  novel  splits  as  well,  where  exons  are  not  annotated.  
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An  additional  set  of  tools,  transcriptome  assemblers,  such  as  Scallop 133 ,  or  StringTie2 134 ,  can  take  
in  spliced  RNA-seq  alignments,  and  attempt  to  resolve  what  isoforms  of  a  transcript  are  present.  
In  humans,  a  phenomenon  called  alternative  splicing  allows  a  single  gene  to  be  spliced  in  
various  ways;  including  and  excluding  different  exons  in  a  given  transcript.  This  is  thought  to  
allow  for  more  flexibility  --  many  more  isoforms,  and  thus  proteins,  are  possible  than  just  the  
number  of  genes.  Short  read  lengths,  however,  make  transcript  assembly  difficult.  Exons  are  
linked  together  based  on  the  presence  of  reads  spanning  the  boundary  of  two  exons,  but  seeing  
for  example,  reads  spanning  exon  1  and  3,  and  reads  spanning  exon  3  and  4,  does  not  
necessarily  mean  that  a  transcript  with  exons  1,  3,  and  4  exists  --  the  spanning  reads  may  belong  
to  different  transcripts.  Reads  spanning  more  than  two  exons  are  rare  with  short  read  
sequencing,  as  exons  are  typically  longer  than  the  read  length.  Transcriptome  assembly  can  
additionally  consider  coverage  information  to  determine  what  transcripts  exist;  if  transcripts  are  
expressed  at  differing  levels,  the  number  of  reads  spanning  each  exon  junction  can  be  examined  
to  determine  the  most  statistically  likely  pattern  of  exons/transcripts.  
  
RNA-sequencing  data  is  abundant.  Data  sets  exist  across  many  populations,  body  tissues,  and  
across  changing  conditions  and  time  points  within  a  single  individual’s  life.  One  of  the  most  
extensive  RNA-seq  datasets  is  from  the  Gene-Tissue  Expression  (GTEx)  Consortium,  which  has  
produced  RNA-seq  data  from  over  50  tissues  due  to  post-mortem  collection,  as  internal  tissue  
samples  are  difficult  to  impossible  to  obtain  from  live  donors,  and  has  over  17,000  samples  in  
the  latest  version 135 .  Much  like  with  whole  genome  sequencing  data,  the  typical  pipelines  for  
analysis,  as  described  above  and  illustrated  in  Figure  3.1,  begin  with  alignment  to  the  reference   
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genome.  Thus  as  with  reference-based  DNA-sequencing  analyses,  this  approach  will  miss  any  
novel  transcribed  sequences.  Furthermore,  RNA-seq  analysis  is  highly  biased  by  the  existing  
gene  annotation,  which  is  often  provided  to  both  alignment  and  transcript  assembly  tools  (and  
for  some  tools  is  required).  While  providing  annotation  can  help  with  downstream  expression  
quantification  on  known  genes  and  transcripts,  it  will  at  best  bias  tools  away  from  finding  new  
genes  and  transcripts,  and  at  worst  will  be  unable  to  find  them  at  all,  in  the  case  of  tools  which  
only  perform  reference-guided  transcriptome  assembly.  Recent  research  has  shown  that  despite  
many  years  of  examining  the  human  genome  through  RNA-seq  data,  we  still  continue  to  find  
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Figure  3.1  |  A  typical  RNA-seq  
analysis  pipeline.  First,  RNA-seq  
reads  are  aligned  to  the  reference  
genome  with  a  spliced  aligner.  
Spliced  alignments  are  indicated  by  
dashed  lines.  Then,  a  transcriptome  
assembler  attempts  to  resolve  the  
alignments  into  isoforms.  Here,  
there  are  three  isoforms,  the  ‘truth’  
of  which  isoform  a  read  originated  
from  is  indicated  by  color,  but  an  
assembler  may  not  be  able  to  
resolve  this,  as  there  are  no  spliced  
links  between,  for  example,  the  two  
exons  with  pink  reads  aligned  to  
them.  Figure  from  Costa  et  al  
2018 136 .  
new  transcripts  present  in  reference  sequence  and  ‘known’  transcripts  that  appear  to  be  simply  
noise 71 ;  what  transcription  we  might  find  in  non-reference  sequence  is  still  largely  unexplored.  
  
3.2  Analysis  of  296  Mb  non-reference  sequence  for  transcription  potential  
  
While  the  location  of  much  of  the  296  Mb  of  non-reference  sequence,  described  in  Chapter  2,  is  
unknown,  it  is  possible  that  some  of  the  novel  sequence  is  transcribed.  Unfortunately,  we  don’t  
have  RNA-seq  data  from  the  individuals  these  sequences  came  from,  but  RNA-seq  data  is  
available  from  many  thousands  of  other  individuals  through  the  GTEx  consortium.  Since  the  
novel  sequences  are  expected  to  be  present  in  many  individuals  based  on  our  analyses  of  
sequence  present  in  data  from  the  Simons  Genome  Diversity  Project 52   and  the  Korean 100   and  
Chinese 99   reference  genomes,  we  can  look  at  public  RNA-seq  data  for  and  see  if  any  individuals  
and  tissues  appear  to  have  these  sequences  transcribed.  To  do  this  we  can  align  GTEx  RNA-seq  
data,  which  in  the  latest  version,  v8,  consists  of  over  17,000  samples  from  948  post-mortem  
donors  across  54  tissues 135 ,  to  the  novel  sequences.  Indications  of  transcription  in  the  African  
Pan  Genome  (APG)  sequences  would  include:  
1. Spliced  alignments  of  RNA-seq  reads  to  APG  contigs  with   
a. Deep  coverage  of  these  spliced  alignments  
b. Spliced  alignments  in  multiple  individuals  and  multiple  tissues  
c. Clear  differential  expression  across  tissues  
2. Alignments  are  predominantly  not  from  multi-mapped  reads  
3. Regions  the  reads  align  to  are  not  repetitive/low-complexity  
4. Regions  with  alignments  have  matches  to  known  mammalian  proteins  when  translated  
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5. Regions  with  alignments  align  to  annotated  genes  in  primates  or  other  mammals  
  
We  have  performed  a  preliminary  analysis,  using  a  subset  of  93  GTEx  samples,  3  samples  in  
each  of  31  tissues,  to  examine  these  questions  and  decide  whether  to  proceed  further  using  the  
full  GTEx  data  set.  Reads  from  each  of  the  93  samples  which  did  not  align  to  GRCh38  were  
aligned  to  the  125,715  APG  sequences,  using  TopHat2 132   (a  HISAT2 63   bug  at  the  time,  which  has  
since  been  resolved,  led  us  to  use  TopHat2).  StringTie2 134   was  then  run  in  a  per  contig  (pooling  
reads  from  samples)  manner,  as  in  many  cases  a  single  sample  did  not  have  sufficient  coverage  
for  StringTie2  to  produce  a  novel  transcript,  even  where  splice  alignments  existed.  Contigs  were  
then  analyzed  and  using  a  python  script  a  number  of  features  were  reported  per  contig.  These  
features  included  the  number  tissues  with  alignment,  the  total  number  of  reads  aligning  and  
the  percentage  of  those  aligning  in  a  spliced  manner,  information  from  StringTie2  (number  of  
transcripts,  number  of  exons),  how  many  of  the  potential  exon  regions  were  masked  with  
RepeatMasker 117 ,  and  a  breakdown  of  read  mapping  quality.  This  information  was  provided  for  
pooled  sample  data  per  contig,  as  well  as  reported  for  the  single  sample  with  the  most  aligned  
reads  to  the  contig.  By  using  this  method,  different  metrics  can  easily  be  used  to  determine  the  
‘best’  candidates,  which  can  then  be  examined  by  hand,  prior  to  proceeding  and  determining  
how  to  prioritize  candidates  in  a  more  principled  manner.  A  sample  of  the  csv  output  produced  




Top  potentially  transcribed  candidate  contigs  were  then  examined  by  hand  in  IGV  to  determine  
if  they  appeared  to  have  the  expected  intron/exon  structure  of  a  gene.  Several  contigs  were  
deemed  to  be  reasonable  candidates,  including  CAAPA_OneEndPlaced_1042,  a  contig  which  
had  been  placed  within  the  MUC19  gene  on  chromosome  12  (Figure  3.3),  and  
CAAPA_OneEndPlaced_337,  which  appears  to  be  a  variant  of  1042.  This  top  candidate,  in  fact,  
has  been  previously  examined  in  a  2011  study  which  cloned  and  characterized  the  MUC19  gene,  
and  reported  as  a  known  alternative  splicing/transcript  variant  (Genbank  entry  HM801863.1 ) 137 .  
However,  despite  being  reported  in  2011,  the  sequence  of  this  transcript  is  still  not  included  in  
any  version  of  the  human  reference  genome.  These  transcribed  sequences,  as  well  as  
CAAPA_TwoEndPlaced_218  within  MUC16  (Figure  3.4),  are  of  particular  interest  as  mucin  genes  
are  known  to  be  involved  in  asthma.  As  the  CAAPA  cohort  consists  of  nearly  half  asthma  cases,  
we  are  further  examining  whether  there  might  be  SNPs  or  small  variants  within  these  novel  
regions  that  show  a  significant  association  with  asthma  in  the  original  CAAPA  sequences,  though  
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Figure  3.2  |  Sample  pipeline  output  summarizing  GTEx  alignments  to  APG  contigs.  In  addition  to  producing  statistics  on  
splicing  and  transcripts  from  StringTie2  (if  applicable),  the  report  also  provides  vectors  of  the  tissues  and  the  percentage  of  
reads  from  each,  and  a  vector  with  a  distribution  of  the  read  mapping  qualities.   
the  presence  of  the  contigs  themselves  are  not  correlated  (refer  back  to  Figure  1.11  for  an  
illustration  of  SNP  discovery  in  novel  sequence).  
  
  
While  not  all  candidates  for  novel  transcription  are  as  clear  candidates  as  that  in  Figure  3.3,  
many  candidates  without  previously  reported  non-reference  sequence  also  appear  to  be  
transcribed.  Just  based  on  our  preliminary  analysis,  nearly  30  candidates  show  promising  
patterns  of  spliced  alignment,  though  some  are  noisier  than  others  (Figure  3.4).  We  expect  
using  the  full  GTEx  dataset  may  produce  additional  candidates,  particularly  as  it  includes  over  




Figure  3.3  |  IGV  screenshot  of  spliced  GTEx  alignments  to  an  APG  contig.  CAAPA_OneEndPlaced_1042  is  5,688  bases,  and  
appears  to  contain  9  exons.  Nearly  all  reads  aligning  to  the  contig  are  spliced  (indicated  by  blue  lines  connecting  reads).  It  has  a  
clear  signature  of  exons,  although  they  are  fairly  close  together,  and  does  not  have  spurious  read  alignments  in  the  intronic  
regions.  None  of  the  contig  is  masked  by  RepeatMasker.  
  
Candidate  contigs  were  additionally  run  through  a  translated  BLAST  search,  to  look  for  possible  
protein  homology  with  other  species,  even  if  the  sequences  are  not  well  conserved  at  a  DNA  
level.  This  would  provide  an  additional  line  of  evidence  that  these  human  sequences  are  indeed  
transcribed.  For  example,  BLAST-X  on  CAAPA_TwoEndPlaced_218  yields  hits  to  mucin-16  in  
several  primates,  covering  up  to  21%  of  the  contig  at  over  97%  identity  (predicted  mucin-16-like  
in  Gorilla),  providing  additional  validation  that  this  sequence  is  placed  correctly,  transcribed,  
and  part  of  the  human  MUC16  gene.  
  
Additional  novel  sequence  sets,  many  of  which  are  described  in  Table  1.1,  can  additionally  be  
added  to  further  extend  these  analyses.  The  full  v8  GTEx  data  set  can  then  be  aligned  to  all  
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Figure  3.4  |  Clearly  spliced  alignments  may  still  exhibit   low  coverage  and/or  noise.  Read  alignments  to  this  7,121bp  APG  
contig,  CAAPA_TwoEndPlaced_218,  placement  of  which  intersect  the  MUC16  gene,  are  shown  in  two  distinct  samples.  Both  
samples  have  low  (~10x)  coverage  of  the  region,  but  do  appear  to  have  spliced  alignments  indicating  exons,  though  there  are  
un-spliced  alignments  between  two  possible  exons;  possibly  due  to  noise  from  alignment  to  repetitive  sequence,  though  this  
region  is  not  masked  by  RepeatMasker.  A  similar  alignment  pattern  is  seen  in  24  samples  across  16  different  tissues.  
available  novel  sequence  sets.  As  novel  sequence  sets  are  now  being  produced  with  long  reads  
as  well,  more  sequences  are  localized  in  the  reference  genome,  an  added  benefit  to  including  
these  in  RNA-Seq  analyses.  A  recent  study  similarly  examined  alignments  of  reference-unaligned  
GTEx  reads  to  their  novel  sequence  set  based  on  novel  sequences  from  338  human  assemblies,  
finding  nearly  5,000  sequences  which  appeared  to  be  transcribed  across  all  tissues,  and  
additional  tissue  specific  transcription 138 .  However,  this  work  too  is  preliminary,  using  a  subset  
of  the  GTEx  data  --  10  samples  from  each  of  31  tissues  --  and  the  analysis  appears  to  primarily  
consider  whether  reads  align,  regardless  of  if  they  align  in  a  spliced  manner.  Despite  potential  
shortcomings,  though,  this  analysis  again  highlights  the  importance  of  examining  sequences  
missing  from  the  reference  genome;  many  of  these  sequences  are  common,  genic,  and  likely  
functional,  and  further  analyzing  non-reference  sequences  for  transcriptional  potential  may  
lead  to  new  insights  in  functional  genomics.   
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Chapter  4:  Utilizing  graph-based  genotyping  to  assess  disease  relevance  of  structural  
variants  (SVs)  detected  with  long-read  sequencing  
  
In  this  chapter  we  examine  structural  variation  solely  utilizing  alignment,  rather  than  assembly  
based  methods,  a  strategy  made  possible  due  to  the  recent  advances  in  long  read  (third  
generation)  sequencing  technologies.  The  work  in  Chapter  4  was  primarily  overseen  by  Mike  
Schatz  and  portions  of  Chapter  4  are  also  described  in  the  following  publications,  on  which  I  am  
an  author:  
Aganezov,  S.,  Goodwin,  S.,  Sherman,  R.  M.,  Sedlazeck,  F.  J.,  Arun,  G.,  Bhatia,  S.,  ...  &  Schatz,  M.  C.  
(2020).  Comprehensive  analysis  of  structural  variants  in  breast  cancer  genomes  using  
single-molecule  sequencing.  Genome  Research.  
  
Chen,  S.*,  Krusche,  P.*,  Dolzhenko,  E.,  Sherman,  R.  M.,  Petrovski,  R.,  Schlesinger,  F.,  ...  &  Eberle,  
M.  A.  (2019).  Paragraph:  A  graph-based  structural  variant  genotyper  for  short-read  sequence  
data.  Genome  Biology  20,  291.  
  
This  chapter  focuses  on  the  aspects  of  these  projects  which  I  was  most  heavily  involved  in,  
regardless  of  if  those  portions  of  the  analyses  ended  up  in  the  final  publication.  For  more  
complete  descriptions  of  the  findings,  please  refer  to  the  publications  themselves.  
  
4.1  Background:  Long-read  based  structural  variant  detection  in  breast  cancer   
Within  the  field  of  cancer  genomics,  dramatic  improvements  in  the  throughput  and  cost  of  
whole-genome  sequencing  (WGS)  and  whole-exome  sequencing  (WES)  over  the  past  decade  
have  made  these  technologies  increasingly  important  in  cancer  studies,  opening  the  door  to  
widespread  sequencing  of  patients,  and  the  advancement  of  precision  and  personalized  
medicine.  Within  the  Cancer  Genome  Atlas  Project 139 ,  the  International  Cancer  Genome  
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Consortium 140 ,  the  Hartwig  Medical  Foundation 141 ,  and  other  large-scale  efforts,  several  
thousands  of  tumors  have  been  sequenced  using  short-read  Illumina  sequencing  across  dozens  
of  major  cancer  types.  These  studies  have  had  a  tremendous  impact  in  cancer  genomics,  
leading  to  the  discovery,  for  example,  of  different  signatures  and  mutation  rates  across  cancer  
types,  and  new  insights  into  the  clonal  structural  and  evolution  of  tumors 142–144 .  
However,  despite  these  advances,  we  still  struggle  to  identify  and  understand  the  genetic  
alterations  in  cancer.  A  major  factor  contributing  to  this  difficulty  is  that  the  known  mutations  
have  chiefly  been  detected  using  short-read  Illumina  sequencing 12 .  This  technology  is  very  
effective  for  identifying  single  nucleotide  variants  (SNVs)  and  large  copy  number  variants  (CNVs,  
especially  those  100kb  or  larger),  however,  several  studies  have  found  it  has  poor  accuracy  for  
structural  variant  (SV)  detection 26 .  These  SVs,  typically  defined  as  variants  of  50  bp  or  larger,  
where  sequence  is  added,  removed,  or  rearranged  in  the  genome,  are  difficult  to  detect  with  
short-read  lengths.  Short-read  Illumina  sequencing  is  difficult  to  map  across  SV  breakpoints,  
especially  insertions  that  are  not  present  in  the  reference  genome,  where  the  reads  may  not  
map  to  the  reference  genome  at  all  (refer  to  Chapter  1.3  for  an  overview  of  SV  detection  
strategies  for  short  reads).  As  described  in  Chapter  2,  even  when  we  can  assemble  these  
insertions  from  short-reads,  they  often  cannot  be  subsequently  placed  back  into  their  genomic  
context.  This  is  due  to  the  fact  that  SVs  are  frequently  flanked  by  repetitive  sequences,  which  
means  de  novo  assembly  techniques  fail  to  capture  these  novel  sequences  as  well 25 .  
Consequently,  short-read  analysis  approaches  systematically  fail  to  detect  SVs,  with  false  
negative  and  false  positive  rates  above  50% 41 .  As  a  result,  we  are  facing  a  major  limitation  with  
short-read  sequencing  studies  of  cancer  where  the  field  has  systematically  missed  many  
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important  variants,  potentially  making  it  blind  to  entire  classes  of  inherited  genetic  risk  factors  
and  blind  to  how  SVs  may  mediate  cancer  progression  and  patient  survival.  
New  long-read,  single  molecule  sequencing  technologies  from  Pacific  Biosciences  (PacBio)  and  
Oxford  Nanopore  Technologies  (ONT)  have  been  shown  to  more  reliably  identify  SVs  with  
substantial  improvements  to  both  sensitivity  and  specificity.  Reports  by  several  groups  have  
found  a  typical  healthy  human  genome  contains  approximately  twenty  thousand  SVs,  and  that  
they  can  be  detected  with  95%  or  greater  sensitivity  and  specificity  with  long-reads 26,27,145 .  These  
variants  are  especially  important  to  accurately  identify  for  somatic  mutations  that  are  not  in  
linkage  disequilibrium  with  any  nearby  SNVs.  Long-reads  can  also  improve  the  detection  of  SNVs  
and  smaller  insertion/deletion  (indel)  variants,  especially  in  repetitive  sequences  and  other  
sequences  that  are  poorly  resolved  by  short-reads 146,147 .  Notably,  748  genes  have  been  identified  
that  are  inaccessible  to  short-read  sequencing 146 ,  including  193  medically-relevant  genes  with  at  
least  1  exon  that  cannot  be  sequenced  with  short-reads,  but  are  accessible  to  long-reads 9,148 .  
Recent  work  in  cancer  genetics  led  to  one  of  the  first  reports  using  PacBio  long-read  sequencing  
to  study  SVs  in  a  cancer  cell  line  genome  and  found  that  long-reads  could  detect  tens  of  
thousands  of  variants  that  had  been  missed  by  short-reads 26,149 .  This  work  examined  a  Her2  
amplified  breast  cancer  cell  line,  SK-BR-3,  detected  over  20,000  variants  above  50bp  in  length  
using  long  reads.  In  addition  to  detecting  a  vast  number  of  variants,  variants  in  known  cancer  
genes  were  detected  including  a  complex  variant  in  the  HER2  gene,  and  variants  in  APOBEC3B  
and  CDH1,  as  well  as  dozens  of  novel  gene  fusions  and  other  complex  rearrangements  that  had  
substantially  altered  the  expression  and  regulation  of  genes  in  the  cell.  This  work  demonstrated  
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that  these  mid-sized  variants  are  of  huge  import  in  cancer,  that  they  are  quite  prevalent,  and  
had  gone  previously  undetected  due  to  the  limitations  of  short  reads.   
  
4.2  Structural  variant  discovery  in  breast  cancer  patient  organoids  
We  have  performed  a  similar  analysis  to  the  previous  SK-BR-3  study  on  two  tumor  organoid  
samples  and  a  matched  normal  sample  from  two  breast  cancer  patients,  sequenced  with  Oxford  
Nanopore,  and  the  resulting  analyses  are  now   published  in  Genome  Research 150 .  
  
We  utilize  several  tools  designed  for  long  read  analyses  to  call  structural  variants  within  the  
samples:  
● NGM-LR 26 ,  a  long  read  aligner  
● Sniffles 26 ,  a  variant  caller,  designed  to  work  on  alignments  produced  by  NGM-LR  
● Iris  ( https://github.com/mkirsche/Iris ),  which  was  formerly  a  module  of  CrossStitch,  
( https://github.com/schatzlab/crossstitch )  to  refine  variant  call  breakpoints  and  
insertion  sequences  by  performing  local  assemblies  around  the  variant  call  regions  
This  pipeline  produces  a  set  of  variant  calls,  which  can  then  be  filtered  by  considering  the  
number  and  percentage  of  reads  supporting  the  variant,  an  output  of  Sniffles.  This  allows  for  
either  filtering  of  highly  confident  variants,  or  only  variants  which  appear  to  be  homozygous.  
We  used  this  pipeline  to  analyze  PacBio  and  Oxford  Nanopore  data  from  two  patient-  derived  
tumor  organoid  samples,  and  Nanopore  sequencing  of  normal  tissue  from  the  same  patient.  We  
additionally  examined  Illumina  (10X  Genomics)  short-read  data  to  compare  the  variants  which  
can  be  detected  via  long  and  short  reads.   
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To  perform  the  variant  calling,  and  compare  with  Illumina  short-read  variant  calls,  we  utilized  an  
ensemble  of  methods  to  infer  all  types  of  SVs  at  least  50bp  in  size,  including  insertions,  
deletions,  inversions,  translocations,  and  duplications.  For  both  ONT  and  PacBio  datasets  we  
used  two  state-of  the  art  methods  Sniffles 26   and  PBSV  
( https://github.com/PacificBiosciences/pbsv ),  and  for  Illumina/10X  dataset  we  used  6  SV  
inference  methods,  with  3  (Lumpy 14 ,  Manta 16 ,  and  SvABA 151 )  designed  for  regular  paired-end  
short  Illumina  reads,  and  3  (NAIBR 152 ,  GrocSVS 153 ,  and  LongRanger 154 )  which  also  utilize  the  
single-molecule  10X  Genomics  barcode  information.  We  then  iteratively  merged  SVs  using  the  
SURVIVOR 155   package,  first  merging  calls  from  all  SV  detection  methods  for  each  sequencing  
technology  separately,  and  then  merging  across  sequencing  technologies  to  obtain  
sample-specific  SV  callsets  (Figure  4.1a).  
  
Since  SVs  inferred  from  paired-end  short-reads  are  notorious  for  high  rates  of  false  
positives 19,20,26 ,  for  the  Illumina/10X  dataset  we  only  considered  SVs  supported  by  at  least  2  
methods.  To  mitigate  false  positives  in  the  long-read  SV  calls  we  only  report  SVs  that  were  
supported  by  at  least  one  quarter  of  the  average  alignment  read-depth  in  either  ONT  or  PacBio  
datasets.  During  the  merging,  we  optimize  parameters  to  minimize  the  effects  of  small  
thresholding  issues,  such  as  a  variant  present  in  10  reads  in  one  sample,  and  hence  called  as  a  
variant,  but  only  9  reads  in  other,  and  hence  not  called.  Our  results  indicate  a  very  strong  
concordance  between  SVs  inferred  with  ONT  and  PacBio.  Between  90%  and  95%  of  variants  
called  in  at  least  one  of  the  long-read  data  types  were  supported  by  both,  with  slightly  lower  
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concordance  between  PacBio-only  calls  (Figure  4.1b).  We  observe  that  while  more  than  50%  of  
SVs  inferred  from  short-read  data  were  also  identified  by  long-reads,  the  total  quantity  of  SVs  
inferred  from  short-reads  is  approximately  4  times  less  than  for  either  of  the  long-read-based  
inferences.   
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Figure  4.1  |  Structural  variation  inference  across  sequencing  platforms  for  a  patient  sample.  Patient  sample  51  was  sequenced 
with  Illumina/10XG,  ONT,  and  PacBio.  a)  Ensemble  worfklow  for  SV  inference,  with  multiple  methods  and  technologies  used  to  
infer  SVs,  subsequent  merging  of,  first  method-specific  results,  and  then  technology-specific  results,  with  size  and  support  
restrictions  applied.  b)  SV  inference  comparison  across  SVs  inferred  from  Platform  (x)  sequencing  experiments,  where  Platform 
corresponds  to  sequencing  technology,  and  (x)  determines  the  average  alignment  read-depth  coverage  in  the  tumor  sample.  
Methods-specific  breakdown  is  provided  for  every  sequencing  technology.  SVs  detected  in  the  normal  sample  are  in  
parentheses.  
For  patient  51  for  which  we  sequenced  both  the  tumor  and  the  matching  normal  cells  we  
observed  that  77%  (20,388/26,148)  of  the  SVs  identified  in  the  tumor  sample  were  also  
identified  in  the  matching  normal  sample  (Figure  4.1b).  A  high  fraction  of  SVs  present  both  in  
the  cancer  and  in  the  normal  cells  is  expected  since  the  cancer  cells  originate  from  normal  
tissue.  Cancer  cells,  however,  will  generally  acquire  new  mutations  resulting  in  the  addition  of  
nearly  6,000  variants,  although  large  deletions  and  loss-of-heterozygosity  can  potentially  
decrease  the  count  of  inherited  SVs 47 .  We  also  observe  that  for  SVs  called  exclusively  by  
short-reads  only  ∼11%  (291/2,683)  of  SVs  inferred  in  the  tumor  were  also  present  in  the  
matching  normal  cells.  This  is  several  fold  less  than  for  SVs  inferred  both  exclusively  with  
long-reads  (88%),  and  with  both  long  and  short-reads  (97%),  and  we  attribute  this  discrepancy  
to  a  high  false  positive  rate  in  short-read  SV  inference.  
 
To  better  understand  the  level  of  patient-specific  and  shared  germline  SVs,  both  in  observed  
patients  and  the  SK-BR-3  cancer  cell-line,  we  compared  SVs  inferred  with  multiple  sequencing  
technologies  in  the  presented  study  to  SVs  identified  in  15  healthy  human  genomes  sequenced  
with  PacBio  long-reads  presented  in  the  recent  study  by  Audano  et  al 27 .  We  find  a  high  level  of  
agreement  between  the  SVs  themselves  and  the  distributions  of  their  breakends  locations  
identified  in  the  cancer  samples  and  the  healthy  samples  (Figure  4.2).  We  observe  that  2,577  of  
the  tumor-only  SVs  in  patient  51  are  present  in  other  observed  healthy  samples  and  we  thus  
hypothesize  that  many  of  them  are  actually  present  in  the  normal  cells  of  patient  51,  and  the  
inability  to  infer  them  in  normal  cells  stems  from  the  lack  of  coverage  in  the  ONT  and  the  
absence  of  PacBio  long-read  sequencing  of  the  normal  sample.  This  conjecture  is  supported  by  
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the  comparison  of  SV  types  exclusively  inferred  with  different  long-read  sequencing  
technologies,  since  the  vast  majority  (1,806/2,577)  are  insertions,  with  ∼70%  having  lengths  of  
50-200  bp.  More  accurate  basecalling  and  better  SV-genotyping  algorithms  can  help  address  
this  limitation  in  the  future.  
  
 
While  all  variants  in  the  sample  were  catalogued,  we  focused  further  on  variants  in  genes  
known  to  be  cancer  related  as  part  of  the  COSMIC  gene  set.  On  average,  more  than  twice  as  
many  SVs  (622)  affect  COSMIC  census  genes  as  the  genes  being  affected  (237)  in  51T.  The  
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Figure  4.2  |  Structural  Variations  in  samples  51T(N),  48T,  SK-BR-3,  and  in  Audano  et  al   27   dataset.  Circos  plot  on  the  left  shows  
the  SVs  breakends  distributions  across  genome  chromosomes.   Every  track  is  dataset-specific  shows  the  total  number  of  SVs’  
breakends  over  5MB  segment-length  windows.  Panel  on  the  right  shows  intersection  of  SVs  across  observed  cancer  datasets  
(with  matching  normal  SVs  shown  in  parentheses)  and  the  healthy  SV  set  generated  from  15  samples  from  Audano  et  al .  
majority  (199/237)  of  the  SV-affected  COSMIC  census  genes  in  patient  51  were  affected  both  
the  tumor  and  matching  normal  cells,  and  furthermore,  a  majority  (466/622)  of  SVs  affecting  
COSMIC  census  genes  were  also  present  in  both  the  tumor  and  the  matching  normal  cells.  
Long-read  based  SV  inference  identified  five  times  as  many  COSMIC  census  genes  affected  by  
SVs  and  SVs  affecting  COSMIC  census  genes  than  was  possible  to  infer  with  short-reads.  
Furthermore,  the  lack  of  concordance  between  SVs  inferred  exclusively  with  short-reads  
between  the  tumor  and  normal  samples  (6/79)  provides  additional  evidence  that  the  short-read  
SV  calling  is  error-prone.  In  both  patient  48  and  the  SK-BR-3  cell  line  we  observed  similar  results  
with  long-read  SV  inference  outperforming  short-read  SV  inference  in  both  the  number  of  
COSMIC  census  genes  affected,  as  well  as  the  number  of  SVs  affecting  them.  Although  these  
COSMIC  affecting  SVs  may  be  of  relevance  to  breast  cancer,  of  the  622  SVs,  it  is  likely  many  are  
present  in  healthy  individuals  as  well.  To  explore  this  further,  short-read  WGS  datasets  are  
needed,  as  there  are  not  enough  samples  available  to  perform  any  meaningful  analyses  of  
which  variants  may  be  cancer  associated.  
  
4.3  Development  of  Paragraph:  a  short-read  structural  variant  genotyper  
While  structural  variant  discovery  in  long  reads  is  able  to  discover  tens  of  thousands  of  novel  
structural  variants,  human  long-read  WGS  samples  are  still  being  produced  slowly.  To  date,  no  
single  human  dataset  of  more  than  15  long-read  sequenced  individuals  is  readily  available,  
though  Iceland  has  sequenced  1,817  genomes  with  long  reads  which  are  not  publicly  
available 28 ,  and  the  Human  Pangenome  Consortium  is  aiming  to  sequence  350  genomes,  but  is  
still  in  its  pilot  phase  ( https://humanpangenome.org/ )  of  sequencing  an  initial  10  genomes.  The  
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long-read  sequenced  samples  that  are  accessible  are  almost  entirely  of  healthy  individuals 27,29 .  
Meanwhile,  a  plethora  of  short-read  samples  exist  for  many  disease  phenotypes  including  
breast  cancer,  as  well  as  many  additional  healthy,  diverse  genomes,  such  as  the  1000  Genomes  
Project 19 ,  which  recently  re-sequenced  their  2,504  samples  with  high  coverage  Illumina  data.   
 
While  variant  discovery  in  these  short-read  samples  would  result  in  a  high  false  positive  rate,  if  
we  search  for  only  a  specific  subset  of  variants,  rather  than  undertaking  a  broad  search  across  
all  locations,  this  false  positive  rate  can  be  dramatically  reduced.  Rather  than  calling  all  variants,  
we  can  instead  aim  to  genotype  variants  we  suspect  may  be  present.  To  determine  the  set  of  
variants  to  genotype,  we  leverage  the  growing  number  of  long-read  samples  being  sequenced  
to  discover  structural  variants,  and  then  can  use  a  genotyping  tool,  Paragraph 156 ,  to  call  these  
variants  in  additional  samples,  and  leverage  the  statistical  power  of  having  large  cohorts,  
particularly  to  determine  if  a  variants  are  present  significantly  higher  frequencies  in  disease  
cohorts  vs  healthy  cohorts  or  not,  an  exercise  which  is  impossible  with  only  one  of  two  disease  
samples  when  using  long  reads  alone.  
  
We  have  been  actively  involved  in  the  development  of  Paragraph,  collaborating  with  the  team  
at  Illumina  leading  the  project.  Paragraph  uses  a  graph  based  method,  where  the  variant  is  
encoded  in  a  graph,  and  then  short  reads  aligning  to  the  region  with  the  variant  are  re-aligned  
to  the  graph.  If  they  align  uniquely  to  either  the  graph  path  with  the  variant  or  without  the  
variant,  the  read  is  considered  for  genotyping.  To  test  recall  of  insertion  and  deletion  
genotyping,  we  calculated  the  genotyping  performance  using  sequencing  data  and  SVs  from  the  
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individual  HG002  (also  known  as  NA24385)  from  Genome  in  a  Bottle  (GIAB) 98,157 .  We  used  the  
short-read  sequence  data  to  run  Paragraph  as  well  as  other  methods,  and  used  SVs  from  
long-read  sequence  data  as  the  ground  truth.  The  short-read  data  was  generated  on  an  Illumina  
HiSeqX  system  to  34.5-fold  depth  using  150bp  paired-end  reads.  The  long-read  data  was  
generated  on  a  Pacific  Biosciences  (PacBio)  Sequel  system  using  the  Circular  Consensus  
Sequencing  (CCS)  technology 158 ,  to  28-fold  coverage  with  average  read  length  of  13,500  bp.  
Previous  evaluations  showed  high  recall  (0.91)  and  precision  (0.94)  for  SVs  called  from  PacBio  
CCS  HG002  against  the  GIAB  benchmark  dataset 98,158 ,  indicating  SVs  called  from  CCS  data  can  be  
effectively  used  as  ground  truth  to  evaluate  the  performance  of  SV  genotypers  and  callers.  This  
long-read  ground  truth  (LRGT)  set  of  SVs,  all  of  which  are  expected  to  be  present  in  HG002,  
includes  8,355  deletions  and  8,956  insertions.  Using  this  LRGT  set,  we  estimated  the  
performance  of  Paragraph  and  two  widely-used  SV  genotypers,  SVTyper 159   and  Delly  
Genotyper 15 ,  as  well  as  three  methods  that  independently  discover  SVs  (i.e.  de  novo  callers),  
Manta 16 ,  Lumpy 14   and  Delly 15 .  Measured  against  the  LRGT  calls,  Paragraph  has  the  highest  recall  




Table  4.1  |  Recall  for  different  genotypers  and  de  novo  callers  measured  against  HG002  LRGT.  
   
Type  





(100+  bp)  
Manta  
Lumpy  
(100+  bp) 
Delly  
(100+  bp) 
   Paragraph  Manta  
#  Tested  SVs  8,355  8,355  5,372  8,355  5,372  5,372     8,956  8,956  
Recall  0.82  0.68  0.35  0.45  0.36  0.21     0.82  0.33  
Run  time  (min) 11  39  16  840*  280  116     14  840*  
Genotyping/calling  was  evaluated  using  a  dataset  of  HG002  with  150  bp  paired-end  reads  sequenced  to  34.5-fold  depth  on  an  
Illumina  HiSeqX.  Run  time  is  shown  for  this  data  processed  on  an  Intel  Xeon  E5-2670  2.6GHz  eight-core  CPUs.  Note  that  SVTyper, 
Lumpy,  and  Delly  are  limited  to  deletions  100bp  or  larger  so  have  fewer  tested  SVs  than  the  other  methods.  
* Total  run  time  for  Manta  was  840  minutes  for  deletions  and  insertions  combined.  
However,  this  test  case  measuring  recall  does  not  represent  the  primary  use-case  of  Paragraph;  
to  genotype  variants  discovered  in  one  sample  in  a  different  short-read  sample.  Applying  
Paragraph  to  a  sample  using  SVs  identified  from  a  large  population  will  also  include  genotyping  
variants  that  are  not  present  in  the  test  sample.  To  aid  in  the  improvement  of  the  beta  version  
of  Paragraph  we  provided  our  Illumina  collaborators  with  a  test  data  set  where  we  considered  
SVs  identified  from  a  second  sample,  ENC002,  that  was  sequenced  on  PacBio  RS  II  platform  as  
part  of  the  ENCODE  project 160 .   
 
SVs  were  called  from  the  PacBio  CCS  and  CLR  data  using  the  long  read  SV  caller,  Sniffles 26   with  
parameters  “--report-seq  -n  -1”  to  report  all  supporting  read  names  and  insertion  sequences.  
Additional  default  parameters  require  10  or  more  variant  supporting  reads  to  report  a  call,  and  
require  variants  be  at  least  50  bp  in  length.  Insertion  calls  were  refined  using  the  insertion  
refinement  module  of  CrossStitch  ( https://github.com/schatzlab/crossstitch ),  which  has  since  
been  released  as  a  separate  program,  Iris  ( https://github.com/mkirsche/Iris )  developed  by  
Melanie  Kirsche.  The  module  uses  FalconSense,  an  open-source  method  originally  developed  
for  the  Falcon  assembler 161   and  used  as  the  consensus  module  for  Canu 162 ,  to  determine  a  
consensus  sequence  for  insertions  from  variant  supporting  reads,  as  Sniffles  just  reports  the  
sequence  taken  from  a  single  read.  CrossStitch/Iris  also  performs  breakpoint  refinement  on  the  
variant  calls,  by  aligning  the  consensus  insertion  sequence  back  to  the  reference  region.  
  
Confident  reference  positions  were  defined  using  SVs  from  CLR  ENC002  and  CCS  HG002.  If  a  
deletion  is  only  observed  in  ENC002  and  no  deletion  is  observed  500  bp  upstream  or  
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downstream  in  HG002  with  at  least  3  supporting  reads,  this  deletion  is  defined  as  a  confident  
reference  position  in  HG002.  Similarly,  if  an  insertion  is  only  observed  in  ENC002  and  there  is  no  
insertion  observed  in  upstream  or  downstream  200  bp  regions  in  HG002  with  at  least  3  
supporting  reads,  or  there  is  an  insertion  in  HG002  within  200  bp  but  their  insertion  sequences  
are  than  25%  concordant,  this  insertion  is  defined  as  a  confident  reference  position  in  HG002  
(Figure  4.3).  The  precision  of  Paragraph  and  other  genotypers  was  then  estimated  by  
genotyping  these  confident  reference  positions  in  the  short-read  HG002.  For  each  genotyper,  
the  recall  was  calculated  as  the  fraction  of  SVs  in  LRGT  that  were  genotyped  as  non-reference,  
or  the  fraction  of  true  positions  (TP).  The  precision  was  estimated  as  the  fraction  of  confident  
reference  positions  that  were  genotyped  as  reference  genotypes.  The  confident  reference  
positions  that  were  genotyped  as  non-reference  are  the  false  positions  (FP).  Thus,  the  precision  





Figure  4.3  |  The  scheme  of  building  
LRGT  and  confident  reference  positions.  
We  define  SVs  called  from  CCS  HG002  as  
LRGT.  We  define  SVs  that  were  only  
called  in  CLR  ENC002  and  have  no  
same-type  SVs  called  in  the  nearby  
region  of  CCS  HG002  as  confident  
reference  positions.  On  short-read  
HG002,  LRGT  was  used  to  calculate  recall  
for  genotypers  and  de  novo  callers’  
recall,  while  confident  reference  
positions  were  used  to  calculate  
genotypers’  precision.  Genotypers’  
precision  and  F-score  were  estimated  
from  LRGT  and  confident  reference  
positions  together.  
Incorporating  the  2,366  deletions  and  2,855  insertions  that  occur  in  ENC002  but  not  HG002,  the  
precision  for  Paragraph  was  estimated  as  0.92  for  deletions  and  0.90  for  insertions  (Table  4.2).  
Notably,  the  precision  for  deletions  was  0.10  higher  than  that  of  Delly  Genotyper  (0.80).  
SVTyper  is  limited  to  deletions  longer  than  100bp,  and  when  estimating  precision  just  on  the  
deletions  longer  than  100bp,  Paragraph  has  a  slightly  lower  precision  (0.96)  than  SVTyper  (0.98)  
though  the  recall  is  much  higher  for  Paragraph  (0.89  vs  0.35).  Combining  recall  and  precision,  
Paragraph  has  the  highest  F-score  for  deletions  in  all  of  the  tested  genotypers  (0.89  vs  0.78  for  
Delly  Genotyper  and  0.52  for  SVTyper),  and  also  has  a  high  F-score  for  insertions  (0.89).  Nearly  
all  (97%)  of  false  positive  (FP)  deletions  and  the  majority  (78%)  of  FP  insertions  are  completely  
within  TRs.  Of  the  48  FP  insertions  that  are  outside  of  TRs:  32  have  one  or  more  indels  (longer  
than  10  bp)  in  the  target  region;  9  have  two  or  more  supporting  reads  for  the  insertion  in  
HG002  CCS  data  and  those  could  be  false  negatives  in  SV  calling  from  the  CCS  data;  7  have  no  
evidence  of  variants  in  the  CCS  alignments  in  the  target  region,  and  these  FPs  likely  come  from  
alignment  artifacts  in  short-read  mapping.  
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Table  4.2  |  Overall  performance  for  different  genotypers.  
  
The  recall  was  evaluated  on  an  Illumina  HiSeqX  sequenced  HG002  data  using  LRGT  (same  as  in  Table  
4.1).  Specificity  was  evaluated  on  the  same  Illumina  HiSeqX  data  using  confident  reference  positions.  
4.4  Genotyping  variants  of  interest  in  large  short-read  cohorts  with  Paragraph  
Breast  cancer  patient  organoid  variant  genotyping  
To  assess  the  population  frequency  of  the  COSMIC  affecting  breast  cancer  organoid  structural  
variants,  we  genotyped  identified  SVs  affecting  COSMIC  genes  from  the  three  analyzed  cancer  
samples  with  Paragraph 156   in  the  dataset  of  2,504  short-read  WGS  samples  from  the  recent  
re-sequencing  of  the  1000  genomes  project  (1KGP)  samples 19 .  Paragraph  genotypes  SVs  by  
constructing  localized  sequence  graphs  containing  the  reference  allele  and  the  candidate  SV  
allele  and  performs  a  localized  realignment  of  paired-end  short  reads  to  the  graph.  The  
genotype  is  then  determined  based  on  the  coverage  of  reads  uniquely  supporting  the  reference  
or  variant  allele  breakpoints.  Not  all  variants  can  be  genotyped  by  Paragraph  in  all  samples,  
resulting  in  no  genotype  call  when  support  is  ambiguous,  so  we  consider  only  SVs  that  




Table  4.3  |  Genotyping  of  COSMIC  gene  affecting  SVs  in  1KGP  and  Audano  et  al  datasets.   
Sample  
  




Number  of  SVs 
in  COSMIC  
genes  [l|s]  
  
  
1KGP  genotyping  [l|s]  Not  in  Audano  et  
al  union  SV  callset  
&  <0.1%  in  1KGP 
  
GT  in  >1k  
individuals  <  5%  <  1%  <  0.1%  
51T  26,148  
[23,465  |  5,941] 
622  




[185  |  25]  
144  
  [143  |  17]  
112  
  [111  |  13]  
30  
[29  |  9]  
48T  21,333  
[21,333  |  NA]  
467  




[188  |  NA]  
156  
[156  |  NA]  
124  
[124  |  NA]  
45  
[45  |  NA]  
SKBR3  20,783  
[19,316  |  4,799] 
564  




[213  |31]  
194  
[192  |  25]  
185  
[183  |  23]  
121  
[119  |  19]  
For  every  observed  tumor  sample,  we  report  the  total  number  of  identified  SVs,  the  number  of  SVs  directly  affecting  known  
COSMIC  census  genes,  and  the  number  of  COSMIC  gene  affecting  SVs  that  were  successfully  genotyped  (i.e.,  called  in  at  least  
1000  samples)  in  1KGP  WGS  short-read  dataset  with  frequencies  of  <5%,  <1%,  and  <0.1  %  respectively.  For  the  rarest  (i.e.,  
<0.1%  in  1KGP)  SVs  report  the  number  of  such  SVs  that  missing  in  the  Audano  et  al  union  SV  set.  For  every  reported  SVs  count  x 
we  also  show  the  numbers  [l|s]  of  how  many  of  the  SVs  in  x  were  inferred  by  long  (l)  or  short  (s)  reads,  respectively.   
We  then  summarize  rare  variants  identified  in  <5%,  <1%,  and  <0.1%  of  the  overall  observed  
samples  (Table  3).  We  note  that  Paragraph  v2.1  cannot  genotype  inversions,  translocations,  and  
large  duplications,  and  thus  we  exclude  such  SVs  from  the  genotyping  analysis.  SVs  that  were  
rarely  present  in  1KGP  individuals  (i.e.,  <0.01%  frequency)  were  further  filtered  for  variants  
which  were  not  present  in  any  of  the  15  healthy  genomes  from  the  Audano  et  al  study 27 .  We  
show  that  around  1/5  to  1/4  of  the  SVs  we  identified  in  COSMIC  genes  are  genotyped  at  low  
frequency  in  the  1KGP  individuals,  and  about  half  of  these  rarely  genotyped  SVs  are  also  absent  
across  all  of  the  15  healthy  long-read  genomes.  These  cancer  variants  found  at  low-frequency  in  
a  healthy  population  are  thus  the  most  likely  candidates  for  cancer  risk-factor-type  mutations.  
These  variants  of  interest  are  identified  almost  exclusively  with  long-reads,  and  although  
short-read  genotyping  can  help  determine  population  frequency,  the  ability  of  15  long-read  
samples  to  additionally  narrow  the  variants  of  interest  further  underscores  the  need  for  
long-read  sequenced  genomes,  both  with  healthy  and  disease  phenotypes.   
  
Given  our  candidate  set  of  structural  variants  which  are  present  in  several  breast  cancer  
samples,  and  at  low  frequency  in  healthy  individuals  across  populations,  the  natural  question  to  
ask  is  if  these  variants  are  cancer-associated.  With  only  three  samples,  we  are  unable  to  
determine  if  these  variants  are  present  at  a  significantly  higher  frequency  in  breast  cancer  than  
expected  without  examining  their  frequency  in  a  larger  breast  cancer  cohort.  The  Hartwig  
Medical  Foundation  (HMF)  and  The  Cancer  Genome  Atlas  (TCGA)  both   have  hundreds  of  breast  
cancer  short-read  WGS  samples  available.  By  using  a  large  breast  cancer  patient  cohort  to  
genotype  our  discovered  LR  variants,  we  will  gain  the  ability  to  perform  statistical  analyses  
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between  a  large  healthy  cohort  like  1KGP  and  a  large  breast  cancer  cohort.  Assuming  variants  
could  be  found  which  differ  significantly  in  frequency  between  the  healthy  1KGP  cohort  and  the  
HMF  and/or  TCGA  breast  cancer  sample  cohort,  genes  and  gene  networks  can  be  examined  to  
see  if  there  is  a  clear  potential  mechanism  that  might  indicate  the  variant  is  causal.  RNA-seq  
data  available  for  a  subset  of  these  samples  could  be  utilized  to  determine  if  the  SVs  seem  to  be  
having  a  functional  effect,  as  well.  This  area  of  future  work  will  be  useful  for  gaining  more  
insight  into  association  of  SVs,  rather  than  just  discovering  and  narrowing  candidates  of  interest,  
as  we  have  done  using  the  breast  cancer  organoid  samples.  These  techniques  could  of  course  
be  extended  to  other  cancer  types  as  well,  so  a  small  number  of  LR-sequenced  cancer  samples  
can  be  utilized  in  conjunction  with  Paragraph  and  pre-existing  short-read  cancer  and  healthy  
samples.  
  
Rare  Mendelian  disorder  variant  discovery  and  genotyping  
Another  area  in  which  we  are  utilizing  Paragraph  is  in  an  examination  of  several  families  with  
rare  Mendelian  disorders.  Two  families  appear  to  have  X-linked  disorders,  based  on  the  pattern  
of  inheritance  in  the  pedigrees  (Figure  4.4).  Affected  individuals  in  family  1  experience  a  severe  
slowly  degenerative  muscular  myopathy,  and  six  individuals  have  been  sequenced  with  ONT  
reads,  four  affected  and  two  unaffected  males.  The  depth  of  sequencing  coverage  varies,  but  is 
approximately  20-30x  per  individual.  Family  2  affected  individuals  experience  a  cleft  palate  and  
underdeveloped  facial  structure  phenotype.  As  affected  individuals  in  family  2  do  not  often  
make  it  past  childhood,  sequencing  data  is  more  limited.  We  have  ONT  data  from  one  affected  










Figure  4.4  |  Pedigrees  of  two  ONT-sequenced   families  with  rare  mendelian  disorders.  (A)  Family  1  has  a  slowly  degenerative  
muscular  myopathy  that  appears  to  be  X-linked,  as  it  only  affects  males.  Six  males  in  the  family,  four  affected,  and  two  
unaffected,  have  been  sequenced  with  ONT  to  ~20-30x  coverage.  (B)  Family  2  exhibits  a  cleft  palate  disorder,  and  also  appears  
to  have  an  X-linked  inheritance  pattern.  An  unaffected  (carrier)  mother  and  her  affected  son  have  been  sequenced  with  long  
reads.  Additional  DNA  from  an  affected  male  is  available  to  perform  PCR  validations,  but  not  sequencing.  
other  affected  individual  in  the  family,  however,  there  is  not  enough  sample  to  sequence  --  it  is  
being  reserved  for  validation  experiments,  if  needed.   
  
Alignment  with  NGM-LR  and  variant  calling  with  Sniffles 26   was  performed  on  the  sequenced  
individuals,  using  the  same  methods  described  in  Chapter  4.2  and  Aganezov  et  al  2020 150   to  
produce  both  sensitive  and  specific  call  sets.  SVs  of  individuals  within  families  were  then  
compared  to  find  SVs  common  to  affected  individuals  but  absent  from  unaffected  individuals. 
Once  these  SVs  were  identified,  they  were  further  screened  against  both  individuals  in  the  other  
family,  and  the  SVs  called  from  Audano  et  al  2019 27 ,  initially  using  SURVIVOR 163   (as  described  in  
Chapter  4.2).  In  this  family-based  analysis,  where  very  few  variants  are  expected  between  family  
members,  especially  the  mother  and  son  in  Family  2,  it  quickly  became  evident  that  small  issues  
with  SURVIVOR’s  merging  algorithm  were  presenting  problems;  variants  were  both  being  
merged  erroneously  (for  example,  when  variants  were  different  sizes  but  in  nearby  locations)  or  
erroneously  left  unmerged.  To  mitigate  this,  the  merging  tool  Jasmine  has  been  developed,  led  
by  Melanie  Kirche  ( https://github.com/mkirsche/Jasmine ,  paper  forthcoming).  Switching  from  
SURVIVOR  to  Jasmine  produced  additional  candidate  variants,  such  as  a  35  bp  intronic  deletion  
in  Family  1  in  the  MTM1  gene  on  the  X  chromosome,  a  gene  with  other  variants  known  to  be  
related  to  myopathy.  This  variant  had  not  initially  passed  screening,  because  a  450  bp  deletion  
exists  in  other,  non-family  1  long  read  samples  that  overlaps  the  smaller  deletion’s  location  
(Figure  4.5).  Having  a  merging  tool  such  as  Jasmine,  which  accounts  for  not  just  location,  but  
size  and  type  of  a  variant,  is  crucial  to  uncovering  potentially  disease  related  variants,  as  








Figure  4.5  |  MTM1  deletion  candidate  overlaps  larger  deletion  in  healthy  individuals.  (A)  A  ~35  bp  deletion  is  present  in  the  
four  affected  individuals  (rows  1,2,4,5)  in  Family  1  and  in  neither  of  the  unaffected  individuals  (rows  3,6).  (B)  A  ~450  bp  deletion  
overlapping  the  coordinates  is  present  in  several  healthy  individuals  (matching  coordinates  indicated  by  vertical  lines  in  (A)  and  
(B).  This  demonstrates  the  need  for  careful  merging  of  SVs  in  filtering  analyses.   
We  then  used  Paragraph  to  screen  the  candidate  X  chromosome  variants  from  both  families  in  
the  1KGP  cohort,  using  the  same  method  as  for  the  breast  cancer  patient  structural  variants.  
Although  several  candidate  variants  in  each  family  had  low  frequency  in  the  1KGP  cohort,  and  
were  present  only  in  affected  individuals,  thus  far  no  candidate  variant  has  segregated  as  
expected  when  examined  by  PCR  amplification  in  the  families,  where  individuals  without  long  
read  sequencing  data  were  included  in  the  PCR  based  validation.  (These  analyses  were  
performed  by  our  collaborator,  Nara  Sobreira,  and  members  of  her  lab,  who  also  recruited  the  
families  in  the  study  and  have  procured  samples  as  needed.)  This  work  is  ongoing,  and  we  hope  
that  as  we  continue  to  fine-tune  and  improve  our  variant  calling,  merging,  and  large  cohort  
screening  pipeline,  that  we  might  discover  a  disease-associated  variant  either  in  these  or  
additional  families.  As  Mendelian  disease  associated  variants  have  been  discovered  recently  
using  long  read  sequencing 92,164–166 ,  we  are  hopeful  that  overall  this  strategy  will  prove  to  be  
effective,  even  if  a  large  SV  is  not  ultimately  the  culprit  in  these  two  particular  families.  
  
  
   
104  
Conclusions  
For  many  years  scientists  have  understood  that  considering  more  than  just  a  single  
representative  genome  can  help  identify  genes  and  phenotypically  consequential  variants  in  
bacterial  and  plant  species.  However,  in  human  studies,  nearly  all  analyses  still  begin  by  aligning  
sequence  data  from  a  subject  or  a  set  of  subjects  to  the  human  reference  genome,  discarding  
sequences  that  do  not  align.  Considering  more  than  just  a  single  reference  genome  is  necessary  
if  we  are  to  link  more  phenotypes  of  interest  to  their  causal  variants.  From  the  work  presented  
in  this  thesis  as  well  as  from  other  recent  studies,  we  now  know  that  populations  across  the  
globe  contain  many  thousands  of  DNA  sequences  that  are  not  present  in  the  human  reference 
genome  and  thus  not  examined  in  standard  analyses.  Although  we  are  amassing  a  wealth  of  
pan-genomic  data  in  both  global  and  population-specific  studies,  what  to  do  with  these  data  
remains  an  open  question.  The  creation  of  a  single,  global  human  pan-genome  holds  conceptual  
appeal,  and  cataloguing  all  human  variation  is  a  noble  goal.  However,  to  date  no  computational  
method  is  capable  of  aligning  human  sequences  to  a  pan-genome  of  all  human  variation,  while  
enforcing  that  alignments  be  biologically  plausible,  and  without  introducing  additional  
alignment  ambiguities,  although  these  subjects  are  all  active  research  areas.   
  
Population-specific  pan-genomes  may  prove  more  feasible,  and  multiple  such  projects  such  as 
the  Icelandic  and  Danish  efforts  are  underway.  Developing  additional  linear  reference  genomes  
has  the  benefit  of  representing  a  real  individual,  and  a  linear  representation  does  not  introduce  
variants  that  are  never  seen  together.  Furthermore,  our  ability  to  accurately  assemble  linear  
reference  genomes  is  rapidly  improving:  recently  the  first  telomere-to-telomere  assembly  of  a  
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human  chromosome 125   demonstrated  that  newly  produced  genomes  have  the  potential  to  be  of  
much  higher  contiguity  than  the  current  reference,  and  the  Telomere-to-Telomere  Consortium  
has  since  finished  additional  human  chromosomes.  Long  read  sequencing  has  been  critical  to  
these  efforts,  and  although  long  read  sequencing  is  still  not  the  standard,  it  is  rapidly  growing  in  
use  and  declining  in  cost.  In  addition  to  providing  better  assembly  resolution,  long  reads  provide 
previously  unprecedented  resolution  for  structural  variant  detection,  even  when  using  a  
reference-based  approach.   
  
As  we  have  demonstrated  in  our  analyses  of  several  cancer  organoid  samples,  robust  SV  
detection  is  possible  at  relatively  low  ∼30x  average  read-depth  coverage  with  either  ONT  or  
PacBio  long  read  sequencing  platforms.  When  applied  at  scale,  costs  for  30x  coverage  is  below  
$1000  per  sample  for  ONT  PromethION  and  below  $2,000  for  PacBio  CLR  Sequel  II,  which  is  
highly  comparable  to  ∼$800/$1,000  (Illumina/10XG)  for  short  read  sequencing,  a  good  
indication  that  long  read  sequencing  is  the  way  forward.  However,  the  lower  throughput  nature 
of  single  molecule  sequencing,  and  the  fact  that  new  technologies  are  often  slow  to  be  
approved  and  adopted  for  clinical  use,  makes  hybrid  approaches  utilizing  available  short  read  
and  a  small  amount  of  long  read  data,  appealing  in  the  interim.  Utilizing  graph-based  
genotyping  with  Paragraph,  even  a  small  number  of  long  read  sequenced  samples  are  a  
valuable  resource  to  examine  structural  variants  of  interest  at  a  population  scale.  In  our  
examination  of  several  breast  cancer  patient  samples,  we  initially  discovered  thousands  of  novel  
structural  variants  detected  via  long  read  sequencing,  and  genotyping  in  a  healthy  cohort  
enabled  this  variant  set  to  be  narrowed  significantly.  While  we  wait  for  ONT  and  PacBio  
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technologies  to  become  more  widely  adopted  and  for  the  creation  of  new,  long  read  datasets,  
we  must  utilize  the  data  already  available  to  make  clinically  actionable  discoveries,  now.   
  
Eventually  we  will  be  armed  with  a  plethora  of  long  read  derived,  highly  contiguous,  
near-perfect  quality,  human  reference  genomes,  and  individuals  can  be  analyzed  by  comparing  
them  to  their  closest  matching  population  or  populations,  even  if  this  information  is  not  known  
a  priori.  And  although  the  representations  we  will  ultimately  use  to  align  to  these  genomes  
while  taking  known  variation  into  account  is  still  unclear,  it  seems  inevitable  that  we  will  soon  
move  beyond  our  reliance  on  a  single  human  reference  genome.  We  have  shown  here  that  
hundreds  of  megabases  of  novel  sequence  can  be  found  in  a  modestly  sized  cohort,  that  any  
given  individual  has  on  the  order  of  20,000  structural  variants  from  the  reference  genome  
which  can  only  be  reliably  detected  with  long  reads,  and  that  many  of  these  variants  are  not  just  
within  genes,  but  in  genes  with  known  disease  relevance.  Finding  a  way  to  capture  and  consider  
these  vast  amounts  of  variation  in  the  population  will  be  critical  moving  forward  if  we  are  
ultimately  to  truly  understand  the  genetic  instructions  that  make  us  human.  
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